Skip to main content
Toxics logoLink to Toxics
. 2024 Jan 5;12(1):43. doi: 10.3390/toxics12010043

Binding Affinity and Mechanism of Six PFAS with Human Serum Albumin: Insights from Multi-Spectroscopy, DFT and Molecular Dynamics Approaches

Mingguo Peng 1,2, Yang Xu 2, Yao Wu 2, Xuewen Cai 2, Weihua Zhang 2, Lu Zheng 2, Erdeng Du 2,*, Jiajun Fu 1,*
Editor: Michael Petriello
PMCID: PMC10819430  PMID: 38250999

Abstract

Per- and Polyfluoroalkyl Substances (PFAS) bioaccumulate in the human body, presenting potential health risks and cellular toxicity. Their transport mechanisms and interactions with tissues and the circulatory system require further investigation. This study investigates the interaction mechanisms of six PFAS with Human Serum Albumin (HSA) using multi-spectroscopy, DFT and a molecular dynamics approach. Multi-spectral analysis shows that perfluorononanoic acid (PFNA) has the best binding capabilities with HSA. The order of binding constants (298 K) is as follows: “Perfluorononanoic Acid (PFNA, 7.81 × 106 L·mol−1) > Perfluoro-2,5-dimethyl-3,6-dioxanonanoic Acid (HFPO-TA, 3.70 × 106 L·mol−1) > Perfluorooctanoic Acid (PFOA, 2.27 × 105 L·mol−1) > Perfluoro-3,6,9-trioxadecanoic Acid (PFO3DA, 1.59 × 105 L·mol−1) > Perfluoroheptanoic Acid (PFHpA, 4.53 × 103 L·mol−1) > Dodecafluorosuberic Acid (DFSA, 1.52 × 103 L·mol−1)”. Thermodynamic analysis suggests that PFNA and PFO3DA’s interactions with HSA are exothermic, driven primarily by hydrogen bonds or van der Waals interactions. PFHpA, DFSA, PFOA, and HFPO-TA’s interactions with HSA, on the other hand, are endothermic processes primarily driven by hydrophobic interactions. Competitive probe results show that the main HSA–PFAS binding site is in the HSA structure’s subdomain IIA. These findings are also consistent with the findings of molecular docking. Molecular dynamics simulation (MD) analysis further shows that the lowest binding energy (−38.83 kcal/mol) is fund in the HSA–PFNA complex, indicating that PFNA binds more readily with HSA. Energy decomposition analysis also indicates that van der Waals and electrostatic interactions are the main forces for the HSA–PFAS complexes. Correlation analysis reveals that DFT quantum chemical descriptors related to electrostatic distribution and characteristics like ESP and ALIE are more representative in characterizing HSA–PFAS binding. This study sheds light on the interactions between HSA and PFAS. It guides health risk assessments and control strategies against PFAS, serving as a critical starting point for further public health research.

Keywords: human serum albumin (HSA), per- and polyfluoroalkyl substances (PFAS), multi-spectroscopy, DFT calculations, molecular docking, molecular dynamics simulation

1. Introduction

Per- and Polyfluoroalkyl Substances (PFAS) are a class of compounds composed of fluorinated carbon chains with one or more functional groups [1,2]. These compounds have strong carbon–fluorine bonds, which provide high chemical stability and bio-accumulation potential, as well as an ultra-low surface energy [3,4]. Therefore, PFAS are widely used in industrial and commercial applications, including the production of firefighting foam, non-stick, and stain-resistant materials [5,6]. PFAS have a high hydrophobicity and acidity, allowing for them to persist in the environment for a long time while resisting biodegradation, photolysis and hydrolysis. This property of PFAS increases the possibility of bioaccumulation in the food chain and facilitates long-distance transport via air or water [5]. Currently, PFAS concentrations, ranging from 1 ppt to 1000 ppt, have been detected in a variety of environmental samples in water around the world [7]. According to a global study, the concentration of PFAS in China ranges from 20 to 300 ppt, while concentrations in the United States, the United Kingdom, and Germany range between 16 and 75 ppt in wastewater, surface water, groundwater, and drinking water [8,9].

Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic acid (PFOS) were the most extensively used PFAS and are now restricted. These two compounds have attracted widespread attention due to their frequent detection in environmental samples and the human body. Numerous scientific studies have revealed the phenomenon of PFAS bioaccumulating in humans [5]. PFAS have relatively long half-lives in the human body. According to a study on 19 PFAS, the average half-life of PFOA and PFOS was approximately 2.47 and 4.52 years, respectively [10]. Another research also reported that the average half-lives of PFOA and PFOS were 3.8 and 5.4 years, respectively [5]. PFAS are primarily known to accumulate in human blood, liver and kidney, indicating their high affinity for proteins. The prolonged presence of PFAS in the human body can lead to potential cytotoxicity and health risks. PFOS and PFOA have been linked to an increase in total serum cholesterol levels, lowered immunity, and the development of chronic diseases such as Chronic Kidney Disease (CKD), asthma, and Attention Deficit/Hyperactivity Disorder (ADHD) in children. The mechanisms of PFAS transport within the human body, as well as their interactions with human tissues and the blood system, remain subjects for further exploration [11].

Proteins serve as the fundamental building blocks for all forms of life in organisms [12]. As a ligand-binding protein, human serum albumin (HSA) is widely present throughout the blood system, accounting for 60% of protein content [13]. One of its primary functions is to transport endogenous and exogenous ligand compounds between tissues and organs [1]. According to research, HSA is the primary entity that binds to a variety of small molecule compounds, including PFAS [7], picloram [14], and noscapine [15].

PFAS primarily enter the human body through ingestion and inhalation and accumulate as enterohepatic circulation metabolites. This leads to a high concentration of PFAS in the blood, which may induce protein abnormalities, thereby causing physiological dysfunction [1]. As a result, it is critical to thoroughly investigate the interaction of PFAS and HSA in order to comprehend their distribution, metabolism, and toxicity mechanisms in human body [4].

Several PFAS, such as PFOA [7], PFOS [2], PFBS [16] and PFHxS [17], have been chosen as the focus for explorations of HSA–PFAS binding. PFAS with different carbon chain lengths or functional groups have varying binding behaviors with HSA [2]. Most of these studies, however, have primarily focused on traditional PFAS and frequently only involve the interaction of a single PFAS compound with HSA. Furthermore, current research usually employs techniques such as fluorescence spectroscopy and molecular docking [7], resulting in a lack of a comprehensive approach to investigate the binding characteristics of a variety of PFAS with HSA. This research gap has resulted in uncertainty about the key structural features that influence the binding affinity of PFAS under similar binding conditions. Therefore, more in-depth studies are urgently needed, not only to broaden the range of PFAS being studied, but also to employ a variety of analytical techniques to understand the complex interactions between these PFAS and HSA.

This study focuses on the binding interactions between HSA and six common PFAS compounds, as listed in Table 1. All six are perfluorocarboxylic acids, each with one or two carboxyl groups. Among them, two PFAS feature oxygen atoms as ether linkages (-O-) within the carbon chain, representing novel PFAS selected for their distinct structures. The binding characteristics, structural changes, and thermodynamic properties of these HSA–PFAS complexes will be thoroughly investigated using multispectral techniques. These techniques, such as fluorescence quenching, 3D-EEM and UV-visible spectroscopy, are used to not only quantify binding constants and sites, but also to reveal conformational changes in HSA. Furthermore, the electronic structures will be computed using Density Functional Theory (DFT), and molecular docking and kinetic simulations will be used to gain a better understanding of the nature of HSA–PFAS binding. These findings will provide critical scientific evidence for assessing the biological and environmental effects of PFAS.

Table 1.

Physico-chemical characteristics of six PFAS.

Compound Abbreviation Molecular Formula Molecular Structure Relative Molecular Mass CAS
Perfluorononanoic Acid PFNA C9HF17O2 graphic file with name toxics-12-00043-i001.jpg 464.08 375-95-1
Perfluoro-2,5-dimethyl-3,6-dioxanonanoic Acid HFPO-TA C9HF17O4 graphic file with name toxics-12-00043-i002.jpg 496.07 13252-14-7
Perfluorooctanoic Acid PFOA C8HF15O2 graphic file with name toxics-12-00043-i003.jpg 414.07 335-67-1
Perfluoro-3,6,9-trioxadecanoic Acid PFO3DA C7HF13O5 graphic file with name toxics-12-00043-i004.jpg 412.06 151772-59-7
Perfluoroheptanoic Acid PFHpA C7HF13O2 graphic file with name toxics-12-00043-i005.jpg 364.06 375-85-9
Dodecafluorosuberic Acid DFSA C8H2F12O4 graphic file with name toxics-12-00043-i006.jpg 390.08 678-45-5

2. Chemical and Process

2.1. Chemicals

HSA (≥96%) and six PFAS were all purchased from Aladdin Chemicals (Shanghai, China), including Perfluorooctanoic Acid (PFOA, CAS:335-67-1), Perfluorononanoic Acid (PFNA, CAS:375-95-1), Perfluoro-2,5-dimethyl-3,6-dioxanonanoic Acid (HFPO-TA, CAS:13252-14-7), Perfluoro-3,6,9-trioxadecanoic Acid (PFO3DA, CAS:151772-59-7), Perfluoroheptanoic Acid (PFHpA, CAS:375-85-9) and Dodecafluorosuberic Acid (DFSA, CAS:678-45-5). Three probe substances, including warfarin (≥98%), ibuprofen (≥98%), and lidocaine (≥99%), were also obtained from the same company. PBS buffer (Sigma-Aldrich, St. Louis, MO, USA) was used to prepare HSA stock solution (1 × 10−6 mol·L−1) to ensure the maintenance of appropriate ionic strength (pH = 7.4) and biocompatibility. Six PFAS aqueous stock solutions were also prepared at a concentration of 1 × 10−6 mol·L−1 for subsequent binding experiments.

2.2. Fluorescence Quenching Experiments

Fluorescence quenching experiments greatly benefit studies on the interactions between ligands and proteins. Initially, 3 mL of HSA stock solution was put into a 10 mm square quartz cuvette. Following that, PFAS stock solution was gradually added to achieve various final concentrations, namely 0, 3, 6, 9, 12, 15, 18 × 10−6 mol·L−1. By incrementally increasing the molar ratio of PFAS vs. HSA up to 18, their binding characteristics can be better investigated.

A thermostat (TR-01A, Bishui Corp, Beijing, China) was used to precisely control the solution temperature, which was set at 298, 304, and 310 K. This device includes a temperature controller and a metal heating cuvette module in conjunction with a fluorometer. This thermostat has a temperature range of 20–60 °C (293–333 K) and an accuracy of 0.1 °C Celsius. This step is critical for keeping the experimental conditions stable. Following that, the samples were fluorescence-scanned with a fluorometer (Cary Eclipse, Agilent, CA, USA). The excitation wavelength was set at 275 nm to efficiently stimulate tryptophan (Trp) and tyrosine (Tyr) residues [18]. Additional test parameters include an emission of 275–500 nm, scanning rate of 1200 nm/min and PTV voltage of 700 v. Fluorescence quenching experiments were repeated three times, and the average values were taken for further calculation. It is worth noting that none of the six PFAS tested in this study exhibited significant fluorescence signals, indicating that the intrinsic fluorescence properties of PFAS do not interfere with the study of their binding to HSA.

Fluorescence internal filtration (IFE) refers to the phenomenon where the fluorescence intensity decreases during fluorescence measurement due to the absorption of excitation or emission light by sample components (small molecules or proteins) in solution [19,20]. This phenomenon is more obvious in the samples with a high concentration of adsorbent. A fluorescence correction formula was used in this study to correct the IFE effect on the data, as follows:

Fcorr=Fobs×10Aex+Aem/2

where Fcorr and Fobs are corrected and observed fluorescence emission intensities, respectively, Aex and Aem are UV-vis absorbances at the excitation and emission wavelengths [18].

2.3. Spectroscopic Scanning

A UV-vis spectrophotometer (Specord 50, Analytik Jena, Germany) was used with a wavelength of 190–600 nm and 1 nm increments. The UV-vis spectra of single PFAS were subtracted from the UV-vis data to remove the influence of the absorption peaks inherent in PFAS, allowing for a more distinct differentiation of HSA absorption features.

Synchronous fluorescence scanning was set with two wavelength differences of 15 nm and 60 nm at 298 K. Other scanning parameters included an excitation wavelength of 200–400 nm.

The 3D-EEM spectra were recorded using specific scanning parameters at the scanning rate of 2400 nm·min−1, an emission of 220–400 nm with 5 nm increments, and an emission of 280–550 nm with 2 nm increments. The concentrations of PFAS and HSA were set at 18 × 10−6 mol·L−1 and 1 × 10−6 mol·L−1, respectively.

2.4. Circular Dichroism (CD) Spectrum

CD measurements (190–260 nm) were taken before and after the addition of PFAS to HSA using a J-815 CD spectrometer equipped with a PMT detector (JASCO, Tokyo, Japan). The protein concentration was set at 1 × 10−6 mol/L, with a fixed HSA-to-PFAS concentration ratio of 1:18. The scanning rate was set to 100 nm/min with 0.5 nm increments, and the photometric mode of HT. Each sample was scanned three times. The blank buffer control was automatically subtracted during the scanning process. All tests were carried out at 298 K. The CONTIN analysis method from the DichroWeb [21] was employed to determine the contents of the protein’s secondary structure.

2.5. Competitive Probe Experiment

Competitive probe experiments are commonly used to identify specific binding sites in the structure of proteins. Three probe molecules known to bind to distinct binding sites on HSA were selected: warfarin (subdomain IIA), ibuprofen (subdomain IIIA), and lidocaine (subdomain IIB) [22,23]. These probe molecules would compete with PFAS for the same protein sites when binding with HSA. The potential binding sites can be inferred by monitoring and comparing changes in fluorescence intensity when probe molecules are present. The probe molecules were concentrated at 1 × 10−6 mol·L−1, with PFAS adding up to 18 × 10−6 mol·L−1.

2.6. Quantum Chemical Computation

Quantum chemical computations serve as a scientific tool, allowing for a thorough analysis of molecular structure and properties at the microscopic level. The molecular structures of six PFAS were acquired via ChemSpider. The Gaussian 16 [24] software suite was used to perform molecular structure optimization based on the m062x density functional at the 6–31+g(d,p) level, with water as the solvent, in a PCM model [25,26,27]. All optimized structures were further post-processed with MultiWFN 3.7 [28], and several quantum chemistry descriptors were also visualized with VMD 1.9.3 [29] software.

2.7. Molecular Docking Studies

Molecular docking of the HSA–PFAS complex was carried out to explore HSA–PFAS binding at the active site [30]. The 3D structure of HSA was acquired via the RSCB database (ID 7JWN). Autodock Vina 1.1.2 [31,32] was used to process HSA and PFAS, which involved removing water molecules, co-crystal ligands and adding polar hydrogens. The molecules were placed in a cubic grid space for molecular docking with a side length of 22.5 Å and set exhaustiveness of 32 for global search. The optimal conformations were analyzed and visualized using PyMol 2.5 [33]. The obtained docking conformations were utilized for subsequent molecular dynamics simulations.

2.8. Molecular Dynamics Simulation (MD)

AMBER 18.0 was employed to run a full-atom MD simulation based on the initial structures of HSA–PFAS complexes from the molecular docking presented above [34]. The force fields of GAFF2 and ff14SB were used in the pre-simulation processing to characterize PFAS and HSA, respectively [35,36]. The LEaP module is critical for supplementing the system with missing hydrogen atoms. A TIP3P solvent box was introduced to provide an appropriate solvation environment [37]. Furthermore, a proper amount of Na+/Cl ions was also incorporated into the simulation framework to mimic the electrolytic environment and maintain electro-neutrality in the system.

MD simulations were performed in several steps, including energy minimization, heating, equilibration, production run and analysis. The process began with system energy optimization to achieve the system’s minimum energy state. NVT phylogenetic simulation of 500 ps at 298 K was performed to ensure a uniform distribution of solvent molecules within the solvent box. Under periodic boundary conditions, a 100 ns NPT simulation was conducted to understand the behavioral dynamics of the HSA–PFAS complexes under simulated biological conditions. Other process conditions were set as follows: a non-bond cutoff distance of 10 Å, PME method for long-range electrostatic interaction calculation [38], SHAKE method for hydrogen bond length constraints [39], and Langevin algorithm for temperature control [40]. During MD simulation, key indicators like root mean square deviation (RMSD) were monitored to track structural changes in HSA–PFAS complexes over time and determine whether the system had reached thermodynamic equilibrium.

The MM/GBSA method combines molecular mechanics energy components (MM) with the implicit solvent model (GBSA) to determine the binding free energy of HSA–PFAS binding [41,42,43], as shown in Equation (2):

ΔGbind=ΔGcomplex(ΔGHSA+ΔGPFAS)=ΔEVDW+ΔEELE+ΔGGB+ΔGSA

ΔGcomplex, ΔGHSA, and ΔGPFAS indicate the free energy of complex, HSA, and PFAS, respectively. ΔEVDW, ΔEELE, ΔGGB, and ΔGSA refer to van der Waals, electrostatic, polar solvation and non-polar solvation-free energy [44]. ΔGGB was calculated using the GB model [45]. ΔGSA was also determined to reflect the interaction of the molecular surface’s non-polar portions with the solvent [46].

3. Results and Discussion

3.1. Fluorescence Quenching Mechanism

Figure 1 exhibits changes in the HSA spectrum with the continuous addition of PFAS. The fluorescence peak of HSA is located at 337 nm. The fluorescence intensity gradually decreases with PFAS concentration at 298 K, 304 K, 310 K, indicating the formation of complexes between PFAS and HSA [47]. Among the six PFAS, PFNA has the greatest effect on the fluorescence intensity. PFNA causes a 30.6% quenching of fluorescence intensity at a concentration of 1.8 × 10−5 mol·L−1, while HFPO-TA, PFOA, PFO3DA, PFHpA, and DFSA cause fluorescence quenching rates of 25.1%, 20.1%, 15.3%, 12.1%, and 9.7% at 298 K, respectively. This phenomenon suggests that PFNA has the greatest influence on HSA.

Figure 1.

Figure 1

Fluorescence spectra of the HSA–PFAS system at different temperatures. C[HSA] = 1 × 10−6 mol·L−1, C[PFAS] = 0, 3, 6, 9, 12, 15 and 18 × 10−6 mol·L−1, T = 298 K, 304 K, 310 K. (a1) HSA–PFNA–298 K (a2) HSA–PFNA–304 K (a3) HSA–PFNA–310 K (b1) HSA–HFPO-TA–298 K (b2) HSA–HFPO-TA–304 K (b3) HSA–HFPO-TA–310 K (c1) HSA–PFOA–298 K (c2) HSA–PFOA–304 K (c3) HSA–PFOA–310 K (d1) HSA–PFO3DA–298 K (d2) HSA–PFO3DA–304 K (d3) HSA–PFO3DA–310 K (e1) HSA–PFHpA–298 K (e2) HSA–PFHpA–304 K (e3) HSA–PFHpA–310 K (f1) HSA–DFSA–298 K (f2) HSA–DFSA–304 K (f3) HSA–DFSA–310 K.

Furthermore, Figure 1 shows that all six PFAS cause a blue shift in the fluorescence peak of HSA, indicating that PFAS have altered the polarity of the microenvironment near amino acid residues. The blue shift caused by the binding of three PFAS (PFNA, HFPO-TA, and PFOA) to HSA is the most significant compared to the others. The fluorescence peak shifts from 337 nm to 317 nm (PFNA), 315 nm (HFPO-TA), and 320 nm (PFOA) as the concentration of PFAS increases, indicating that they may have a greater influence on microenvironment hydrophobicity in HSA.

Fluorescence quenching is usually caused by a series of complex processes. Dynamic quenching, static quenching, and mixed-type quenching are the three types of quenching processes [48]. Static quenching is primarily manifested by organic small molecules forming ground state complexes with proteins via intermolecular forces, whereas dynamic quenching is typically associated with the collision between fluorescent groups and quenchers. Dynamic quenching depends on molecular diffusion, and its quenching constant increases with the rising temperature; however, static quenching is due to the fact that high temperatures promote the dissociation of complexes, resulting in a decrease in quenching constants [3]. The quenching constant can be calculated using the Stern–Volmer Equation (3). The results are shown in Table 2 and Figure 1:

F0/F=1+Kqτ0=1+KsvQ

where F0 and F refer to HSA fluorescence intensities without and with the quencher (PFAS solution); Kq is the biomacromolecule’s quenching rate constant; τ0 is the average fluorescence lifetime of the fluorescent molecule when the quencher PFAS is absent, usually taken as 10−8 s; [Q] is the PFAS concentration; Ksv is the Stern–Volmer quenching constant; F0/F is the vertical axis; the Stern–Volmer curves of this system are 298, 304, and 310 K.

Table 2.

Binding constant and thermodynamic parameters of HSA–PFAS binding.

Binding
System
T
(K)
KSV × 104
(L·mol−1)
Kq × 1012
(L·mol−1·s−1)
Kb
(L·mol−1)
n ΔH
(kJ·mol−1)
ΔS
(J·mol−1·K−1)
ΔG
(kJ·mol−1)
HSA–PFNA 298 2.52 ± 0.10 2.52 ± 0.10 (7.81 ± 0.37) × 106 1.51 ± 0.06 −278.25 ± 5.46 −805.8 ± 13.8 −39.32
304 2.35 ± 0.11 2.35 ± 0.11 (2.02 ± 0.10) × 1 05 1.18 ± 0.03 −30.86
310 1.27 ± 0.04 1.27 ± 0.04 (9.9 ± 0.36) × 104 1.10 ± 0.04 −29.65
HSA–HFPO-TA 298 1.78 ± 0.09 1.78 ± 0.09 (3.7 ± 0.14) × 106 1.49 ± 0.03 412.15 ± 8.44 1508.3 ± 30.8 −37.47
304 1.95 ± 0.13 1.95 ± 0.13 (8.54 ± 0.40) × 107 1.78 ± 0.07 −46.16
310 1.98 ± 0.08 1.98 ± 0.08 (2.31 ± 0.09) × 109 2.09 ± 0.08 −55.57
HSA–PFOA 298 1.39 ± 0.07 1.39 ± 0.07 (2.27 ± 011) × 105 1.26 ± 0.04 146.68 ± 6.39 593.3 ± 22.7 −30.55
304 1.46 ± 0.09 1.46 ± 0.09 (2.23 ± 0.05) × 106 1.31 ± 0.02 −32.85
310 1.47 ± 0.11 1.47 ± 0.11 (1.98 ± 0.14) × 106 1.47 ± 0.03 −37.67
HSA–PFO3DA 298 1.05 ± 0.06 1.05 ± 0.06 (1.59 ± 0.06) × 105 1.25 ± 0.03 −106.57 ± 3.92 −259.2 ± 9.4 −29.67
304 1.03 ± 0.06 1.03 ± 0.06 (4.55 ± 0.27) × 104 1.33 ± 0.02 −27.11
310 0.87 ± 0.04 0.87 ± 0.04 (2.99 ± 0.08) × 104 1.10 ± 0.03 −26.56
HSA–PFHpA 298 0.69 ± 0.05 0.69 ± 0.05 (4.53 ± 0.34) × 103 0.96 ± 0.04 324.98 ± 14.22 1166.7 ± 42.7 −20.86
304 0.53 ± 0.07 0.53 ± 0.07 (5.35 ± 0.48) × 105 1.42 ± 0.06 −33.34
310 0.32 ± 0.04 0.32 ± 0.04 (7.47 ± 0.63) × 105 1.50 ± 0.05 −34.86
HSA–DFSA 298 0.58 ± 0.06 0.58 ± 0.06 (1.52 ± 0.11) × 103 0.88 ± 0.02 167.49 ± 4.28 622.5 ± 15.3 −18.15
304 0.51 ± 0.04 0.51 ± 0.04 (4.93 ± 0.39) × 103 0.98 ± 0.05 −21.49
310 0.45 ± 0.05 0.45 ± 0.05 (2.07 ± 0.17) × 104 1.13 ± 0.07 −25.62

The Ksv values decrease with temperature for HSA–PFNA, HSA–PFO3DA, HSA–PFHpA, and HSA–DFSA binding (Table 1), revealing that the quenching mechanism is primarily static. Furthermore, Kq values at 298 K range from 5.83 × 1011 to 2.50 × 1012 L·mol−1·s−1, which are much larger than the maximum dynamic diffusion quenching constant of the fluorescent agent for the fluorescent molecule (2.0 × 1010 L·mol−1·s−1). As a result, PFNA, PFO3DA, PFHpA, and DFSA can easily quench fluorescence groups by generating a complex, resulting in a static quenching process.

Furthermore, for the HSA–PFOA and HSA–HFPO-TA binding systems, Ksv values increase with temperature, implying a dynamic quenching process. However, at 298 K, the Kq values are 1.78 × 1012 L·mol−1·s−1 (HFPO-TA) and 1.39× 1012 L·mol−1·s−1 (PFOA). Both of the Kq values are greater than maximum dynamic diffusion quenching constant, implying the presence of a static quenching mechanism. Therefore, the fluorescence quenching mechanism of PFOA and HFPO-TA on HSA is a mixed quenching process that combines dynamic and static mechanisms.

3.2. Binding Constant and the Numbers of Binding Sites

The double logarithmic formula can be used to calculate the binding constants and binding site numbers of HSA–PFAS complexes [49]:

logF0F/F=logKb+nlogQ

where F0 and F are parameters representing the initial fluorescence intensity and the fluorescence intensity after adding PFAS, respectively. The binding characteristics are represented by the binding constant, Kb, and the number of binding sites, n. The slope of the straight line is the number of binding sites, n, and the binding constant Kb is obtained from the exponent of the straight line’s intercept using the double logarithmic graph. Figure A2 and Table 2 show the calculation results.

In theory, the number of binding sites should be an integer because each represents a unique binding site on the protein. In practice, however, the value of “n” is typically derived by fitting binding models to the experimental data, which yields non-integer values. Table 2 shows that the n values range from 0.8757 to 2.0857, indicating that PFAS bind on over one site of HSA. Except for the HSA–HFPO-TA binding at 310 K (n = 2.09, all the derived binding constants are close to one, indicating the presence of a single binding site on the HSA–PFAS complex. The binding constants Kb values of the six PFAS at 298 K range from 1.52 × 103 to 7.81 × 106 L·mol−1. The binding constants are listed in the following order: PFNA (7.81 × 106 L·mol−1) > HFPO-TA (3.70 × 106 L·mol−1) > PFOA (2.27 × 105 L·mol−1) > PFO3DA (1.59 × 105 L·mol−1) > PFHpA (4.53 × 103 L·mol−1) > DFSA (1.52 × 103 L·mol−1), with PFNA having the largest binding constant. PFNA, PFOA, and PFHpA are structurally similar perfluoroalkyl carboxylic compounds with carbon chain lengths in the order PFNA (C9) > PFOA (C8) > PFHpA (C7). The binding constants of these three PFAS are positively correlated with their carbon chain lengths, i.e., the longer the carbon chain, the larger the binding constant. The results of the above analysis show that increasing the carbon chain length significantly increases the binding affinity of HSA–PFAS, which is consistent with previous research findings [7].

Furthermore, the Kb values for the HSA–PFHpA and HSA–DFSA binding systems (4.53 × 103 L·mol−1, 1.52 × 103 L·mol−1) are much lower than 105 L·mol−1. The Kb of PFHpA, DFSA and HSA is weaker than that of other PFAS. The lower binding constant increases the concentration of free PFHpA and DFSA in the blood system, slowing their metabolic process in the body and potentially increasing their toxicity to the biological blood system [5].

3.3. Thermodynamic Analysis of the Binding Process

The enthalpy change (∆H), entropy change (∆S), and free energy change (∆G) calculated from the Van’t Hoff equation [50] can be used to determine the type of interaction.

lnKb=ΔH/RT+ΔS/R
ΔG=ΔHTΔS=RTlnKb

where R represents the ideal gas constant (8.314 J·mol−1·K−1).

When both ∆H and ∆S are positive, they indicate the interaction force of the hydrophobic interaction. When they are both negative, they indicate the interaction forces of hydrogen bonds or van der Waals forces. When ∆H is close to 0, and especially when it is less than 0, and ∆S is greater than 0, electrostatic interaction may be the dominant interaction force [12].

According to the results in Table 2, ∆H and ∆S for HSA–PFNA and HSA–PFO3DA binding are both negative, indicating the presence of hydrogen bonds or van der Waals forces. For the other four bindings (HSA–HFPO-TA, HSA–PFOA, HSA–PFHpA, and HSA–DFSA), both ∆H (146.68–412.15 kJ·mol−1) and ∆S (593.3–1508.3 J·mol−1·K−1) are positive, indicating the presence of hydrophobic interactions. Hydrogen bonding and hydrophobic interactions are two major types of molecular interactions that frequently coexist and influence molecular binding behavior. With its longer nine-carbon chain, PFNA may increase the van der Waals contact area with proteins, facilitating hydrogen bond formation at specific sites. However, PFOA and PFHpA have shorter carbon chains, with eight and seven carbon atoms, respectively. This shorter length may confer greater flexibility, allowing molecules to fit and embed more easily into the hydrophobic pockets of proteins, enhancing hydrophobic interactions. The ∆G results calculated from Equation (6) are all negative, ranging between −39.32 and −18.15 kJ·mol−1, indicating that six HSA–PFAS binding is a spontaneous process that is mainly driven by entropy.

3.4. Changes in HSA Conformation after Interaction with PFAS

3.4.1. UV-vis Absorption Spectroscopy

The UV–vis absorption spectrum is a rapid technique for exploring complex formation and changes in protein conformation [50]. Figure 2 depicts HSA UV-vis spectra with PFAS (0, 3, 6, 9, 12, 15, 18 × 10−6 mol·L−1) at 298 K. HSA displays a significant absorption peak at 210 nm. With the increase in PFAS concentration, the peak value of absorption gradually decreases, and the maximum absorption wavelength shifts from 210 nm to 213 nm. This phenomenon, known as a red shift, is due to the binding of PFAS and the base pairs of HSA to the π electrons, which reduces the energy and leads to a decrease in the energy of the π→π* transition [18]. An increase in the hydrophobicity and a decrease in the hydrophilicity of residues lead to polarity reduction in the microenvironment of HSA. UV-vis red shift reveals that the presence of PFAS altered the secondary structure of HSA [51].

Figure 2.

Figure 2

UV-vis absorption spectra of HSA–PFAS. C[HSA] = 1 × 10−6 mol·L−1, C[PFAS] = 0, 3, 6, 9, 12, 15 and 18 × 10−6 mol·L−1. (a) HSA–PFNA (b) HSA–HFPO-TA (c) HSA–PFOA (d) HSA–PFO3DA (e) HSA–PFHpA (f) HSA–DFSA.

3.4.2. Synchronous Fluorescence Spectroscopy

Figure 3 shows that the synchronous fluorescence peak in Δλ = 15 nm, which is associated with tyrosine (Tyr) residues, remains largely unchanged as PFAS concentrations increase. Notably, there is little change in peak shape and only a minor amount of fluorescence quenching for the six HSA–PFAS complexes, in the range of 3.2–17.0%.

Figure 3.

Figure 3

Synchronized fluorescence spectra of HSA–PFAS. C[HSA] = 1 × 10−6 mol·L−1, C[PFAS] = 0, 3, 6, 9, 12, 15 and 18 × 10−6 mol·L−1. Δλ(1) = 15 nm, Δλ(2) = 60 nm.

However, significant decreases were observed for the synchronous fluorescence peak of Δλ = 60 nm, regarding tryptophan (Trp) residues [52]. In this case, a 3.0 nm red shift in the fluorescence peak of Δλ = 60 nm is observed. This shift is accompanied by significant fluorescence quenching, as indicated by a decrease in the range of 16.1–37.0%. These changes indicate that PFAS increases its polarity around tryptophan (Trp) residues in HSA. As a result, their hydrophobicity is reduced, and HSA undergoes some conformational changes [52].

3.4.3. Three-Dimensional Fluorescence Spectra

Figure 4 depicts the 3D-EEM contour plots of the HSA–PFAS complex. Peak A (λexem = 280/337 nm) and peak B (λexem = 230/340 nm) refer to the characteristics of amino acid residues. Take PFNA, for example: peak A’s intensity was reduced by 37.8% after binding with HSA, while peak B’s intensity was reduced by 19.7%. The decrease in fluorescence intensity suggests that PFAS cause the partial unfolding of the HSA polypeptide chains, converting the initially hydrophobic regions to hydrophilic and initiating conformational changes within HSA [53].

Figure 4.

Figure 4

The 3D-EEM spectra of HSA–PFAS. C[HSA] = 1 × 10−6 mol·L−1, C[PFAS] = 1.8 × 10−5 mol·L−1. (a) HSA (b) HSA–PFNA (c) HSA–HFPO-TA (d) HSA–PFOA (e) HSA–PFO3DA (f) HSA–PFHpA (g) HSA–DFSA.

With the addition of PFAS, the positions of peak A and peak B are also shifted. In the HSA–PFAS mixed system, peak A transitioned from λexem = 280/337 nm to 280/331 nm, and peak B from λexem = 230/340 nm to 230/314 nm, leading to a blue shift. The presence of PFAS disrupts the molecular surface of HSA, causing depolymerization and reduced protein size. This leads to weaker fluorescence, indicating changes in HSA’s secondary structure.

3.4.4. Circular Dichroism (CD) Spectral Analysis

Figure 5 demonstrates that HSA exhibits two prominent negative absorption bands at 208 nm and 222 nm, which are closely related to its α-helix structure [54]. HSA’s secondary structure is made up of 41.6% α-helix, 4.9% β-sheet, 16.9% β-turn, and 36.7% random coil. Changes in HSA’s secondary structure were observed with the addition of 18 × 10−6 mol/L PFAS, which manifested as a decrease in α-helix content and an increase in β-fold, β-turn, and random coil contents, except for DFSA. This may be due to the smallest binding constant occurring in HSA–DFSA, and the binding of DFSA to some extent stabilizes the α-helix structure of HSA. PFNA had the greatest influence on the CD spectrum of HSA. The α-helix content decreased from 41.6% to 36.2% when PFNA was added to the HSA solution, while the β-sheet content increased from 4.9% to 7.6%. Following that, the two compounds PFHpA and PFOA also reduced the α-helix content to 36.4% and 37.2%, respectively. The α-helix is usually formed by twisting and folding the polypeptide chain. The introduced PFAS interact with HSA, disrupting its hydrogen bonding and loosening the peptide chains [55]. As a result, HSA–PFAS binding leads to alterations in the protein’s secondary structure.

Figure 5.

Figure 5

The circular dichroism spectra of HSA interacting with six PFAS. C[HSA] = 1 × 10−6 mol·L−1, C[PFAS] = 18 × 10−6 mol·L−1, T = 298 K, pH = 7.4. (a) HSA–PFNA (b) HSA–HFPO-TA (c) HSA–PFOA (d) HSA–PFO3DA (e) HSA–PFHpA (f) HSA–DFSA.

3.5. Competition Binding of PFAS with HSA

In the presence of three probe substances (warfarin, ibuprofen, and lidocaine), the binding constants of the ternary system exhibit varying degrees of decrease, as calculated using Equation (7), and listed in Table 3.

φ=KbKbKb×10

where Kb and Kb’ are the binding constants of the HSA–PFAS complex with and without the probe, respectively.

Table 3.

Competition experiment data in the absence and presence of three different site probes. (φ is the rate of decrease in Kb).

System Kb (L·mol−1) φ R2
HSA–PFNA 7.81 × 106 - 0.9992
HSA–PFNA–warfarin 1.33 × 105 98.3% 0.9942
HSA–PFNA–ibuprofen 6.73 × 106 13.8% 0.9919
HSA–PFNA–lidocaine 4.38 × 106 43.9% 0.9945
HSA–HFPO-TA 2.70 × 106 - 0.9913
HSA–HFPO-TA–warfarin 1.48 × 104 99.6% 0.9905
HSA–HFPO-TA–ibuprofen 2.82 × 106 23.8% 0.9912
HSA–HFPO-TA–lidocain 2.39 × 106 35.3% 0.9965
HSA–PFOA 2.27 × 105 - 0.9993
HSA–PFOA–warfarin 8.85 × 104 96.1% 0.9994
HSA–PFOA–ibuprofen 2.26 × 105 40.8% 0.9994
HSA–PFOA–lidocaine 2.09 × 105 8.1% 0.9991
HSA–PF03DA 1.59 × 105 - 0.9918
HSA–PF03DA–warfarin 7.79 × 103 95.1% 0.9905
HSA–PF03DA–ibuprofen 1.18 × 105 25.8% 0.9924
HSA–PF03DA–lidocaine 1.40 × 105 11.8% 0.9941
HSA–PFHpA 4.53 × 103 - 0.9933
HSA–PFHpA–warfarin 4.98 × 101 98.9% 0.9924
HSA–PFHpA–ibuprofen 2.60 × 103 42.7% 0.9917
HSA–PFHpA–lidocaine 2.32 × 103 48.8% 0.9961
HSA–DFSA 1.52 × 103 - 0.9927
HSA–DFSA–warfarin 1.02 × 102 93.3% 0.9983
HSA–DFSA–ibuprofen 1.13 × 103 25.4% 0.9905
HSA–DFSA–lidocaine 1.04 × 103 31.7% 0.9945

Table 3 shows that the three competing probe substances have different effects on HSA–PFAS binding. The Kb values of six PFAS decreased in the presence of ibuprofen (subdomain IIIA) by 13.8–42.7%, whereas lidocaine (subdomain IB) decreased by 8.1–48.8%. This suggests that the effect of ibuprofen and lidocaine on HSA–PFAS binding is limited. There was no competitive binding between ibuprofen/lidocaine and PFAS. The decreases in the HSA–PFAS binding constants are primarily due to micro-structural changes in HSA after binding with ibuprofen or lidocaine, which further affect HSA–PFAS binding.

However, the presence of warfarin probe (subdomain IIA) leads to a significant reduction in the binding constants of HSA–PFAS complexes, with the value of φ ranging from 93.3% to 99.6%. The binding of HFPO-TA, in particular, showed a decrease in the Kb value of 99.6% from 2.70 × 106 to 1.48 × 104. This suggests that the binding region of the HSA–PFAS complex is primarily in subdomain IIA of HSA.

When warfarin is already bound to subdomain IIA of HSA, it creates a competitive environment for PFAS. Since warfarin occupies the subdomain IIA, PFAS are hindered or inhibited from binding to this same site, leading to a reduced binding affinity for PFAS on HSA. The conclusion was later validated by the molecular docking results. PFAS are frequently found in mixtures in environmental and biological systems. The primary focus of this research is on the binding properties of single PFAS with HSA, but understanding the competitive binding of mixed PFAS is also important. Different PFAS may compete for the same binding sites on HSA in mixtures. This type of competition can have an impact on the binding affinity and stability of each PFAS. Existing research [56] also revealed that multiple drugs in a mixture may exhibit synergistic binding behaviors in complex drug–protein systems, significantly enhancing the bioactivity and toxicological properties of individual drugs. Future research will explore various PFAS mixtures to gain a better understanding of their binding dynamics with HSA, providing an improved understanding of PFAS interactions.

3.6. Quantum Chemistry Structural Analysis of PFAS

3.6.1. Frontier Molecular Orbital (FMO) Analysis

HOMO and LUMO are the important descriptors that influence the electrical and optical properties of compounds. The HOMO often serves as an electron contributor, while the LUMO often acts as an electron acceptor in chemical reactions, as shown in Figure 6. Table A3 also shows the molecular structures of six PFAS, as well as their HOMO and LUMO electron densities and radical electron densities. Most of the electron densities of these six PFAS in orbitals are clearly observed on the carbonyl oxygen in the carboxyl (-COOH) group, revealing that the carboxyl group can undergo radical reactions. The charge of the HOMO orbital is primarily located on the carboxyl (-COOH) groups, the oxygen atoms connected to carboxyl groups, and the carbon–fluorine (C-F) bond. The orbital distribution of DFSA is obviously different from that of the other five PFAS due to the presence of two carboxyl groups in DFSA, as shown in Figure 6.

Figure 6.

Figure 6

The HOMO and LUMO orbitals of six PFAS. (a) PFNA (b) HFPO-TA (c) PFOA (d) PFO3DA (e) PFHpA (f) DFSA.

The energy gap (named ∆EHOMO-LUMO) can provide insights into a molecule’s stability, reactivity, and even some of its photophysical properties [57]. The ∆EHOMO-LUMO values of the six PFAS range from 0.3802 eV to 0.3970 eV, implying that these molecules are conducive to chemical reactions.

3.6.2. Molecular Surface Properties Approach (MSPA) Analysis

The MSPA technique is a powerful tool for analyzing molecular surface attributes such as the electrostatic potential (ESP) and average localized ionization energy (ALIE). These descriptors can depict the entire charge distribution [58], potentially aiding in a better understanding of the molecule’s chemical reactivity.

As shown in Figure 7 and Table A5, Table A6, Table A7, Table A8, Table A9, Table A10, Table A11, Table A12, Table A13, Table A14, Table A15 and Table A16, the total electron density profile is represented by a color gradient, making it easier to identify the most active sites for nucleophiles and electrophiles [26]. Electrophilic reactions are more likely to occur in regions with a higher negative electrostatic potential. The local minima for six PFAS were notably located proximal to the oxygen atom in six PFAS, with values of −32.34 kcal/mol (PFNA), −32.12 kcal/mol (HFPO-TA), −32.37 kcal/mol (PFOA), −32.98 kcal/mol (PFO3DA), −32.29 kcal/mol (PFHpA), and −32.47 kcal/mol (DFSA). This implies that electrophilic reagents can easily target the oxygen atom, highlighting its strong electro-positive character, resulting in an increase in the reactive activity at these sites in PFAS.

Figure 7.

Figure 7

ESP and ALIE maps of six PFAS. (a1) ESP map of PFNA (a2) ALIE map of PFNA (b1) ESP map of HFPO-TA (b2) ALIE map of HFPO-TA (c1) ESP map of PFOA (c2) ALIE map of PFOA (d1) ESP map of PFO3DA (d2) ALIE map of PFO3DA (e1) ESP map of PFHpA (e2) ALIE map of PFHpA (f1) ESP map of DFSA (f2) ALIE map of DFSA.

ALIE is an index for electron localization in molecules, which is used to identify electrophilic sites as an effective complement to ESP [26,59]. The blue region in the ALIE maps of PFAS, as shown in Figure 7 and Table A17, Table A18, Table A19, Table A20, Table A21, Table A22, Table A23, Table A24, Table A25, Table A26, Table A27 and Table A28, primarily hovers around the carboxyl group and its neighboring oxygen atoms. Using PFHpA as an example, the deepest blue was clearly seen adjacent to the O atom in the -COO group, representing the local minimum value of 295.52 kcal/mol. This indicates that the electron activity near the oxygen atom is stronger, making it more prone to undergoing electrophilic reactions.

3.6.3. Conceptual Density Functional Theory (CDFT) Analysis

CDFT, grounded in the study of electronic density, offers comprehensive qualitative and quantitative insights into the chemical reactivity of molecular systems. Typical CDFT descriptors, such as Fukui function and dual descriptor (DD, Δf(r)), can reveal the regions of molecules that are most vulnerable to electrophilic or nucleophilic attacks [60]. The results are shown in Figure 8 and Table A29, Table A30, Table A31, Table A32, Table A33 and Table A34.

Figure 8.

Figure 8

Visualization of CDFT descriptors: (1) nucleophilic Fukui function f+(r), (2) electrophilic Fukui function f(r), (3) free radical Fukui function f0(r), and (4) condensed dual descriptors Δf(r) of PFAS. (a1) f⁺₍ᵣ₎ of PFNA (a2) f₍ᵣ₎ of PFNA (a3) f0₍ᵣ₎ of PFNA (a4) ∆f₍ᵣ₎ of PFNA (b1) f⁺₍ᵣ₎ of HFPO-TA (b2) f₍ᵣ₎ of HFPO-TA (b3) f0₍ᵣ₎ of HFPO-TA (b4) ∆f₍ᵣ₎ of HFPO-TA (c1) f⁺₍ᵣ₎ of PFOA (c2) f₍ᵣ₎ of PFOA (c3) f0₍ᵣ₎ of PFOA (c4) ∆f₍ᵣ₎ of PFOA (d1) f⁺₍ᵣ₎ of PFO3DA (d2) f₍ᵣ₎ of PFO3DA (d3) f0₍ᵣ₎ of PFO3DA (d4) ∆f₍ᵣ₎ of PFO3DA (e1) f⁺₍ᵣ₎ of PFHpA (e2) f₍ᵣ₎ of PFHpA (e3) f0₍ᵣ₎ of PFHpA (e4) ∆f₍ᵣ₎ of PFHpA (f1) f⁺₍ᵣ₎ of DFSA (f2) f₍ᵣ₎ of DFSA (f3) f0₍ᵣ₎ of DFSA (f4) ∆f₍ᵣ₎ of DFSA.

Higher Fukui function values for a given site often indicate an increased sensitivity to electrophilic attacks [61]. Notably, the DD index outperforms the Fukui function alone in predicting both electrophilic and nucleophilic reactive sites. That is, positive DD values indicate nucleophilic attack potential, whereas negative values represent electrophilic attack potential [62].

Using PFNA as an example, the Δf(r) value for the C28 atom in the carboxyl group is 0.0764. This not only highlights its extreme sensitivity to electrophilic attacks, but also its critical role in PFNA’s overall reactivity and the carboxyl group’s importance in electrophilic reactions. Furthermore, F13 and F14 in the PFNA structure both have the same significant Δf(r) values of 0.0371. The other five PFAS have the same distribution and nature of potential reactive sites as PFNA. This suggests that the structure–reactivity patterns of these compounds may be similar.

The calculated global reactivity descriptors of the PFAS are also listed in Table A29, Table A30, Table A31, Table A32, Table A33 and Table A34. As shown in Table A29, the chemical hardness (η) for PFNA is 6.8335 eV, while its chemical softness (s) is 0.1463 eV−1; these can be interpreted as indicators of intra-molecular charge transfer characteristics. The high hardness (η) and low softness (s) reveal that PFNA is a soft molecule. PFNA also has an electrophilicity index (ω) of 2.4383 eV, which classifies it as a “strong electrophile” (>1.50 eV) according to the organic classification criteria [57]. The electronegativity (χ) of PFNA is 5.7727 eV, a descriptor that quantifies an atom or molecular group’s ability to attract electrons.

3.6.4. Electron Localization Characteristic Analysis

The Electron Localization Function (ELF) and Localized Orbital Locator (LOL) serve as tools for delineating the electron localization characteristics of molecules. ELF is often used to examine the nature of chemical bonds and to identify electron distribution, while LOL is commonly used to identify electron orbitals like non-bonding and lone pairs [63]. The topological features of six PFAS were analyzed using MultiWFN software. Figure 9 depicts the ELF and LOL contour projections for these molecules, with a gradient from blue to red representing ELF and LOL values ranging from 0 to 1. Values between 0.5 and 1 represent localized bonding and non-bonding electrons, while values less than 0.5 represent delocalized electrons [64]. The LOL plot offers similar information to ELF, but might be more sensitive to electron delocalization features.

Figure 9.

Figure 9

ELF and LOL diagram of six PFAS. (a1) ELF map of PFNA (a2) LOL map of PFNA (b1) ELF map of HFPO-TA (b2) LOL map of HFPO-TA (c1) ELF map of PFOA (c2) LOL map of PFOA (d1) ELF map of PFO3DA (d2) LOL map of PFO3DA (e1) ELF map of PFHpA (e2) LOL map of PFHpA (f1) ELF map of DFSA (f2) LOL map of DFSA.

Areas around the C, F, and O atoms are highlighted in blue in the ELF plots of the six PFAS (Figure 9), indicating the presence of low ELF values (<0.5) and electron delocalization. On the other hand, areas surrounding the H atoms are depicted in rich reds with high ELF values, indicating a strong localization of both bonding and non-bonding electrons.

3.6.5. Interaction Region Indicator (IRI) Analysis

IRI analysis is a novel tool that can identify and reflect various interactions in chemical systems, particularly weak interactions [65]. Figure 10 shows the IRI isosurfaces of six PFAS, with blue representing a notable attraction of H-bond or chemical bonds, green representing van der Waals interactions, and orange and red representing notable repulsion, such as the steric hindrance effect [66].

Figure 10.

Figure 10

IRI diagram of six PFAS. (a) PFNA (b) HFPO-TA (c) PFOA (d) PFO3DA (e) PFHpA (f) DFSA.

Taking PFNA as an example, the Van der Waals interaction and steric effect (green and orange) are visible near the F and O atoms in the PFNA molecule (Figure 10a). The orange color near one end of the C–C bonds indicates steric hindrance. Furthermore, the isosurfaces near the O atoms are significantly larger than those near the F atoms, implying that the O atoms have stronger van der Waals interactions and steric hindrance. The other five PFAS have similar structural features.

3.7. Analysis of Molecular Docking

Molecular docking techniques were used to explore the binding characteristics of HSA–PFAS binding with the best conformation of HSA–PFAS complexes (Figure 11). The amino acid residues that significantly impact the binding are additionally listed near the PFAS binding sites in Figure 11.

Figure 11.

Figure 11

Binding modes of the HSA–PFAS interaction predicted by molecular docking.

As shown in Figure 11, the binding sites of the six PFAS with HSA are all located in subdomain IIA of HSA, a region known to have a high affinity for various small molecule ligands. This agrees with the findings of the competitive probe experiments (Section 3.3), providing additional support and validation for the molecular docking results. Table A4 also contains detailed docking results.

According to the results of molecular docking (Figure 11), PFAS bind to various amino acid residues on HSA through hydrogen bonds, van der Waals forces, and halogen bonds. In the case of PFNA–HSA binding, the polar end of the PFNA carboxyl group forms a hydrogen bond with the protein’s SER-192 residue, which is critical for the ligand–protein complex’s stability. This is consistent with the thermodynamic results indicating that hydrogen bonding is the primary binding force of PFNA with HSA. Additionally, the Fatom in PFNA is observed to form halogen bonds with positively charged parts of the GLN-196 and ARG-257 residues. Halogen bond is a non-covalent interaction, similar to hydrogen bonds. As the halogen atom of PFOA approaches the nucleophilic site of HSA, it forms a halogen bond, increasing the PFOA’s affinity to and specificity for HSA. PFO3DA docking results are comparable to PFNA.

The other four PFAS (HFPO-TA/PFOA/PFHpA/DFSA) interact with HSA in various ways, including hydrogen bonds, halogen bonds, and hydrophobic interactions. Thermodynamic studies show that the binding forces of these four PFAS with HSA are primarily due to hydrophobic interactions. For example, PFOA, a common perfluorinated compound, is hydrophobic and binds to the non-polar amino acid residue PHE-149, where hydrophobic interactions help to stabilize PFOA in the HSA binding pocket [67].

Molecular docking studies further revealed the binding energies of the six PFAS and HSA. A lower binding energy (more negative) indicates tighter binding between PFAS and HSA. The binding energies of HSA–PFNA, HSA–HFPO-TA, HSA–PFOA, HSA–PFO3DA, HSA–PFHpA, and HSA–DFSA were calculated to be −8.2, −7.9, −7.8, −7.8, −7.1, and −7.3 kcal/mol, respectively. HSA–PFNA has the lowest binding energy of −8.2 kcal/mol, indicating that PFNA more easily binds to HSA. This observation is consistent with the thermodynamic analysis (Section 3.3), which revealed that PFNA exhibits the highest binding constant (7.81 × 106 L·mol−1), indicating the strongest affinity between PFNA and HSA. The molecular docking results not only provide an important perspective for understanding the interaction mechanism between PFAS and HSA, but they also provide a scientific foundation for future pollutant removal strategies.

3.8. Analysis of MD Simulation Results

The MD simulation is helpful for investigating the complex interactions of small molecules and proteins, revealing the real-time structural dynamics of small molecule–protein complexes under different environmental conditions. The simulation process not only records spatial conformation changes within the complex but also evaluates the dynamic equilibrium and stability of small molecule–protein complexes by calculating dynamic parameters like root mean square deviation (RMSD), the radius of gyration (Rog), root mean square fluctuation (RMSF), and the number of hydrogen bonds.

3.8.1. RMSD

RMSD is an important indicator for determining whether a system has reached equilibrium, particularly when monitoring displacements of molecular backbone atoms [68]. A larger and more volatile RMSD indicates intense motion. As shown in Figure 12a, the RMSDs of six HSA–PFAS complexes varied between 2 and 4 Å. Among them, HSA–PFHpA and HSA–DFSA complexes have particularly high values and significant fluctuations (over 3.5 Å), indicating a less stable complex binding. HSA–PFNA and HSA–HFPO-TA, on the other hand, have smaller RMSDs (below 3.0 Å) with regular fluctuations during the simulation, indicating a more stable complex formation. All systems show stabilized fluctuations and a gradual reduction after 50 ns, indicating a transition to a new equilibrium state.

Figure 12.

Figure 12

Molecular dynamics simulation of six PFAS and HSA bindings. (a) RMSD (b) RMSF (c) ROG (d) SASA.

3.8.2. RMSF

RMSF reflects protein molecule flexibility during molecular dynamics simulations. Binding with small molecules typically reduces protein flexibility, resulting in protein structure stabilization [69]. Figure 12b shows that after binding with various PFAS, most regions of HSA, except the ends and some local areas, have an RMSF of less than 2.5 Å, indicating a relatively rigid core protein structure. The HSA protein exhibits even lower RMSFs (below 2.0 Å) when bound with PFNA and HFPO-TA, implying that these two small molecules can suppress the protein’s active states, potentially affecting protein function. In contrast, when PFHpA and PFOA bind, HSA exhibits higher RMSFs (above 2.5 Å) in several segments, indicating that these molecules have a less inhibitory effect on the protein.

3.8.3. Rog

Rog reflects the system’s compactness, and monitoring its variations allows for observations of the protein’s folding and unfolding processes [70]. Figure 12c depicts the evolution of Rog over time for six complex systems during MD simulation. All systems have a Rog that ranges between 26.7 Å and 28.5 Å, indicating structural compactness. The PFNA–HSA complex varies between 26.7 Å and 27.3 Å, with the smallest observed Rog values and a downward trend throughout the MD simulation. The low Rog values and minimal fluctuations imply that the system has an increased compactness, which could be attributed to specific interactions between the PFNA molecule and HSA binding sites, further enhancing the stability of the PFNA–HSA complex. Other PFAS–HSA complexes, on the other hand, have larger Rog values and fluctuations, indicating a looser structure.

3.8.4. Number of H-Bonds

The variation in the Number of H-bonds in HSA–PFAS complexes during MD simulation is depicted in Figure 13. As a strong non-covalent binding force, the H-bond is key to complex stability. The H-bond number in the MD simulation varies between 0 and 4, indicating dynamic interactions between PFAS and HSA. Specifically, the HSA–PFNA and HSA–HFPO-TA complexes have 2 stable H-bonds, compared to the 0–2 found in other complex systems, implying more stable interactions that help maintain the structure and function of the complexes.

Figure 13.

Figure 13

MD simulation of six PFAS binding with HSA. (a) HSA–DFSA (b) HSA–HFPO-TA (c) HSA–PFHpA (d) HSA–PFNA (e) HSA–PFO3DA (f) HSA–PFOA.

3.8.5. Binding Free Energy Calculation Results

As shown in Table 4, the binding free energy was calculated using the MM-GBSA method, which provides a more accurate assessment of the binding between PFAS and HSA [71]. Notably, all complexes have negative binding free energies, indicating that all six PFAS can form stable ligand–receptor complexes with HSA. The lowest binding energy (−38.83 kcal/mol) is found in the PFNA–HSA complex, indicating its high affinity for HSA, followed by the HSA–HFPO-TA complex (−35.20 kcal/mol). HSA–DFSA, on the other hand, has a lower affinity (−17.98 kcal/mol). Furthermore, energy decomposition analysis also indicates that van der Waals and electrostatic interactions are the primary driving forces for HSA–PFAS binding.

Table 4.

Binding free energies and energy components predicted by MM/GBSA (kcal/mol).

System Name ΔEvdw ΔEelec ΔGGB ΔGSA ΔGbind
HSA–HFPO-TA −36.91 25.66 −18.10 −5.85 −35.20
HSA–PFO3DA −21.38 −55.09 58.37 −4.36 −22.46
HSA–PFOA −20.96 −7.20 4.38 −4.27 −28.04
HSA–PFHpA −35.30 49.13 −29.24 −5.91 −21.31
HSA–PFNA −28.64 −29.20 24.50 −5.49 −38.83
HSA–DFSA −35.18 −20.45 43.33 −5.68 −17.98

3.9. The Relationship between PFAS Structural Characteristics and Binding Behavior

Multiple factors influence protein–small molecule interactions, including small molecule structural characteristics, environmental variables, and affinity. The correlation analysis in Figure 14 reveals a significant interrelationship between binding constants, docking binding energies, and molecule structural properties. The binding constant (Y1), in particular, has a significant inverse relationship with Gibbs free energy (Y2, R = 0.79), docking binding energy (Y3, R = 0.75), and binding free energy (Y4, R = 0.90). This inverse relationship emphasizes the importance of binding energy in characterizing energy changes during the molecular binding process. A higher binding energy indicates a more powerful interaction between molecules, which promotes the formation of a stable binding state. Because of this improved interaction, molecules are more likely to aggregate and form stable binding complexes.

Figure 14.

Figure 14

The correlation analysis for the results from multispectral analysis, quantitative calculations, and molecular docking. Y1—Kb, Y2—ΔG, Y3—molecular docking binding energy, Y4—binding free energy,Y5—energy gap (ΔEHOMO-LUMO), Y6—highest ESP maximum, Y7—lowest ESP minimum, Y8—lowest ALIE minimum, Y9—f(r) maximum, Y10—Δf(r) minimum, Y11—highest ALIE maximum, Y12—nucleophilicity index, Y13—electrophilicity index, Y14—Mulliken electronegativity, Y15—chemical potential.

Several quantum chemical descriptors, including the lowest ESP minimum (Y7, R = 0.37), highest ALIE maximum (Y11, R = 0.37), electrophilicity index (Y13, R = 0.36), and Mulliken electronegativity (Y14, R = 0.34), show a weak but noticeable positive correlation with the binding constant in this study. These descriptors mainly concern the electrostatic potential and distribution properties of small molecules. The reaction process is generally divided into two stages: the molecular approach (first step) and electronic structural rearrangement (second step). Long-range electrostatic interactions are frequently essential during the molecular approach phase. Only when the molecules are close to each other can the molecular electronic structure be rearranged. Binding reactions between small molecules and proteins are typically driven by weak forces; hence, descriptors related to electrostatic distribution and characteristics like ESP and ALIE are more representative when characterizing the binding. In contrast, descriptors usually used to describe electronic reaction characteristics, such as HOMO and LUMO, show no significant correlation with binding characteristics.

Furthermore, there are numerous quantum chemical descriptors that influence molecular structural features, but this study only considers a subset of them. The samples used in the study are limited to only six PFAS, resulting in a small sample size. To obtain more meaningful analytical results, a broader range of quantum chemical descriptors must be included, as well as an increased experimental data sample size.

3.10. Perspective and Application

The increase in binding affinity tends to increase the biological half-lives. As shown in Table 2, the binding constant of PFHpA (4.53 × 103 L·mol−1) is significantly lower than that of PFOA (2.27 × 105 L·mol−1). Similarly, the half-life of PFHpA (62–70 days) [72] is much shorter than that of PFOA (2.47–4.52 years). This correlation suggests that PFASs’ binding constants with HSA may influence their biochemical behaviors within the human body, affecting their bioaccumulative potential and internal half-lives, as previously observed [73].

Therefore, the binding behavior of PFAS with plasma proteins is key to understanding their bioavailability, toxicological properties, and bioaccumulative potential. Several studies have found significant variations in binding affinity among PFAS of various structures. Long-chain PFAS, such as certain perfluoroalkanoyl chlorides, for example, have a higher binding affinity, whereas binding decreases as the carbon chain length exceeds 11 [74].

The current study is a preliminary investigation into the interrelationship between binding constants and molecular structural properties. Quantum Structure–Activity Relationship (QSAR) models can also be used to predict and interpret their interactions in the future.

Researchers can predict the binding characteristics of new PFAS compounds by developing QSAR models that correlate the PFAS molecular structure with plasma protein binding affinity. For example, PFAS with specific functional groups may form more stable hydrogen or ionic bonds with protein amino acid residues. These models typically rely on experimental data from known compounds combined with statistical or machine learning methods.

Understanding the patterns of interaction between various PFAS and proteins allows for researchers to better predict their behavior in organisms, including their distribution, metabolism, and excretion pathways. This is critical not only for assessing the risk of individual PFAS, but also for understanding complex PFAS mixtures, and providing scientific evidence for risk assessments and environmental regulations.

4. Conclusions

This study investigates the interactions between six PFAS and HSA using multi-spectral techniques, Density Functional Theory (DFT), and molecular dynamics approaches.

Fluorescence quenching experiments revealed that four PFAS (PFNA, HFPO-TA, PFOA, and PFO3DA) have a high affinity for HSA, while the other two (PFHpA and DFSA) have a low affinity. PFNA, PFO3DA, PFHpA, and DFSA can easily quench fluorescence groups by generating a complex, resulting in a static quenching process, while the fluorescence quenching of PFOA and HFPO-TA on HSA is a mixed quenching process. The HSA–PFNA complex has the highest binding constant (7.81 × 106 L·mol−1) at 298 K, with the binding constants in the following order: PFNA (7.81 × 106 L·mol−1) > HFPO-TA (3.70 × 106 L·mol−1) > PFOA (2.27 × 105 L·mol−1) > PFO3DA (1.59 × 105 L·mol−1) > PFHpA (4.53 × 103 L·mol−1) > DFSA (1.52 × 103 L·mol−1).

Furthermore, synchronous fluorescence, 3D-EEM, and UV-vis spectroscopy show that HSA–PFAS binding changes the microenvironment around the amino acid residues, and causes structural changes in HSA. Molecular docking results show that the binding energy of HSA–PFNA is the lowest (−8.2 kcal·mol−1), indicating that PFNA is more likely to bind with HSA. The competitive probe results reveal that six HSA–PFAS binding sites are mainly located in HSA subdomain IIA, which further validates the findings of molecular docking. Molecular dynamics simulation (MD) analysis further shows the lowest binding free energy (−38.83 kcal/mol) in the HSA–PFNA complex, indicating that PFNA binds more readily with HSA.

This study also looked into the quantum chemical descriptors of the six PFAS, such as HOMO, LUMO, ESP, ALIE, and CDFT. Correlation analysis reveals that DFT quantum chemical descriptors related to electrostatic distribution and characteristics, like ESP and ALIE, are more representative when characterizing HSA–PFAS binding. However, the descriptors usually used to describe electronic reaction characteristics, such as HOMO and LUMO, show no significant correlation with binding characteristics. The binding constant (Y1) has a particularly significant inverse relationship with Gibbs free energy (Y2, R = 0.79), docking binding energy (Y3, R = 0.75), and binding free energy (Y4, R = 0.90). A higher binding energy indicates a more powerful interaction between molecules when forming a stable binding state. These findings shed light on the experimental and theoretical mechanisms of HSA–PFAS binding. Researchers can predict the binding characteristics of new PFAS compounds by developing QSAR models that correlate the PFAS molecular structure with the protein binding affinity in the future. Understanding the interactions between various PFAS and proteins allows for researchers to better predict their behavior in organisms, including their distribution, metabolism, and excretion pathways. This is critical not only for assessing the risk of individual PFAS, but also for understanding complex PFAS mixtures, providing scientific evidence for risk assessments and environmental regulations.

Acknowledgments

The authors would like to thank the anonymous reviewers for their valuable comments.

Appendix A

Table A1.

Characteristic parameters of 3D-EEM of HSA–PFAS binding.

System Peak A Peak B
Position Intensity F Position Intensity F
λexem (nm/nm) a.u. λexem (nm/nm) a.u.
HSA 280/338 673.66 230/340 996.906
HSA–PFNA 280/329 418.74 230/310 800.96
HSA–HFPO-TA 280/321 499.16 230/314 861.38
HSA–PFOA 280/336 476.59 230/327 812.58
HSA–PFO3DA 280/329 525.07 230/325 886.91
HSA–PFHpA 280/336 656.89 230/335 997.01
HSA–DFSA 280/336 629.75 230/330 839.38

Table A2.

Conformational changes in the secondary structure of HSA with and without six PFAS.

Sample Secondary Structure (%)
α-Helix β-Sheet β-Turn Random Coil
HSA 41.6 4.9 16.9 36.7
HSA–PFNA 36.2 7.6 15.1 41.2
HSA–HFPO-TA 40.6 5.1 15.8 38.5
HSA–PFOA 37.2 6.4 15.8 40.5
HSA–PFO3DA 36.4 5.8 17.3 40.6
HSA–PFHpA 39.6 5.5 15.5 39.4
HSA–DFSA 43.2 4.0 15.8 37.0

Table A3.

Calculation of electron density at the free radical front of six PFAS.

Matter Label Atom HOMO Electron Density
(×100%)
LUMO Electron Density
(×100%)
Radical Frontier Electron Densities
(fr Values × 100%)
PFNA 1 F 0.620 0.110 0.730
2 F 0.620 0.110 0.730
3 F 0.348 0.046 0.394
4 F 0.348 0.046 0.394
5 F 1.077 0.426 1.503
6 F 1.077 0.426 1.503
7 F 0.180 0.015 0.195
8 F 0.180 0.015 0.195
9 F 2.164 1.172 3.336
10 F 2.164 1.172 3.336
11 F 0.087 0.006 0.093
12 F 0.087 0.006 0.093
13 F 4.285 5.750 10.035
14 F 4.285 5.750 10.035
15 F 0.047 0.001 0.047
16 F 0.026 0.001 0.027
17 F 0.026 0.001 0.027
18 O 8.180 10.095 18.275
19 O 45.244 25.077 70.321
20 C 1.447 0.114 1.561
21 C 0.853 0.044 0.897
22 C 2.453 0.369 2.822
23 C 0.471 0.015 0.486
24 C 3.398 1.886 5.284
25 C 0.241 0.005 0.246
26 C 9.747 11.538 21.285
27 C 0.093 0.002 0.095
28 C 9.720 34.703 44.423
29 H 0.533 1.097 1.630
HFPO-TA 1 F 0.039 0.389 0.428
2 F 0.071 0.166 0.237
3 F 0.280 1.528 1.808
4 F 0.001 0.041 0.042
5 F 0.001 0.035 0.036
6 F 0.006 0.039 0.045
7 F 0.125 0.573 0.698
8 F 0.090 0.192 0.282
9 F 0.001 0.020 0.020
10 F 0.001 0.011 0.011
11 F 4.392 1.647 6.039
12 F 0.001 0.009 0.009
13 F 0.001 0.004 0.004
14 F 0.001 0.004 0.004
15 F 0.920 2.075 2.995
16 F 0.965 0.738 1.703
17 F 0.133 1.095 1.228
18 O 0.010 0.141 0.151
19 O 3.743 3.386 7.129
20 O 8.666 11.385 20.051
21 O 56.118 24.429 80.547
22 C 0.044 0.522 0.566
23 C 0.491 0.901 1.392
24 C 0.002 0.065 0.067
25 C 0.070 0.252 0.322
26 C 0.002 0.036 0.038
27 C 10.506 9.091 19.597
28 C 0.001 0.017 0.018
29 C 1.743 4.328 6.071
30 C 10.980 35.622 46.602
31 H 0.601 1.258 1.859
PFOA 1 F 0.569 0.110 0.679
2 F 0.569 0.110 0.679
3 F 1.030 0.427 1.457
4 F 1.030 0.427 1.457
5 F 0.289 0.046 0.335
6 F 0.289 0.046 0.335
7 F 2.148 1.175 3.323
8 F 2.148 1.175 3.323
9 F 0.139 0.014 0.153
10 F 0.139 0.014 0.153
11 F 4.321 5.757 10.078
12 F 4.321 5.757 10.078
13 F 0.074 0.001 0.075
14 F 0.041 0.004 0.045
15 F 0.041 0.004 0.045
16 O 8.269 10.095 18.364
17 O 46.032 25.067 71.099
18 C 1.341 0.114 1.455
19 C 2.369 0.369 2.738
20 C 0.746 0.044 0.790
21 C 3.355 1.892 5.247
22 C 0.381 0.014 0.395
23 C 9.830 11.552 21.382
24 C 0.147 0.005 0.152
25 C 9.840 34.685 44.525
26 H 0.540 1.096 1.636
PFO3DA 1 F 0.069 0.041 0.110
2 F 0.069 0.041 0.110
3 F 0.012 0.001 0.013
4 F 0.012 0.001 0.013
5 F 0.172 0.200 0.372
6 F 0.172 0.200 0.372
7 F 0.003 0.001 0.004
8 F 0.003 0.001 0.004
9 F 3.915 4.575 8.490
10 F 3.915 4.575 8.490
11 F 0.001 0.001 0.001
12 F 0.001 0.001 0.001
13 F 0.001 0.001 0.001
14 O 0.066 0.004 0.070
15 O 1.401 1.626 3.027
16 O 0.003 0.001 0.003
17 O 8.353 11.173 19.526
18 O 60.506 27.230 87.736
19 C 0.265 0.074 0.339
20 C 0.026 0.002 0.028
21 C 0.337 0.453 0.790
22 C 0.012 0.001 0.013
23 C 9.200 10.372 19.572
24 C 0.001 0.001 0.001
25 C 10.861 38.321 49.182
26 H 0.624 1.105 1.729
PFHpA 1 F 0.966 0.427 1.393
2 F 0.966 0.427 1.393
3 F 0.484 0.108 0.592
4 F 0.484 0.108 0.592
5 F 2.103 1.174 3.277
6 F 2.103 1.174 3.277
7 F 0.229 0.043 0.272
8 F 0.229 0.043 0.272
9 F 4.362 5.756 10.118
10 F 4.362 5.756 10.118
11 F 0.118 0.001 0.119
12 F 0.067 0.012 0.079
13 F 0.067 0.012 0.079
14 O 8.384 10.096 18.480
15 O 47.038 25.084 72.122
16 C 2.240 0.370 2.610
17 C 1.195 0.113 1.308
18 C 3.280 1.892 5.172
19 C 0.617 0.042 0.659
20 C 9.923 11.550 21.473
21 C 0.238 0.013 0.251
22 C 9.995 34.703 44.698
23 H 0.550 1.095 1.645
DFSA 1 F 1.125 0.403 1.528
2 F 1.125 0.403 1.528
3 F 1.125 0.403 1.528
4 F 1.125 0.403 1.528
5 F 1.496 0.706 2.202
6 F 1.496 0.706 2.202
7 F 1.496 0.706 2.202
8 F 1.496 0.706 2.202
9 F 2.256 2.941 5.197
10 F 2.256 2.941 5.197
11 F 2.256 2.941 5.197
12 F 2.256 2.941 5.197
13 O 4.144 4.927 9.071
14 O 4.144 4.927 9.071
15 O 20.731 12.270 33.001
16 O 20.731 12.270 33.001
17 C 2.522 0.374 2.896
18 C 2.522 0.374 2.896
19 C 2.552 1.080 3.632
20 C 2.552 1.080 3.632
21 C 5.207 5.780 10.987
22 C 5.207 5.780 10.987
23 C 4.828 16.929 21.757
24 C 4.828 16.929 21.757
25 H 0.261 0.540 0.801
26 H 0.261 0.540 0.801

Table A4.

Details of molecular docking results.

PFAS Binding Site Amino Acid Residue Binding Affinity
(kcal/mol)
PFNA Sub-domain IIA GLN-196, SER-192, LYS-195, ARC-157 −8.2
HFPO-TA Sub-domain IIA GLN-29, ASP-249, LYS-106, PHE-149 −7.9
PFOA Sub-domain IIA ARG-257, LYS-199, LEU-238 −7.8
PFO3DA Sub-domain IIA ASP-249, LYS-106, PHE-149 −7.8
PFHpA Sub-domain IIA ARG-257 −7.1
DFSA Sub-domain IIA ARG-257 −7.3

Table A5 shows the minimum points for the ESP of PFNA. The points with a smaller ESP value are prone to the electrophilic reaction or electron loss reaction.

Table A5.

Detailed information of minima points on the ESP map of PFNA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.00256476 −0.069791 −1.609415 −2.733042 −4.399004 −1.354155
2 −0.0025635 −0.069756 −1.608622 −2.71706 −4.390909 1.432051
3 −0.00310688 −0.084543 −1.949599 −2.110511 −2.418047 −1.899939
4 −0.00310165 −0.0844 −1.946316 −2.056609 −2.418278 1.952226
5 −0.00182446 −0.049646 −1.144867 −1.943003 0.229967 −2.015871
6 −0.00181719 −0.049448 −1.140304 −2.012692 0.260418 1.957219
7 0.00172291 0.046883 1.081146 −1.689175 2.734329 −2.185543
8 0.00172172 0.046851 1.080399 −1.673282 2.71025 2.206598
9 −0.00072568 −0.019747 −0.455369 −1.030583 −1.098369 −2.708088
10 −0.00072528 −0.019736 −0.455118 −1.033686 −1.101005 2.708316
11 −0.00018964 −0.00516 −0.119002 −1.004442 1.183892 −2.668494
12 −0.0035917 −0.097735 −2.25383 −0.718917 −7.256671 −1.034456
13 −0.00359286 −0.097767 −2.254555 −0.720813 −7.258846 1.031159
14 −0.00312285 −0.084977 −1.959619 1.252509 −6.230336 2.216935
15 −0.00311471 −0.084756 −1.95451 1.262496 −6.208841 −2.235629
16 −0.00329991 −0.089795 −2.070729 1.927462 −3.853978 −1.890087
17 −0.00331016 −0.090074 −2.077158 1.881056 −3.874691 1.946601
18 −0.005165 −0.140547 −3.241087 2.027359 −1.079597 −1.857081
19 −0.00517123 −0.140716 −3.244997 2.089185 −0.957638 1.844006
20 −0.00284419 −0.077394 −1.78476 2.359588 −5.984822 1.488193
21 −0.05153992 −1.402473 −32.341817 3.204304 6.311526 −0.041848

Table A6 shows the maximum points for the ESP of PFNA. The points with a higher ESP value are prone to the nucleophilic reaction.

Table A6.

Detailed information of maxima points on the ESP map of PFNA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.00078408 0.021336 0.492018 −2.198569 −3.715034 2.395152
2 0.00174453 0.047471 1.094711 −2.251314 −0.98438 −2.328944
3 0.00377408 0.102698 2.368272 −2.226006 1.815523 −2.299084
4 0.00375375 0.102145 2.355519 −2.314512 1.830511 2.217806
5 0.1369104 3.725522 85.912647 −2.261447 6.450843 −0.057965
6 0.02009527 0.54682 12.609981 −2.100253 −4.932545 −0.049461
7 0.00078732 0.021424 0.494052 −2.185753 −3.728205 −2.40383
8 0.03619023 0.984786 22.709731 −2.165058 −2.386444 −0.005823
9 0.00175421 0.047734 1.100782 −2.172007 −0.952454 2.386437
10 0.03670319 0.998745 23.031619 −2.136952 0.294628 0.00346
11 0.04159386 1.131827 26.100565 −2.099417 2.869966 −0.048825
12 −0.00037348 −0.010163 −0.234359 −1.641064 −7.163151 −0.009394
13 0.02388422 0.649923 14.987588 −0.611037 −5.323351 1.745663
14 0.02387469 0.649663 14.981606 −0.60944 −5.322585 −1.746802
15 0.01446999 0.393748 9.080064 −0.346449 −2.394971 2.126069
16 0.01394373 0.379428 8.74983 −0.331086 0.246292 −2.122432
17 0.01387798 0.377639 8.708568 −0.317189 0.256435 2.126274
18 0.01542621 0.419768 9.680099 −0.328018 2.894377 −2.118471
19 0.01542283 0.419676 9.677978 −0.323027 2.898299 2.11953
20 0.01422157 0.386989 8.924178 −0.317852 −2.396234 −2.136735
21 0.01482924 0.403524 9.305495 0.199664 −3.720799 2.113965
22 0.01378201 0.375028 8.648351 0.20886 −1.063509 2.134037
23 0.05297924 1.441638 33.245 0.166545 5.38545 −1.772435
24 0.05293733 1.440498 33.218701 0.151661 5.380913 1.774217
25 0.01475658 0.401547 9.259899 0.198373 −3.731492 −2.115702
26 0.01361038 0.370357 8.540647 0.183669 −1.086309 −2.142551
27 0.01188333 0.323362 7.456907 0.226042 1.555954 −2.143905
28 0.01183968 0.322174 7.429516 0.235588 1.583181 2.142373
29 0.03807345 1.036031 23.891471 1.241083 −6.547584 −0.044599
30 −0.00232106 −0.063159 −1.456485 1.902554 −0.007932 −2.489981
31 −0.00011733 −0.003193 −0.073624 1.941951 −5.170208 −2.408493
32 −0.00011468 −0.003121 −0.071961 1.951114 −5.166276 2.402661
33 0.03890513 1.058662 24.413359 1.981638 −3.748805 −0.059062
34 −0.00006139 −0.001671 −0.038525 2.038846 −2.535183 −2.391643
35 −0.00005025 −0.001367 −0.03153 1.983586 −2.438736 2.435133
36 −0.00232134 −0.063167 −1.456666 1.922253 0.112879 2.492599
37 0.03352563 0.912279 21.03767 2.049706 −1.078568 −0.01805
38 0.02698529 0.734307 16.933537 2.085531 1.474341 −0.001908

Table A7 shows the minimum points for the ESP of HFPO-TA. The points with a smaller ESP value are prone to the electrophilic reaction or electron loss reaction.

Table A7.

Detailed information of minima points on the ESP map of HFPO-TA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.00461712 −0.125638 −2.897286 −8.472543 −0.593419 0.787227
2 −0.00462201 −0.125771 −2.900359 −8.011784 −2.086933 −0.893139
3 −0.00390569 −0.106279 −2.45086 −7.419505 1.725907 0.868959
4 −0.00346531 −0.094296 −2.174514 −6.965548 −0.920238 −2.959857
5 −0.0038568 −0.104949 −2.420182 −5.189791 2.287263 0.134567
6 −0.00284789 −0.077495 −1.787078 −4.343449 −0.282693 −2.840069
7 −0.00861965 −0.234553 −5.408917 −4.106831 −3.279844 0.723678
8 −0.00862762 −0.234769 −5.413916 −4.167206 −1.489338 2.647718
9 −0.00410926 −0.111819 −2.578604 −2.935282 2.44127 −0.876268
10 −0.00592527 −0.161235 −3.718166 −2.529161 2.37292 1.130759
11 −0.00403446 −0.109783 −2.531661 −2.32427 0.557812 −2.58368
12 −0.00368895 −0.100381 −2.314854 −2.25471 2.528925 −1.079009
13 −0.0074728 −0.203345 −4.689259 −1.789279 −1.255814 −2.382837
14 −0.00329602 −0.089689 −2.068284 −1.306799 0.673228 −2.537822
15 −0.01346982 −0.366532 −8.452447 −0.458952 −4.00293 1.990259
16 −0.00053431 −0.014539 −0.335285 −0.36189 4.993083 −0.823153
17 −0.00398428 −0.108418 −2.500175 −0.04823 1.802948 −2.593018
18 −0.00965328 −0.262679 −6.057532 0.442236 −2.15081 −1.230912
19 −0.01784534 −0.485596 −11.198131 1.001009 −0.841836 3.210719
20 0.00218419 0.059435 1.370604 2.148046 5.437683 −0.695317
21 0.00096094 0.026149 0.603 2.184104 2.552594 −2.980563
22 −0.00387087 −0.105332 −2.42901 2.785979 −2.275365 −3.503317
23 −0.05119253 −1.393019 −32.123822 3.17561 −2.267743 3.401694
24 0.00348316 0.094782 2.185715 3.708534 2.48456 −2.4331
25 0.00427689 0.11638 2.683792 3.711152 3.682457 −1.121281
26 −0.00293275 −0.079804 −1.840332 4.739925 −4.43612 −0.202382
27 0.0085342 0.232228 5.355299 5.388592 0.295737 −2.451385

Table A8 shows the maximum points for the ESP of HFPO-TA. The points with a higher ESP value are prone to the nucleophilic reaction.

Table A8.

Detailed information of maxima points on the ESP map of HFPO-TA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.00171219 −0.046591 −1.074415 −8.396321 −1.809999 0.326795
2 0.03810275 1.036829 23.909856 −7.607055 0.495077 −1.285127
3 0.02269288 0.617505 14.240009 −6.697931 0.098194 1.38515
4 −0.00068683 −0.01869 −0.430993 −6.508742 2.580779 0.320673
5 0.01824909 0.496583 11.451486 −6.227526 −2.019959 0.991107
6 0.02322703 0.63204 14.575197 −6.189733 −2.003867 −1.361603
7 −0.00009279 −0.002525 −0.058226 −5.848933 −0.175032 −3.411765
8 −0.00280735 −0.076392 −1.76164 −5.267418 −0.375107 3.028558
9 0.01400506 0.381097 8.788318 −5.042748 1.151653 1.244851
10 −0.00272062 −0.074032 −1.707215 −4.768302 −3.540596 −0.798403
11 0.03667451 0.997964 23.01362 −4.775801 1.174763 −1.407986
12 0.01454919 0.395904 9.129764 −4.67502 −1.525325 −1.934116
13 0.00938778 0.255455 5.890927 −3.842242 −2.072009 1.38515
14 −0.00093436 −0.025425 −0.586318 −3.67684 2.787862 0.220557
15 0.01848978 0.503133 11.602522 −3.551421 0.549293 1.703955
16 −0.00055419 −0.01508 −0.347763 −3.189026 −0.433902 −3.12563
17 0.02098005 0.570896 13.165192 −2.899639 −2.001149 −0.850287
18 −0.00778084 −0.211728 −4.882557 −2.134889 −3.872607 1.641206
19 0.01227945 0.334141 7.705479 −2.188821 −1.256771 2.443504
20 0.01628279 0.443077 10.217613 −2.068557 −2.493833 −0.148523
21 0.00803789 0.218722 5.043855 −1.981162 0.245841 2.191975
22 0.00088588 0.024106 0.555897 −1.747176 1.950314 −2.372383
23 0.00393749 0.107145 2.470813 −1.593239 2.801703 −0.070088
24 −0.00044019 −0.011978 −0.276227 −1.451576 −0.026298 −2.173926
25 −0.0012484 −0.033971 −0.783385 −1.491151 2.557142 2.256567
26 0.00145774 0.039667 0.914748 −1.196356 4.256947 −0.731559
27 −0.00400782 −0.109058 −2.514949 −0.667179 −1.947917 −2.380787
28 −0.00644659 −0.175421 −4.045298 −0.538395 0.326935 3.613938
29 0.01698084 0.462072 10.655645 −0.413152 −2.864575 −0.089793
30 0.00273705 0.074479 1.717528 −0.140324 2.881141 −1.791041
31 0.0212631 0.578598 13.342806 0.266122 −2.40343 2.704226
32 0.02232602 0.607522 14.009798 0.244535 0.203737 −1.720492
33 0.01093347 0.297515 6.86086 0.457411 0.923757 1.980562
34 0.0418412 1.138557 26.25577 0.889847 4.682522 1.11228
35 0.01709159 0.465086 10.725142 1.289829 0.083739 −1.679882
36 0.02898318 0.788672 18.187234 1.293071 3.802434 −1.574311
37 0.00183059 0.049813 1.148716 1.42062 2.201627 −3.291523
38 0.0008131 0.022125 0.510226 1.420245 2.996346 3.188492
39 0.01404789 0.382263 8.815191 1.58441 1.03329 1.778987
40 0.01626472 0.442586 10.206275 2.352581 −1.364616 −2.067066
41 0.01807087 0.491733 11.339649 2.375591 3.405552 −1.738431
42 0.0180674 0.491639 11.337475 2.650086 3.280063 −1.659148
43 0.02384751 0.648924 14.964554 3.00572 1.011513 −2.235777
44 0.02835888 0.771684 17.795479 3.145662 3.131112 1.335447
45 0.02850928 0.775777 17.889858 3.607252 3.049681 0.874115
46 0.00714982 0.194557 4.486586 3.596452 4.747999 −0.314997
47 0.03733294 1.015881 23.426796 3.799693 −3.670415 −2.118871
48 0.02545209 0.692587 15.971443 4.128417 0.098194 −2.254152
49 0.00233111 0.063433 1.462793 4.340349 −1.36692 −3.935832
50 0.03548586 0.965619 22.267733 5.824356 −1.752347 −1.915001
51 0.13163069 3.581853 82.599572 7.092408 0.077673 0.579258

Table A9 shows the minimum points for the ESP of PFOA. The points with a smaller ESP value are prone to the electrophilic reaction or electron loss reaction.

Table A9.

Detailed information of minima points on the ESP map of PFOA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.00200987 −0.054691 −1.261211 −1.775007 −3.243 2.017137
2 −0.00150071 −0.040836 −0.941708 −1.798098 −0.448829 −2.05791
3 −0.00199814 −0.054372 −1.253854 −1.757805 −3.197558 −2.007395
4 −0.00147032 −0.040009 −0.92264 −1.761719 −0.429531 2.083094
5 −0.00275389 −0.074937 −1.728094 −0.982346 −5.463644 2.349377
6 −0.00275111 −0.074862 −1.726352 −0.942351 −5.446859 −2.361242
7 −0.0005793 −0.015764 −0.363517 −0.870278 −1.767582 −2.705951
8 −0.00057836 −0.015738 −0.362929 −0.875627 −1.770956 2.706464
9 −0.00007298 −0.001986 −0.045797 −0.880745 0.621726 2.682915
10 −0.00006483 −0.001764 −0.040684 −0.835353 0.617191 −2.675381
11 −0.00404254 −0.110003 −2.536735 0.925566 −6.522167 1.085761
12 −0.00404479 −0.110064 −2.538148 1.003173 −6.444512 −1.140274
13 −0.00634261 −0.172591 −3.980051 2.193822 −1.6543 −1.80503
14 −0.00631394 −0.171811 −3.962058 2.242767 −1.710627 1.741491
15 −0.05158322 −1.403651 −32.368987 3.025666 5.819282 −0.00821

Table A10 shows the maximum points for the ESP of PFOA. The points with a higher ESP value are prone to the nucleophilic reaction.

Table A10.

Detailed information of maxima points on the ESP map of PFOA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.13704021. 3.729054 85.994099 −2.409296 5.66906 −0.01039
2 0.00399517 0.108714 2.507011 −2.266245 1.03407 −2.253643
3 0.00397656 0.108208 2.495333 −2.302952 1.017791 2.221555
4 0.00223006 0.060683 1.399384 −2.105626 −1.792344 −2.342313
5 0.00223016 0.060686 1.399448 −2.090838 −1.784832 2.354018
6 0.03745099 1.019093 23.50087 −2.056136 −0.440313 −0.038059
7 0.04206036 1.144521 26.393296 −2.116933 2.119702 0.007295
8 0.00088143 0.023985 0.553106 −1.986249 −4.511536 −2.35523
9 0.00088411 0.024058 0.554787 −1.987409 −4.512713 2.354018
10 0.04020066 1.093916 25.226319 −1.962546 −3.095515 −0.063861
11 0.03834027 1.043292 24.058906 −1.175123 −5.922283 −0.058935
12 0.01396082 0.379893 8.760554 −0.298612 −0.41894 −2.115454
13 0.01395474 0.379728 8.756742 −0.300182 −0.420362 2.115262
14 0.01505192 0.409584 9.445231 −0.278421 2.24216 2.139411
15 0.01464266 0.398447 9.188417 −0.169049 −3.066181 −2.117336
16 0.01458243 0.396808 9.15062 −0.162607 −3.063081 2.119685
17 0.01515187 0.412303 9.507951 −0.286165 2.227555 −2.135413
18 0.05308007 1.444382 33.308274 0.059673 4.715223 −1.774456
19 0.05303716 1.443214 33.281346 0.047179 4.711752 1.77596
20 0.01362351 0.370715 8.548892 0.365374 −1.73894 2.123357
21 0.01187587 0.323159 7.452226 0.264205 0.808818 −2.143989
22 0.01194745 0.325107 7.497144 0.261206 0.912525 2.141228
23 0.01353749 0.368374 8.49491 0.349799 −1.757086 −2.128792
24 0.0230319 0.62673 14.452746 0.620425 −4.677041 −1.759885
25 0.02333215 0.6349 14.64116 0.655067 −4.670046 1.741323
26 −0.00113078 −0.03077 −0.709576 1.656236 −6.534042 −0.028127
27 −0.00273802 −0.074505 −1.718133 1.948824 −0.550385 2.515762
28 −0.00120364 −0.032753 −0.755296 2.061528 −3.162191 −2.488254
29 −0.00121152 −0.032967 −0.760241 2.059468 −3.198558 2.485496
30 −0.0027402 −0.074565 −1.719503 1.945421 −0.566356 −2.515328
31 0.01851887 0.503924 11.620777 2.127305 −4.273164 0.038497
32 0.03223493 0.877157 20.227741 2.174863 −1.632658 −0.038597
33 0.02692153 0.732572 16.893526 2.110263 0.921315 −0.001946

Table A11 shows the minimum points for the ESP of PFO3DA. The points with a smaller ESP value are prone to the electrophilic reaction or electron loss reaction.

Table A11.

Detailed information of minima points on the ESP map of PFO3DA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.05255014 −1.429962 −32.975739 −3.28716 6.026046 0.021618
2 −0.00867225 −0.235984 −5.441922 −2.481916 −0.142559 1.842684
3 −0.01618626 −0.440451 −10.157042 −2.479661 2.203244 1.12404
4 −0.0036853 −0.100282 −2.312562 −2.356712 −5.876054 −0.042242
5 −0.00868042 −0.236206 −5.447049 −2.362591 −0.193278 −1.933953
6 −0.016185 −0.440416 −10.15625 −2.404831 2.255065 −1.191848
7 −0.00486167 −0.132293 −3.050747 −2.207291 −4.101209 −0.040243
8 −0.00236537 −0.064365 −1.484296 0.897472 −6.315133 2.365862
9 −0.00236089 −0.064243 −1.481481 0.910678 −6.30216 −2.375327
10 −0.00128105 −0.034859 −0.803869 0.86914 1.592463 −2.68179
11 −0.00129021 −0.035108 −0.809617 0.927075 1.633614 2.690844
12 −0.00093596 −0.025469 −0.587327 1.424469 −0.510601 1.054795
13 −0.0009282 −0.025258 −0.582456 1.415665 −0.518863 −1.066977
14 −0.00434036 −0.118107 −2.723616 1.70143 −3.963915 −2.008507
15 −0.00434557 −0.118249 −2.726887 1.65271 −3.9711 2.040966
16 −0.00103522 −0.02817 −0.649609 1.678634 2.789593 −2.21551
17 −0.00102747 −0.027959 −0.644747 1.836296 2.813763 2.121085
18 −0.00296772 −0.080756 −1.862274 2.197432 0.429843 −1.451889
19 −0.00296614 −0.080713 −1.861282 2.200703 0.438037 1.465588
20 −0.00226113 −0.061529 −1.418883 2.460531 −5.930015 −1.334035
21 −0.00226313 −0.061583 −1.420139 2.466757 −5.928676 1.308587
22 −0.00362853 −0.098737 −2.276941 2.453526 −1.846924 1.301792
23 −0.00362255 −0.098575 −2.273187 2.404248 −1.776566 −1.33238

Table A12 shows the maximum points for the ESP of PFO3DA. The points with a higher ESP value are prone to the nucleophilic reaction.

Table A12.

Detailed information of maxima points on the ESP map of PFO3DA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.00209324 −0.05696 −1.313526 −2.290195 −2.105296 2.43966
2 0.03835598 1.043719 24.068761 −2.395495 −0.365425 0.007326
3 0.01400367 0.381059 8.787441 −2.26331 −3.018514 0.007698
4 −0.00208909 −0.056847 −1.310925 −2.239982 −2.081959 −2.472816
5 −0.00527126 −0.143438 −3.307765 −2.025606 1.003208 2.56989
6 0.0000298 0.000811 0.018699 −2.071707 2.260416 −0.033438
7 −0.0052645 −0.143254 −3.303524 −1.965645 0.968004 −2.595362
8 0.00046446 0.012639 0.291451 −1.795879 −7.271531 −0.032173
9 0.03573752 0.972467 22.425652 −0.800653 −5.130576 −1.562664
10 0.03573142 0.972301 22.421823 −0.777324 −5.118228 1.578095
11 0.02287684 0.622511 14.355449 −0.527908 −3.275863 −1.819096
12 0.02296866 0.625009 14.413067 −0.496951 −3.222527 1.842684
13 0.02069547 0.563152 12.986615 −0.310099 2.273284 −1.864588
14 0.02074901 0.564609 13.020208 −0.296783 2.395436 1.837612
15 0.05415975 1.473762 33.985783 −0.199311 5.291297 −1.772519
16 0.05407664 1.4715 33.933635 −0.1424 5.362713 1.769917
17 0.02236054 0.608461 14.03146 0.091103 −1.147538 −1.803363
18 0.02263293 0.615873 14.202388 0.075628 −1.185359 1.815253
19 0.0220277 0.599404 13.8226 0.116645 0.293412 −1.829727
20 0.0219972 0.598574 13.803461 0.086237 0.290265 1.83966
21 0.03928685 1.06905 24.652894 1.017163 −6.803091 0.022394
22 0.01609798 0.438048 10.101641 1.759392 −1.363067 −0.034657
23 0.01625055 0.4422 10.19738 1.801937 0.309962 0.008531
24 0.00029819 0.008114 0.187115 1.842666 −5.52699 −2.390734
25 0.00031242 0.008501 0.196045 1.892222 −5.549442 2.352285
26 0.04334405 1.179452 27.198825 1.92845 −4.096735 −0.019594
27 −0.00018058 −0.004914 −0.113317 1.943975 −2.500349 −2.392014
28 −0.00018475 −0.005027 −0.115932 1.961573 −2.491781 2.378834
29 0.00134848 0.036694 0.846183 2.074193 1.60188 −2.40639
30 0.00135946 0.036993 0.853073 2.108653 1.619562 2.384041
31 0.04533888 1.233734 28.450602 2.154487 2.909843 −0.041993
32 0.13674252 3.720953 85.807297 2.153761 6.613335 −0.04369

Table A13 shows the minimum points for the ESP of PFHpA. The points with a smaller ESP value are prone to the electrophilic reaction or electron loss reaction.

Table A13.

Detailed information of minima points on the ESP map of PFHpA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.05146101 −1.400325 −32.292301 −3.215565 4.97726 −0.025976
2 −0.00392817 −0.106891 −2.464965 −2.635794 −4.098168 −1.292152
3 −0.00392906 −0.106915 −2.465525 −2.635197 −4.097572 1.295765
4 −0.00498716 −0.135708 −3.129495 −1.902204 −2.436824 −1.880561
5 −0.00498896 −0.135757 −3.130625 −1.899997 −2.511592 1.881956
6 −0.00383752 −0.104424 −2.40808 −1.268736 −4.957645 −2.194388
7 −0.00383647 −0.104396 −2.407422 −1.235018 −4.940963 2.218143
8 −0.00395737 −0.107685 −2.483286 0.719027 −6.008258 0.971913
9 −0.0039506 −0.107501 −2.479044 0.774214 −5.95461 −1.031884
10 −0.0014334 −0.039005 −0.899471 0.994792 −2.310858 −2.699431
11 −0.00143781 −0.039125 −0.90224 1.110826 −2.18313 2.701246
12 0.00171624 0.046701 1.076958 1.669358 1.399664 2.220892
13 −0.0026688 −0.072622 −1.674701 2.068832 −1.113368 −1.943627
14 −0.00267116 −0.072686 −1.676182 2.060152 −1.116604 1.953071
15 −0.00242298 −0.065933 −1.520444 2.616608 −3.254111 −1.491868
16 −0.00242605 −0.066016 −1.522371 2.63958 −3.230077 1.469629

Table A14 shows the maximum points for the ESP of PFHpA. The points with a higher ESP value are prone to the nucleophilic reaction.

Table A14.

Detailed information of maxima points on the ESP map of PFHpA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.02756815 0.750168 17.29929 −2.049851 0.205485 −0.038608
2 −0.001146 −0.031184 −0.719129 −1.911846 −3.894457 −2.414155
3 −0.00114733 −0.03122 −0.719959 −1.899997 −3.891549 2.421932
4 0.03723575 1.013236 23.365802 −1.968163 −2.504478 0.004648
5 −0.00226707 −0.06169 −1.422611 −1.927799 −1.258982 −2.46218
6 −0.00226296 −0.061578 −1.420028 −1.899817 −1.244902 2.479951
7 0.03752633 1.021143 23.548145 −1.172053 −5.280314 −0.027178
8 0.01199426 0.32638 7.526517 −0.294143 0.224963 −2.118995
9 0.01202744 0.327283 7.547338 −0.289415 0.228646 2.11961
10 0.0136875 0.372456 8.589041 −0.165429 −2.423117 −2.122351
11 0.01340244 0.364699 8.410164 −0.14398 −2.408379 2.132516
12 0.05314232 1.446076 33.347335 −0.197049 4.038304 −1.775009
13 0.05310459 1.445049 33.323663 −0.212549 4.034761 1.774666
14 0.01376027 0.374436 8.634706 0.370819 −1.094589 2.120416
15 0.01548536 0.421378 9.717216 0.372062 1.551529 −2.113872
16 0.01549804 0.421723 9.725178 0.367062 1.547726 2.114218
17 0.01366925 0.371959 8.577593 0.358264 −1.110429 −2.124776
18 0.02318658 0.630939 14.549808 0.614673 −4.028331 −1.755704
19 0.02341819 0.637241 14.695148 0.655774 −4.023843 1.734827
20 −0.0006096 −0.016588 −0.382533 1.667707 −5.864591 −0.021787
21 0.02008522 0.546547 12.603675 2.115326 −3.62696 −0.004001
22 0.00095343 0.025944 0.598289 2.221779 −2.416539 2.386456
23 0.03635384 0.989238 22.8124 2.168346 −0.990298 −0.046647
24 0.04211295 1.145952 26.4263 2.110935 1.562847 −0.001204
25 0.00095225 0.025912 0.597545 2.217118 −2.432935 −2.388912
26 0.00362541 0.098652 2.274981 2.312435 0.464503 −2.255935
27 0.00362823 0.098729 2.276753 2.264312 0.537349 2.28501
28 0.13711331 3.731043 86.03997 2.246197 5.138156 0.001004

Table A15 shows the minimum points for the ESP of DFSA. The points with a smaller ESP value are prone to the electrophilic reaction or electron loss reaction.

Table A15.

Detailed information of minima points on the ESP map of DFSA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 −0.05174925 −1.408169 −32.473173 −5.546269 −3.034893 −0.020192
2 −0.00193414 −0.052631 −1.213695 −0.642844 2.51297 −2.099547
3 −0.00193249 −0.052586 −1.212659 −0.65777 2.518375 2.091324
4 −0.00192612 −0.052412 −1.208657 0.646666 −2.538931 −2.077621
5 −0.00193105 −0.052546 −1.211751 0.667083 −2.498787 2.106603
6 −0.05174609 −1.408083 −32.47119 5.54625 3.039861 −0.032836

Table A16 shows the maximum points for the ESP of DFSA. The points with a higher ESP value are prone to the nucleophilic reaction.

Table A16.

Detailed information of maxima points on the ESP map of DFSA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.05131117 1.396248 32.198269 −2.529019 −3.710461 −1.770272
2 0.0512158 1.393653 32.138424 −2.409386 −3.7152 1.785536
3 0.02659949 0.723809 16.691447 −2.122023 0.548931 −0.016167
4 −0.00095645 −0.026026 −0.600179 −1.328425 1.94552 2.337799
5 −0.00094822 −0.025802 −0.595015 −1.263867 1.983793 −2.348268
6 0.13500128 3.673572 84.714654 −0.936178 −5.950881 −0.028729
7 0.01272843 0.346358 7.987217 −0.769774 −1.82962 2.125084
8 0.01274119 0.346705 7.995224 −0.791081 −1.844413 −2.128081
9 0.03726105 1.013925 23.38168 −0.743958 2.819946 −0.004554
10 0.00940433 0.255905 5.901312 −0.530335 −0.373605 2.139909
11 0.00937479 0.255101 5.882773 −0.526195 −0.393771 −2.143381
12 0.0094777 0.257901 5.947349 0.562386 0.420292 2.137277
13 0.009386 0.255406 5.889808 0.528381 0.396458 −2.143002
14 0.0371607 1.011194 23.318713 0.75833 −2.791169 −0.046819
15 0.01263291 0.343759 7.927275 0.830583 1.879797 2.136512
16 0.01259436 0.34271 7.903088 0.8238 1.856303 −2.136389
17 0.13494306 3.671987 84.67812 0.953251 5.97564 −0.021955
18 −0.00095308 −0.025935 −0.598065 1.299757 −1.995275 2.323033
19 −0.00096143 −0.026162 −0.603305 1.321785 −1.928345 −2.35181
20 0.02658154 0.72332 16.680182 2.127916 −0.537859 −0.019122
21 0.05154275 1.40255 32.343594 2.495309 3.696712 −1.773594

Table A17 shows the minimum points for the ALIE of PFNA. The points with a smaller ALIE value are prone to radical and electrophilic reactions.

Table A17.

Detailed information of minima points on the ALIE map of PFNA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.63811477 17.363986 400.423402 −2.55843 −2.677464 −0.635749
2 0.63808464 17.363166 400.404492 −2.577773 −2.739161 0.572579
3 0.6396982 17.407073 401.417018 −2.532831 −2.04712 −0.64876
4 0.63964377 17.405592 401.382862 −2.562024 −1.982565 0.613311
5 0.63970201 17.407177 401.419409 −2.55091 −0.137414 −0.551044
6 0.63821974 17.366842 400.489271 −2.55103 0.701961 −0.554743
7 0.63826734 17.368138 400.51914 −2.581924 0.749257 0.568427
8 0.63199197 17.197376 396.58128 −2.554764 3.345582 0.608968
9 0.63976704 17.408947 401.460218 −2.50661 −0.024462 0.635682
10 0.63202524 17.198281 396.602159 −2.507 3.255412 −0.6251
11 0.63364731 17.24242 397.620026 −2.110344 −5.147755 −0.962784
12 0.63359919 17.241111 397.589826 −2.060921 −5.185703 0.967948
13 0.63916777 17.392639 401.084165 −0.100328 −4.697804 −2.270744
14 0.63917806 17.39292 401.090627 −0.08186 −4.708989 2.283808
15 0.63891857 17.385859 400.927794 −0.13124 −3.735819 −2.329117
16 0.63892489 17.38603 400.93176 −0.127794 −3.652858 2.327643
17 0.63987728 17.411946 401.529392 −0.087898 −1.091609 2.324723
18 0.63989072 17.412312 401.537826 −0.084971 −0.980827 −2.321999
19 0.6402458 17.421974 401.760642 −0.023857 −2.489012 −2.329117
20 0.64024553 17.421967 401.760474 −0.025784 −2.489951 2.327643
21 0.63924233 17.394668 401.130952 0.017447 0.284139 −2.332338
22 0.63340835 17.235918 397.470072 −0.081896 3.881805 −2.334194
23 0.63338188 17.235198 397.453465 −0.07375 3.890861 2.329989
24 0.52951056 14.408715 332.273172 0.044294 7.313668 1.629395
25 0.52951825 14.408924 332.277999 0.023057 7.383718 −1.596969
26 0.63928124 17.395727 401.155372 0.029438 0.394551 2.33419
27 0.63283746 17.220383 397.111832 0.566526 −7.232226 0.006243
28 0.63447313 17.264892 398.138233 1.765984 −6.544735 −0.741585
29 0.63449262 17.265422 398.150465 1.750912 −6.553793 0.751793
30 0.52474424 14.279017 329.282261 1.898895 4.933473 −1.738557
31 0.52471748 14.278289 329.265465 1.875457 4.942688 1.74491
32 0.47201831 12.844271 296.19621 2.053809 7.192063 0.015796
33 0.64281673 17.491933 403.373929 2.341666 −4.056278 −0.643588
34 0.6428381 17.492514 403.387335 2.336142 −4.057804 0.621558
35 0.64080132 17.437091 402.109239 2.421843 −3.312477 −0.545307
36 0.64081347 17.437421 402.116861 2.458191 −3.268825 0.572093
37 0.6401218 17.4186 401.68283 2.448593 −1.516157 −0.536483
38 0.64004808 17.416594 401.63657 2.458191 −1.513274 0.569333
39 0.63909448 17.390645 401.038177 2.458191 −0.723357 0.57751
40 0.63917065 17.392718 401.085974 2.498923 −0.666591 −0.595017
41 0.63498488 17.278817 398.459361 2.525802 1.979295 −0.546146
42 0.63502037 17.279783 398.481633 2.519509 1.979295 0.52844
43 0.52953213 14.409302 332.286705 2.767683 3.907992 0.011061

Table A18 shows the maximum points for the ALIE of PFNA. The points with a higher ALIE value are prone to the nucleophilic reaction.

Table A18.

Detailed information of maxima points on the ALIE map of PFNA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.64931641 17.668798 407.452541 −2.6765 −3.790408 −0.000737
2 0.64914569 17.664153 407.345412 −2.64822 −1.096307 −0.017431
3 0.64775662 17.626354 406.473759 −2.612828 1.562766 0.004908
4 0.64298368 17.496476 403.478689 −2.580699 4.413511 0.019389
5 0.73017977 19.869202 458.195109 −2.183294 −3.719198 −2.405607
6 0.65606121 17.852333 411.68497 −2.112417 −4.906367 −0.014373
7 0.73012172 19.867622 458.158683 −2.141914 −3.654847 2.433479
8 0.66906278 18.206124 419.843585 −2.163046 −2.333538 0.021076
9 0.73158381 19.907408 459.076154 −2.161313 −1.071378 −2.397696
10 0.66757232 18.165567 418.908308 −2.136961 0.274651 −0.029032
11 0.66509259 18.09809 417.352249 −2.103068 2.822754 −0.007142
12 0.72295878 19.672709 453.663866 −2.112764 4.297447 −2.382754
13 0.72301374 19.674204 453.698353 −2.092734 4.290379 2.397625
14 0.64349459 17.510378 403.799288 −2.190657 5.266733 −0.000778
15 0.73137403 19.901699 458.944517 −2.078817 −1.086347 2.451609
16 0.72993457 19.86253 458.041241 −2.078636 1.564446 −2.429991
17 0.72995444 19.86307 458.05371 −2.080714 1.563577 2.428408
18 0.72868242 19.828457 457.255504 −1.621744 −7.180741 0.023202
19 0.72563762 19.745604 455.34486 −1.654193 7.584075 0.00717
20 0.66234078 18.023209 415.625464 −0.611037 −5.413587 1.720721
21 0.66231819 18.022594 415.611287 −0.631927 −5.3317 −1.732716
22 0.65083292 17.710064 408.404164 −0.503545 −2.36004 −2.117788
23 0.65081857 17.709674 408.395163 −0.497966 −2.359336 2.116954
24 0.65611006 17.853663 411.715622 −0.293531 −6.010774 1.746055
25 0.65966301 17.950343 413.945133 0.023975 5.260194 −1.838522
26 0.65948548 17.945512 413.833731 0.129811 5.09681 −1.857489
27 0.65986383 17.955808 414.071154 0.069973 5.200356 1.844463
28 0.65073148 17.707304 408.340509 0.352335 −3.726423 −2.102522
29 0.65785599 17.901172 412.811213 0.341482 4.679287 −1.85167
30 0.65067958 17.705892 408.307942 0.404656 −3.672645 2.115972
31 0.65778089 17.899128 412.764089 0.396816 4.519346 −1.850441
32 0.65801088 17.905386 412.908404 0.387909 4.565774 1.844894
33 0.67187868 18.282749 421.610593 1.228644 −6.552897 0.018911
34 0.73185368 19.914751 459.2455 1.972466 −5.090666 −2.3915
35 0.73181299 19.913644 459.219972 1.983478 −5.137788 2.382108
36 0.67185545 18.282117 421.596016 1.977301 −3.735819 0.024162
37 0.73183192 19.914159 459.231851 2.034849 −2.448918 −2.400566
38 0.7318272 19.914031 459.228885 1.987029 −2.383759 2.433479
39 0.73105145 19.892922 458.742094 2.029975 0.178716 2.431281
40 0.66882953 18.199777 419.697221 2.049305 −1.078826 0.008414
41 0.73111002 19.894515 458.77885 2.046257 0.182642 −2.420491
42 0.6664559 18.135187 418.207742 2.082993 1.498262 0.024057
43 0.72704863 19.783999 456.230283 2.059803 2.838483 −2.434952
44 0.72703296 19.783573 456.220451 2.052489 2.836585 2.439711
45 0.64977231 17.681204 407.738624 2.526325 −2.475734 −0.02377
46 0.6486946 17.651878 407.062351 2.565942 0.2916 0.000361
47 0.59709501 16.247781 374.683088 3.423349 5.269825 0.007179

Table A19 shows the minimum points for the ALIE of HFPO-TA. The points with a smaller ALIE value are prone to radical and electrophilic reactions.

Table A19.

Detailed information of minima points on the ALIE map of HFPO-TA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.6333077 17.233179 397.406913 −8.333313 −0.060559 −0.960434
2 0.63466419 17.270091 398.258124 −7.701657 1.315301 −0.992569
3 0.6346918 17.270842 398.275452 −7.600871 1.421137 −1.103453
4 0.63527194 17.286629 398.639494 −7.440647 0.519488 −2.213255
5 0.63316307 17.229243 397.316157 −6.447362 −1.501489 1.725164
6 0.63384709 17.247856 397.745384 −6.251494 −2.690639 0.343999
7 0.63824827 17.367619 400.507173 −5.535609 0.947175 1.652036
8 0.63980342 17.409936 401.483046 −5.536107 −1.860095 −2.005135
9 0.64442064 17.535577 404.380397 −5.2186 1.845017 −1.156596
10 0.6381751 17.365628 400.461256 −5.002271 1.000949 1.707067
11 0.64417485 17.528889 404.226161 −5.076194 1.139705 −2.087889
12 0.63812101 17.364156 400.427314 −4.873095 −2.049037 −1.858623
13 0.64257173 17.485266 403.220187 −4.3135 1.738643 −1.414488
14 0.64660402 17.59499 405.750492 −4.214853 0.997795 −2.162525
15 0.63775469 17.354188 400.197446 −3.948078 1.103631 1.656233
16 0.5716844 15.556324 358.737675 −2.756053 −2.457001 0.03069
17 0.57245093 15.577182 359.21868 −2.764373 0.058836 2.151515
18 0.62720704 17.067171 393.578689 −1.883788 −2.653029 −0.731559
19 0.6527038 17.760974 409.578164 −1.891303 2.737063 −0.579823
20 0.64915598 17.664432 407.351867 −1.897566 2.796998 0.366433
21 0.63394443 17.250505 397.806469 −1.433296 −3.137988 −0.03304
22 0.63502281 17.279849 398.483165 −0.735781 −0.129162 −2.213255
23 0.63184846 17.193471 396.491226 −0.244205 −3.235323 2.760887
24 0.63784205 17.356565 400.252263 0.073669 4.968668 0.805099
25 0.6374577 17.346106 400.011084 0.294019 3.219392 −1.998434
26 0.63667636 17.324845 399.52078 0.391176 −2.438952 −0.64347
27 0.63386549 17.248357 397.756936 0.384533 −1.852851 3.390872
28 0.63776082 17.354354 400.201291 0.814518 4.53183 1.955792
29 0.57181289 15.55982 358.818308 1.050783 −0.436873 −1.319544
30 0.58051864 15.796716 364.281252 1.262137 0.578007 1.814092
31 0.63810377 17.363687 400.416499 1.669839 5.247383 0.864014
32 0.64341402 17.508186 403.748734 2.083176 3.984283 −1.686326
33 0.53213377 14.480096 333.919262 2.237788 −0.378066 2.020162
34 0.63812007 17.36413 400.426722 2.456964 3.169419 −2.052505
35 0.64905827 17.661774 407.290558 2.770924 3.377543 2.071531
36 0.63389466 17.249151 397.775237 2.909109 −3.986744 −1.913834
37 0.55939092 15.221801 351.023398 2.924089 0.14781 −2.436845
38 0.64829867 17.641104 406.813901 3.409863 3.537846 1.122938
39 0.63177937 17.191591 396.447873 3.86791 −3.473011 −2.959336
40 0.65227968 17.749433 409.31202 3.803126 2.910267 1.19797
41 0.47101112 12.816864 295.564189 4.323911 −1.735453 3.426719
42 0.63475947 17.272684 398.317914 4.603439 −4.19931 −1.913718
43 0.63333201 17.233841 397.422172 5.035427 −0.172304 −2.551443
44 0.63775572 17.354216 400.198091 5.252497 1.842364 0.004282
45 0.53083409 14.44473 333.103702 5.396771 0.586829 2.788918
46 0.63707292 17.335636 399.769631 6.418906 −1.523692 −0.827429
47 0.52837158 14.377722 331.55845 6.529632 −2.314714 1.896897

Table A20 shows the maximum points for the ALIE of HFPO-TA. The points with a higher ALIE value are prone to the nucleophilic reaction.

Table A20.

Detailed information of maxima points on the ALIE map of HFPO-TA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.72975386 19.857612 457.927845 −8.367108 −1.842346 0.339354
2 0.67262773 18.303131 422.080629 −7.631417 0.477485 −1.252149
3 0.66270485 18.033116 415.853921 −6.805635 0.127112 1.335006
4 0.73194701 19.917291 459.30407 −6.478527 2.5845 0.320548
5 0.66349887 18.054722 416.352175 −6.288071 −1.969792 −1.377563
6 0.6578525 17.901077 412.809021 −6.13171 −2.032521 1.067643
7 0.73196148 19.917685 459.31315 −5.763158 −0.27797 −3.401445
8 0.64821268 17.638764 406.759941 −5.238111 −2.435688 1.490985
9 0.72959443 19.853274 457.827801 −5.236772 −0.490229 3.050362
10 0.65045725 17.699842 408.168432 −4.990459 1.230674 1.181184
11 0.66774167 18.170175 419.014576 −4.789553 1.111908 −1.477294
12 0.72917234 19.841788 457.562933 −4.66375 −3.610048 −0.576807
13 0.64779458 17.627387 406.497576 −4.686761 −2.389105 1.597722
14 0.65193 17.739917 409.092595 −4.586467 −1.438158 −2.004347
15 0.6476009 17.622117 406.376038 −4.159748 −2.243485 1.490985
16 0.72806717 19.811715 456.869429 −3.757625 2.764529 0.319871
17 0.64574316 17.571565 405.21029 −3.686761 0.624099 1.702656
18 0.73183048 19.91412 459.230946 −3.01989 −0.49174 −3.096074
19 0.72879253 19.831453 457.324598 −2.059031 −3.903288 1.798666
20 0.65455432 17.811329 410.739384 −2.04304 −1.56279 2.717836
21 0.6545918 17.812349 410.7629 −2.123485 −1.423786 2.564884
22 0.63935328 17.397688 401.200578 −1.848529 −2.643087 −0.139023
23 0.73390661 19.970615 460.533739 −1.747124 1.950314 −2.37232
24 0.7303634 19.874199 458.310334 −1.600196 2.393373 2.341695
25 0.73485359 19.996383 461.127978 −1.254568 4.172859 −0.683936
26 0.72348531 19.687036 453.994267 −0.564174 −1.997717 −2.33129
27 0.72985913 19.860477 457.993902 −0.46485 0.132424 3.769161
28 0.66206673 18.015752 415.453495 −0.329417 −2.878498 −0.056928
29 0.6694424 18.216454 420.081803 0.28534 −2.448062 2.655175
30 0.6750326 18.368571 423.589709 0.924239 4.706368 1.070747
31 0.73488123 19.997135 461.145319 1.123343 2.687266 3.170694
32 0.6517687 17.735528 408.991377 1.231419 −0.485872 2.121306
33 0.72544786 19.74044 455.225787 1.225918 2.156336 −3.291585
34 0.6657158 18.115048 417.743323 1.268414 3.88437 −1.538247
35 0.72805369 19.811348 456.860972 1.505267 −3.468053 −0.425463
36 0.65384515 17.792031 410.294372 2.253827 −1.648091 −2.124549
37 0.64017466 17.420038 401.716003 2.931227 1.403258 −2.362091
38 0.66161351 18.003419 415.169096 3.007259 3.210544 1.482423
39 0.73583373 20.023054 461.743027 3.455855 4.912726 −0.404503
40 0.73495108 19.999036 461.189154 3.688994 1.324272 2.658312
41 0.65330247 17.777264 409.953834 3.859439 −3.976471 −0.031695
42 0.67018738 18.236726 420.54928 3.83047 −3.712241 −2.054861
43 0.65896484 17.931345 413.507027 3.862962 2.960255 0.701723
44 0.72841812 19.821265 457.089657 3.994297 −1.529609 −4.015827
45 0.63972236 17.407731 401.432178 4.35751 −0.060559 −2.374504
46 0.72776367 19.803457 456.678981 4.785849 2.991948 −1.684078
47 0.65676408 17.87146 412.126031 5.012207 1.201793 0.411743
48 0.55772347 15.176427 349.977056 5.155523 −1.326582 3.295731
49 0.66068248 17.978084 414.584861 5.765548 −1.760622 −2.018923
50 0.72998749 19.86397 458.074449 6.247707 −3.870636 −0.484307
51 0.64085816 17.438637 402.144905 6.247095 −1.727455 −0.394266
52 0.72092281 19.617307 452.386276 6.689096 0.416411 −1.366572
53 0.72506515 19.730026 454.985635 7.219034 −0.071063 1.56644

Table A21 shows the minimum points for the ALIE of PFOA. The points with a smaller ALIE value are prone to radical and electrophilic reactions.

Table A21.

Detailed information of minima points on the ALIE map of PFOA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.63840523 17.37189 400.605667 −2.498296 −0.015889 0.522351
2 0.63191734 17.195345 396.534448 −2.565444 2.546935 −0.621485
3 0.63196923 17.196757 396.567009 −2.57339 2.546368 0.649549
4 0.64060539 17.431759 401.986285 −2.444421 −2.614197 −0.529998
5 0.6406248 17.432287 401.998467 −2.452198 −2.621974 0.565555
6 0.63989404 17.412402 401.53991 −2.449946 −0.85997 −0.596384
7 0.63989524 17.412435 401.540664 −2.443072 −0.85997 0.574681
8 0.63841808 17.372239 400.613728 −2.473511 −0.110845 −0.625857
9 0.63442079 17.263468 398.105388 −1.725215 −5.90634 −0.725319
10 0.63441388 17.26328 398.101056 −1.728271 −5.91105 0.754973
11 0.63276202 17.21833 397.064497 −0.51987 −6.582752 −0.02779
12 0.52953856 14.409477 332.290744 −0.185783 6.654347 −1.635733
13 0.63339042 17.23543 397.458822 −0.136438 3.283199 2.336571
14 0.63339171 17.235465 397.459629 −0.134031 3.283676 −2.334735
15 0.52952468 14.409099 332.282033 −0.132763 6.669561 1.622856
16 0.64005585 17.416806 401.641449 0.04265 −1.814712 2.323701
17 0.64006734 17.417118 401.648656 0.046689 −1.808874 −2.320693
18 0.63915853 17.392388 401.078369 0.15649 −4.161611 −2.263432
19 0.63912533 17.391485 401.057538 0.112342 −4.056271 2.283411
20 0.63879646 17.382536 400.851165 0.152836 −2.977661 −2.331017
21 0.6393189 17.396752 401.179002 0.076808 −0.314574 −2.319353
22 0.63932308 17.396866 401.181628 0.079041 −0.314913 2.320817
23 0.63881424 17.383019 400.862322 0.16715 −3.079718 2.34017
24 0.52475504 14.279311 329.289033 1.797567 4.379513 −1.746478
25 0.52475588 14.279334 329.289562 1.797952 4.379898 1.746477
26 0.47184942 12.839676 296.090232 1.900766 6.59942 0.024485
27 0.63351971 17.238948 397.539956 2.061528 −4.537855 −1.046724
28 0.63354396 17.239608 397.555169 2.163986 −4.465516 0.95161
29 0.63792671 17.358869 400.305391 2.584485 −2.02585 −0.640319
30 0.63795253 17.359571 400.321591 2.585746 −2.025469 0.646271
31 0.63901426 17.388462 400.987837 2.542515 −1.331502 −0.578188
32 0.63902398 17.388727 400.993939 2.590705 −1.243499 0.56817
33 0.63513877 17.283005 398.55593 2.556135 1.457816 −0.54711
34 0.63514101 17.283066 398.557337 2.555206 1.46841 0.528356
35 0.52970865 14.414105 332.397475 2.721702 3.364539 0.011467

Table A22 shows the maximum points for the ALIE of PFOA. The points with a higher ALIE value are prone to the nucleophilic reaction.

Table A22.

Detailed information of maxima points on the ALIE map of PFOA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.64298177 17.496424 403.477489 −2.66271 3.614336 0.022803
2 0.64960833 17.676741 407.63572 −2.509567 −1.922931 −0.013639
3 0.64796246 17.631955 406.602923 −2.584721 0.841246 0.005706
4 0.64350538 17.510672 403.806062 −2.281822 4.5579 0.01084
5 0.7228963 19.671009 453.624656 −2.190399 3.575726 −2.379031
6 0.72299463 19.673684 453.686362 −2.17189 3.565329 2.392815
7 0.66558043 18.111364 417.658373 −2.115909 2.159404 −0.026584
8 0.73164572 19.909093 459.115008 −1.960219 −4.433655 2.376786
9 0.73168005 19.910027 459.13655 −2.029705 −1.794461 −2.398687
10 0.66804193 18.178345 419.202994 −2.059281 −0.53924 −0.001778
11 0.73002283 19.864932 458.096629 −2.05105 0.84235 −2.429732
12 0.73002932 19.865108 458.1007 −2.050598 0.84187 2.429911
13 0.73171104 19.91087 459.155996 −1.92604 −4.441356 −2.400857
14 0.67155779 18.274017 421.409232 −1.957816 −3.079489 0.001391
15 0.73143506 19.90336 458.982816 −1.944459 −1.808313 2.453932
16 0.72568945 19.747014 455.377388 −1.846182 6.863406 0.003347
17 0.67174428 18.279092 421.526256 −1.190503 −5.911203 0.013512
18 0.65053138 17.701859 408.214947 −0.383846 −3.087853 2.113169
19 0.65059214 17.703512 408.253072 −0.371364 −3.079094 −2.110074
20 0.65987646 17.956152 414.07908 −0.055181 4.537638 −1.856845
21 0.65980206 17.954127 414.03239 −0.027704 4.555208 1.835734
22 0.65792107 17.902943 412.852051 0.262325 4.00846 −1.851845
23 0.65810042 17.907823 412.964596 0.303259 3.943559 1.839316
24 0.65048546 17.70061 408.186133 0.572187 −1.710075 −2.130974
25 0.65044142 17.699411 408.158497 0.488838 −1.700872 2.115124
26 0.66222742 18.020124 415.554326 0.623304 −4.752495 1.736019
27 0.66228936 18.02181 415.593197 0.675944 −4.685845 −1.726329
28 0.72844702 19.822051 457.107789 1.739489 −6.455609 0.006019
29 0.72689611 19.779849 456.134579 2.049003 2.205796 2.427619
30 0.72694801 19.781261 456.167146 2.055465 2.214034 −2.423235
31 0.655932 17.848817 411.603887 2.167363 −4.203289 0.020154
32 0.72993114 19.862436 458.03909 2.164737 −2.977376 2.432196
33 0.73093965 19.889879 458.671937 2.091694 −0.419341 −2.44113
34 0.73106134 19.893191 458.748302 2.151306 −0.339279 2.401074
35 0.66673682 18.142832 418.384022 2.108379 0.939232 0.023362
36 0.7299505 19.862963 458.05124 2.175157 −2.974636 −2.425208
37 0.66902814 18.205181 419.821846 2.17008 −1.704662 0.000878
38 0.64919848 17.665589 407.37854 2.693988 −3.168615 0.005919
39 0.64867543 17.651356 407.05032 2.645917 −0.381416 −0.02532
40 0.59696002 16.244108 374.598385 3.308064 4.63723 −0.015481

Table A23 shows the minimum points for the ALIE of PFO3DA. The points with a smaller ALIE value are prone to radical and electrophilic reactions.

Table A23.

Detailed information of minima points on the ALIE map of PFO3DA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.63691676 17.331386 399.671634 −2.898749 −0.91548 −0.565905
2 0.63694208 17.332075 399.687525 −2.907297 −0.949033 0.53654
3 0.63640414 17.317437 399.349962 −2.893576 0.202298 −0.609969
4 0.6363292 17.315398 399.302936 −2.884345 0.213927 0.561437
5 0.50289722 13.684529 315.573032 −2.387982 3.547339 0.112889
6 0.47093756 12.814863 295.518031 −2.229194 7.01214 0.043477
7 0.50109997 13.635624 314.445241 −2.073625 3.791768 −1.050226
8 0.5011294 13.636424 314.463709 −2.105888 3.741207 0.969541
9 0.63974606 17.408375 401.447047 −1.417052 −5.678731 −1.464674
10 0.63978301 17.409381 401.470238 −1.481837 −5.68911 1.433934
11 0.5653333 15.383501 354.752297 −1.18715 −4.018122 −1.64388
12 0.56532478 15.383269 354.74695 −1.205382 −4.02098 1.635067
13 0.561448 15.277777 352.314236 −1.106218 3.158002 −1.573369
14 0.56143176 15.277335 352.304046 −1.049156 3.160017 1.604554
15 0.63524285 17.285837 398.621242 −0.358698 −1.58109 −2.271804
16 0.63783056 17.356252 400.245052 −0.252863 −5.115933 2.194718
17 0.6352119 17.284995 398.601821 −0.333162 −1.587138 2.251711
18 0.63487838 17.275919 398.392531 −0.252863 0.774628 −2.262532
19 0.52892098 14.392672 331.903204 −0.263476 7.384357 1.59136
20 0.63781219 17.355752 400.233529 −0.242389 −5.08793 −2.200817
21 0.6350606 17.280878 398.506876 −0.140732 −2.872876 2.249933
22 0.63490174 17.276555 398.407188 −0.238957 0.735189 2.244975
23 0.52885101 14.390768 331.859298 −0.202229 7.338233 −1.625712
24 0.63509192 17.28173 398.526529 −0.112547 −2.856156 −2.276878
25 0.63414012 17.25583 397.929265 0.007865 1.889992 −2.262301
26 0.63416594 17.256533 397.945472 0.011699 1.995827 2.239567
27 0.63123719 17.176837 396.10765 0.121894 4.089249 −2.254108
28 0.63122061 17.176386 396.097248 0.170479 4.059014 2.29188
29 0.63989533 17.412437 401.540717 0.32039 −7.379452 −0.044738
30 0.5701646 15.514968 357.783991 0.651586 −0.462609 −1.676345
31 0.57022753 15.51668 357.823478 0.675885 −0.450027 1.666115
32 0.63831025 17.369305 400.546067 1.54634 −6.840396 −0.723826
33 0.638329 17.369815 400.557831 1.54634 −6.842228 0.733434
34 0.641745 17.46277 402.701406 2.347911 −4.468637 −0.644264
35 0.64174452 17.462757 402.701106 2.352162 −4.47721 0.642649
36 0.63692801 17.331693 399.678698 2.456664 −3.401781 −0.530183
37 0.63691236 17.331267 399.668875 2.46207 −3.401781 0.546199
38 0.63528606 17.287013 398.648358 2.636757 2.336225 0.562661
39 0.63529762 17.287327 398.655608 2.61221 2.423963 −0.615152
40 0.62921902 17.12192 394.841229 2.678548 3.477524 −0.632012
41 0.62923063 17.122236 394.848511 2.678892 3.477524 0.633643

Table A24 shows the maximum points for the ALIE of PFO3DA. The points with a higher ALIE value are prone to the nucleophilic reaction.

Table A24.

Detailed information of maxima points on the ALIE map of PFO3DA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.59606914 16.219866 374.039348 −3.406011 4.97501 0.030687
2 0.65168328 17.733204 408.937776 −2.404956 −2.879598 −0.006436
3 0.72685866 19.77883 456.111076 −2.440884 −1.903436 −2.38267
4 0.72684388 19.778428 456.101806 −2.459067 −1.917844 2.367614
5 0.67104139 18.259965 421.08518 −2.398103 −0.33903 −0.000883
6 0.7263825 19.765873 455.812282 −2.36791 1.15698 2.360939
7 0.65037646 17.697643 408.117731 −2.367745 1.994922 0.025523
8 0.72638734 19.766005 455.815317 −2.334722 1.167668 −2.382344
9 0.73686518 20.051121 462.390269 −1.855831 −7.215043 0.006821
10 0.55631377 15.138067 349.092452 −1.449249 7.499271 0.211367
11 0.66391746 18.066113 416.614845 −0.793099 −5.204562 −1.575364
12 0.66401261 18.068702 416.674553 −0.79234 −5.216215 1.578035
13 0.64244389 17.481787 403.139964 −0.515351 −2.978439 −1.938834
14 0.64225882 17.476751 403.023831 −0.502296 −3.016202 1.92206
15 0.64140354 17.453478 402.487135 −0.374211 2.101663 −1.922064
16 0.64147062 17.455303 402.529228 −0.358698 2.037726 1.963959
17 0.6582239 17.911183 413.042079 −0.379424 4.312985 −1.719687
18 0.65829363 17.913081 413.085835 −0.366456 4.335255 1.732003
19 0.6573612 17.887708 412.500726 −0.252863 −6.471009 1.647817
20 0.65742373 17.88941 412.539966 −0.200967 −6.524949 −1.62445
21 0.66020908 17.965203 414.287801 −0.062983 5.170891 −1.837287
22 0.64261897 17.486551 403.24983 0.064644 −1.437482 −1.934591
23 0.64260727 17.486233 403.242486 0.042471 −1.395358 1.914595
24 0.64203046 17.470537 402.880533 0.064644 0.492472 −1.943435
25 0.64200344 17.469802 402.86358 0.064644 0.453922 1.92206
26 0.65989553 17.95667 414.091042 −0.036142 5.274066 1.813079
27 0.65524256 17.830057 411.171258 0.39762 −7.00858 0.975774
28 0.67419123 18.345676 423.061739 1.003125 −6.807623 0.012569
29 0.72661784 19.772277 455.959961 1.466889 7.721221 0.032951
30 0.73098579 19.891135 458.70089 1.863846 −5.501247 −2.380239
31 0.73100362 19.89162 458.712084 1.879136 −5.503299 2.369452
32 0.67224615 18.292748 421.841181 1.921157 −4.04799 −0.013272
33 0.72595192 19.754156 455.542092 1.969682 −2.534455 −2.378138
34 0.72586426 19.751771 455.487081 1.921616 −2.472254 2.403171
35 0.65113927 17.718401 408.596406 1.929641 −1.536783 −0.002951
36 0.64982749 17.682705 407.773248 2.028343 0.514131 −0.006277
37 0.7246019 19.71742 454.69494 2.065575 1.477981 −2.399331
38 0.72463689 19.718373 454.716897 2.05638 1.45655 2.402057
39 0.66645412 18.135139 418.206624 2.149364 2.940585 −0.003015
40 0.71795485 19.536545 450.523846 2.181353 4.55567 −2.381249
41 0.71797024 19.536964 450.533507 2.2482 4.523806 2.338611
42 0.64732857 17.614706 406.20515 2.275749 5.379919 0.009344
43 0.655114 17.826558 411.090584 2.374878 −5.417472 0.005656

Table A25 shows the minimum points for the ALIE of PFHpA. The points with a smaller ALIE value are prone to radical and electrophilic reactions.

Table A25.

Detailed information of minima points on the ALIE map of PFHpA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.52970838 14.414098 332.397306 −2.764695 2.572858 0.016782
2 0.63540866 17.290349 398.725286 −2.486323 0.63169 0.525609
3 0.63541346 17.29048 398.728302 −2.536889 0.71717 −0.529897
4 0.64006655 17.417097 401.64816 −2.41535 −2.028974 −0.538874
5 0.64005189 17.416698 401.638961 −2.44483 −1.986814 0.54715
6 0.47191765 12.841532 296.133047 −2.146681 5.840994 0.01329
7 0.5248336 14.281449 329.338334 −1.90068 3.648544 −1.747687
8 0.52488749 14.282915 329.372148 −1.872719 3.691128 1.75988
9 0.63430798 17.260398 398.034602 −1.788782 −5.235571 −0.741568
10 0.63427294 17.259444 398.012613 −1.724986 −5.269619 0.754121
11 0.63261253 17.214262 396.97069 −0.492151 −5.972199 −0.012232
12 0.52959508 14.411015 332.326208 −0.060915 6.030524 −1.616159
13 0.52962982 14.41196 332.34801 −0.027746 6.044434 1.613447
14 0.63959238 17.404194 401.350613 0.05022 −1.159251 −2.312514
15 0.63956083 17.403335 401.330819 0.041035 −1.064918 2.319297
16 0.63903248 17.388958 400.999274 0.116696 −3.388831 −2.270362
17 0.63902568 17.388773 400.995002 0.112212 −3.413709 2.276079
18 0.63863486 17.378138 400.749762 0.149403 −2.334359 −2.336194
19 0.6386565 17.378727 400.763338 0.15734 −2.324394 2.341751
20 0.63353656 17.239406 397.550526 0.076282 2.548124 −2.322396
21 0.6335366 17.239408 397.550554 0.07678 2.546825 2.32255
22 0.63329682 17.232883 397.400086 2.014745 −3.918008 −1.059074
23 0.63327483 17.232284 397.38629 2.060574 −3.893981 0.964358
24 0.63783332 17.356327 400.246789 2.578423 −1.383905 −0.647438
25 0.63782418 17.356079 400.241053 2.567673 −1.383919 0.612871
26 0.6383078 17.369239 400.544528 2.533538 −0.70158 −0.594368
27 0.63833989 17.370112 400.564662 2.598009 −0.584283 0.581284
28 0.63213879 17.201371 396.673411 2.534902 2.008777 −0.593004
29 0.63214852 17.201636 396.679516 2.547343 2.008777 0.634293

Table A26 shows the maximum points for the ALIE of PFHpA. The points with a higher ALIE value are prone to the nucleophilic reaction.

Table A26.

Detailed information of maxima points on the ALIE map of PFHpA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.59715342 16.249371 374.719742 −3.428364 3.918411 0.003175
2 0.6492129 17.665981 407.387584 −2.500813 −1.382014 −0.012644
3 0.73099165 19.891294 458.704573 −2.05875 −1.166286 2.382994
4 0.73165524 19.909352 459.12098 −1.975392 −3.823955 −2.374379
5 0.73172501 19.91125 459.164764 −1.952915 −3.834467 2.389865
6 0.6714057 18.269878 421.313789 −1.966177 −2.439367 −0.00911
7 0.73118091 19.896444 458.823331 −2.028661 −1.151378 −2.404846
8 0.66701893 18.150508 418.561046 −2.051435 0.224843 0.013517
9 0.72716429 19.787147 456.302866 −2.048263 1.48583 −2.431227
10 0.72716268 19.787103 456.301855 −2.061268 1.480324 2.422164
11 0.67171522 18.278301 421.50802 −1.194763 −5.267825 0.015083
12 0.65029982 17.695558 408.069641 −0.384088 −2.440533 2.110947
13 0.65821004 17.910806 413.033382 −0.382218 3.269777 −1.843628
14 0.65816586 17.909604 413.00566 −0.365383 3.323582 1.843263
15 0.65034832 17.696878 408.100074 −0.362171 −2.435279 −2.106316
16 0.66005934 17.961128 414.193836 −0.06651 3.902984 −1.84118
17 0.66001415 17.959898 414.165482 −0.047877 3.89384 1.854771
18 0.64998859 17.687089 407.874343 0.493927 −1.054444 −2.116793
19 0.64997276 17.686658 407.864407 0.487746 −1.060008 2.115687
20 0.66216958 18.018551 415.518035 0.622436 −4.110785 1.727948
21 0.6620053 18.01408 415.414945 0.667845 −4.029418 −1.72764
22 0.72851032 19.823774 457.147512 1.64549 −5.884708 0.021551
23 0.72567013 19.746488 455.365264 1.667083 6.251435 0.012727
24 0.72299946 19.673816 453.689393 2.055819 2.957937 2.427444
25 0.72306953 19.675722 453.733358 2.062794 2.967046 −2.422204
26 0.65569305 17.842315 411.453944 2.129523 −3.600502 −0.022781
27 0.72980387 19.858973 457.959229 2.167999 −2.431724 −2.4227
28 0.72978442 19.858444 457.947022 2.161868 −2.333872 2.427567
29 0.66869619 18.196149 419.613548 2.163415 −1.067258 −0.00883
30 0.72990976 19.861855 458.025676 2.174668 0.261503 −2.383007
31 0.72999485 19.86417 458.079067 2.155863 0.305392 2.395445
32 0.66558203 18.111408 417.659382 2.111743 1.618309 0.026886
33 0.6436586 17.514841 403.902211 2.157216 4.014776 −0.012264
34 0.64319389 17.502196 403.610599 2.590003 3.065286 −0.005716
35 0.64895598 17.65899 407.226368 2.681329 −2.548404 −0.014505
36 0.64801125 17.633283 406.633541 2.638546 0.345437 0.025021

Table A27 shows the minimum points for the ALIE of DFSA. The points with a smaller ALIE value are prone to radical and electrophilic reactions.

Table A27.

Detailed information of minima points on the ALIE map of DFSA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.47176366 12.837342 296.036412 −5.036839 −4.321914 0.021566
2 0.53009117 14.424514 332.637511 −4.021707 −1.185442 0.001255
3 0.52473329 14.278719 329.275389 −3.720042 −2.473581 −1.733779
4 0.52467758 14.277203 329.240427 −3.705399 −2.514063 1.74569
5 0.52944867 14.407031 332.234334 −3.395921 −5.532939 −1.591188
6 0.52944138 14.406833 332.229759 −3.354809 −5.497441 1.61987
7 0.63467498 17.270384 398.264896 −2.75288 0.363996 −0.543653
8 0.63469973 17.271058 398.280426 −2.75288 0.358646 0.528432
9 0.63699964 17.333642 399.723646 −2.278623 1.056586 −0.584843
10 0.63700462 17.333777 399.726767 −2.277601 1.08321 0.580368
11 0.63320976 17.230514 397.345456 −1.474252 −2.559816 −2.317118
12 0.63321737 17.230721 397.350231 −1.477265 −2.570835 2.32056
13 0.63181548 17.192573 396.470531 −0.923937 3.382336 −0.615125
14 0.63182928 17.192949 396.479191 −0.911791 3.380737 0.570318
15 0.63184326 17.193329 396.487964 0.932393 −3.312837 −0.646613
16 0.63183267 17.193041 396.481317 0.924468 −3.31443 0.615627
17 0.63327755 17.232358 397.387992 1.489392 2.626725 2.340562
18 0.63326542 17.232028 397.380385 1.485633 2.614857 −2.336818
19 0.6370273 17.334394 399.741003 2.295757 −0.987586 −0.65379
20 0.63471394 17.271445 398.289345 2.766061 −0.349628 −0.524442
21 0.63472602 17.271773 398.296927 2.754966 −0.355913 0.524926
22 0.52949863 14.408391 332.265687 3.279741 5.476363 −1.652922
23 0.52943753 14.406728 332.227343 3.324275 5.496099 1.631321
24 0.52473811 14.27885 329.278409 3.677734 2.51297 1.746642
25 0.5247035 14.277908 329.256693 3.725943 2.557571 −1.755348
26 0.52943072 14.406543 332.223073 3.93625 1.163988 0.016325
27 0.47180249 12.838399 296.060779 5.051765 4.306327 −0.018835

Table A28 shows the maximum points for the ALIE of DFSA. The points with a higher ALIE value are prone to the nucleophilic reaction.

Table A28.

Detailed information of maxima points on the ALIE map of DFSA.

Number a.u. eV kcal/mol X/Y/Z Coordinate (Angstrom)
1 0.59711237 16.248254 374.693983 −5.187095 −1.981966 −0.025987
2 0.7264121 19.766678 455.830855 −2.820207 −0.556258 −2.396453
3 0.72640508 19.766487 455.826449 −2.752067 −0.556244 2.434979
4 0.6598242 17.95473 414.046286 −2.274018 −3.649702 −1.850264
5 0.65978989 17.953796 414.024755 −2.275824 −3.625486 1.852171
6 0.65767439 17.89623 412.697259 −2.268402 −3.220391 1.859593
7 0.65784526 17.90088 412.804476 −2.241119 −2.999618 −1.846282
8 0.65781093 17.899946 412.78294 −2.223702 −2.939755 1.849175
9 0.6653816 18.105954 417.533608 −2.117867 0.558208 −0.023806
10 0.7255519 19.743271 455.291076 −2.012349 −6.583775 0.00033
11 0.64699701 17.605684 405.997093 −1.890447 1.889491 0.001947
12 0.72891381 19.834753 457.400704 −1.444764 1.687977 −2.39687
13 0.72895773 19.835949 457.428268 −1.422839 1.620466 2.43347
14 0.6640284 18.069132 416.684463 −0.802896 2.724641 0.020874
15 0.6433462 17.50634 403.706174 −0.422229 −4.892435 0.003014
16 0.64293787 17.495229 403.449946 −0.417325 4.309077 0.002483
17 0.72280347 19.668483 453.566405 −0.055239 3.994666 −2.383206
18 0.72277604 19.667736 453.549195 −0.004075 3.964412 2.423623
19 0.72279749 19.66832 453.56265 0.048779 −3.998891 −2.385024
20 0.72279027 19.668123 453.558122 0.083254 −3.955321 2.383002
21 0.64321202 17.502689 403.621974 0.422184 4.893617 −0.026803
22 0.64285102 17.492866 403.395444 0.454331 −4.260499 0.015737
23 0.66478446 18.089705 417.158899 0.760175 −2.778802 0.009666
24 0.72893059 19.83521 457.411235 1.423671 −1.614612 −2.434961
25 0.72897096 19.836309 457.436566 1.446935 −1.619244 2.419962
26 0.64693379 17.603964 405.957425 1.920346 −1.836894 0.004695
27 0.7255505 19.743233 455.290197 2.009716 6.582976 0.023207
28 0.66563329 18.112803 417.691545 2.117738 −0.555104 −0.000577
29 0.6577282 17.897695 412.731024 2.221386 2.914058 −1.84743
30 0.65789796 17.902314 412.837551 2.252868 2.95276 1.829939
31 0.65761273 17.894552 412.658564 2.274245 3.200842 −1.852924
32 0.65976438 17.953102 414.008745 2.271587 3.621525 −1.855583
33 0.65982781 17.954828 414.04855 2.27337 3.651266 1.850441
34 0.72661688 19.772251 455.95936 2.766534 0.592119 −2.439673
35 0.72662377 19.772438 455.96368 2.775212 0.614054 2.442536
36 0.59708799 16.24759 374.678683 5.193966 1.991242 0.001022

Table A29 shows the detailed CDFT descriptors, indicating the possible reactive sites of the PFNA molecule.

Table A29.

Detailed information of CDFT descriptors of PFNA.

Atom q(N) q(N + 1) q(N − 1) f (r) f (r) + f (r) 0 Δf(r) Electrophilicity Nucleophilicity s s+ s 0 s+/s s/s+
1(F) −0.0911 −0.097 −0.0837 0.0074 0.0059 0.0067 −0.0015 0.01445 −0.01245 0.0295 0.0236 0.0265 0.8007 1.2489
2(F) −0.0911 −0.097 −0.0837 0.0074 0.0059 0.0067 −0.0015 0.01445 −0.01245 0.0295 0.0236 0.0265 0.8007 1.2489
3(F) −0.0907 −0.0937 −0.087 0.0037 0.003 0.0034 −0.0007 0.00729 −0.00626 0.0148 0.0119 0.0134 0.804 1.2438
4(F) −0.0907 −0.0937 −0.087 0.0037 0.003 0.0034 −0.0007 0.00729 −0.00626 0.0148 0.0119 0.0134 0.804 1.2438
5(F) −0.0923 −0.1032 −0.0777 0.0145 0.0109 0.0127 −0.0036 0.02658 −0.02445 0.0579 0.0434 0.0506 0.7501 1.3332
6(F) −0.0923 −0.1032 −0.0777 0.0145 0.0109 0.0127 −0.0036 0.02658 −0.02445 0.0579 0.0434 0.0506 0.7501 1.3332
7(F) −0.0907 −0.0923 −0.0888 0.0019 0.0016 0.0017 −0.0003 0.00386 −0.00322 0.0076 0.0063 0.007 0.8286 1.2069
8(F) −0.0907 −0.0923 −0.0888 0.0019 0.0016 0.0017 −0.0003 0.00386 −0.00322 0.0076 0.0063 0.007 0.8286 1.2069
9(F) −0.0924 −0.119 −0.0639 0.0285 0.0266 0.0276 −0.0019 0.06494 −0.04792 0.1134 0.1061 0.1097 0.935 1.0695
10(F) −0.0924 −0.119 −0.0639 0.0285 0.0266 0.0276 −0.0019 0.06494 −0.04792 0.1134 0.1061 0.1097 0.935 1.0695
11(F) −0.0917 −0.0925 −0.0906 0.001 0.0009 0.001 −0.0002 0.00211 −0.00177 0.0042 0.0034 0.0038 0.8231 1.2148
12(F) −0.0917 −0.0925 −0.0906 0.001 0.0009 0.001 −0.0002 0.00211 −0.00177 0.0042 0.0034 0.0038 0.8231 1.2148
13(F) −0.095 −0.2159 −0.0112 0.0838 0.1209 0.1023 0.0371 0.29473 −0.14092 0.3336 0.4813 0.4074 1.443 0.693
14(F) −0.095 −0.2159 −0.0112 0.0838 0.1209 0.1023 0.0371 0.29473 −0.14092 0.3336 0.4813 0.4074 1.443 0.693
15(F) −0.0919 −0.0927 −0.091 0.0009 0.0008 0.0009 −0.0001 0.00192 −0.00157 0.0037 0.0031 0.0034 0.848 1.1792
16(F) −0.0914 −0.0919 −0.0909 0.0006 0.0005 0.0005 −0.0001 0.00121 −0.00096 0.0023 0.002 0.0021 0.8698 1.1497
17(F) −0.0914 −0.0919 −0.0909 0.0006 0.0005 0.0005 −0.0001 0.00121 −0.00096 0.0023 0.002 0.0021 0.8698 1.1497
18(O) −0.1486 −0.2676 −0.0096 0.1391 0.119 0.129 −0.0201 0.29012 −0.23394 0.5538 0.4738 0.5138 0.8557 1.1687
19(O) −0.2623 −0.4745 0.0507 0.313 0.2122 0.2626 −0.1008 0.5174 −0.52659 1.2464 0.845 1.0457 0.6779 1.4751
20(C) 0.1816 0.1791 0.1851 0.0035 0.0025 0.003 −0.001 0.00611 −0.00591 0.014 0.01 0.012 0.7131 1.4022
21(C) 0.1818 0.1805 0.1835 0.0017 0.0013 0.0015 −0.0004 0.00314 −0.0028 0.0066 0.0051 0.0059 0.7727 1.2942
22(C) 0.1808 0.1781 0.1876 0.0068 0.0027 0.0048 −0.0041 0.00664 −0.01148 0.0272 0.0108 0.019 0.3991 2.5056
23(C) 0.1814 0.1807 0.1822 0.0009 0.0007 0.0008 −0.0001 0.00179 −0.00144 0.0034 0.0029 0.0032 0.8598 1.163
24(C) 0.1817 0.1778 0.1917 0.01 0.0039 0.0069 −0.0062 0.00944 −0.01687 0.0399 0.0154 0.0277 0.3863 2.5887
25(C) 0.1772 0.1768 0.1776 0.0005 0.0004 0.0004 −0.0001 0.00097 −0.0008 0.0019 0.0016 0.0017 0.8366 1.1953
26(C) 0.1909 0.1221 0.2521 0.0612 0.0688 0.065 0.0076 0.16772 −0.10296 0.2437 0.2739 0.2588 1.124 0.8897
27(C) 0.279 0.2786 0.2794 0.0004 0.0004 0.0004 −0.0001 0.00088 −0.00074 0.0017 0.0014 0.0016 0.8272 1.2089
28(C) 0.2117 0.0226 0.3244 0.1127 0.1891 0.1509 0.0764 0.46115 −0.18962 0.4488 0.7531 0.601 1.678 0.596
29(H) 0.2095 0.1525 0.2757 0.0662 0.057 0.0616 −0.0092 0.13893 −0.11136 0.2636 0.2269 0.2452 0.8608 1.1617

Note: q(N): Hirshfeld charges in neutral state; q(N+1): Hirshfeld charges in a positive charge state; q(N−1): Hirshfeld charges in a negative charge state; f(r): electrophilic Fukui function; f(r)+: nucleophilic Fukui function; f(r)0: radical Fukui function; Δf(r): condensed dual descriptors; electrophilicity: reduced local electrophilic index; nucleophilicity: reduced local nucleophilic index; s: reduced local softness; s+: relative electrophilic index; s0: relative nucleophilic index; E(N): −2190.661502 Hartree; E(N+1): −2190.748081 Hartree; E(N−1): −2190.323797 Hartree; E_HOMO(N): −0.397022 Hartree, −10.8035 eV; E_HOMO(N+1): −0.165714 Hartree, −4.5093 eV; E_HOMO(N−1): −0.43199 Hartree, −11.755 eV; vertical IP: 0.225392 Hartree, 6.1332 eV; vertical EA: 0.071224 Hartree, 1.9381 eV; Mulliken electronegativity: 0.212142 Hartree, 5.7727 eV; chemical potential:−0.212142 Hartree, −5.7727 eV; hardness (=fundamental gap):0.251126 Hartree, 6.8335 eV; Softness: 3.982066 Hartree−1, 0.1463 eV−1; electrophilicity index: 0.089605 Hartree, 2.4383 eV; nucleophilicity index: −0.061824 Hartree, −1.6823 eV.

Table A30 shows the detailed CDFT descriptors, indicating the possible reactive sites of the HFPO-TA molecule.

Table A30.

Detailed information of CDFT descriptors of HFPO-TA.

Atom q(N) q(N + 1) q(N − 1) f (r) f (r) + f (r) 0 Δf(r) Electrophilicity Nucleophilicity s s+ s 0 s+/s s/s+
1(F) −0.0961 −0.1258 −0.0865 0.0096 0.0298 0.0197 0.0202 0.10554 −0.01764 0.0454 0.1412 0.0933 3.1109 0.3214
2(F) −0.0974 −0.2034 −0.0627 0.0346 0.106 0.0703 0.0714 0.37604 −0.06384 0.1643 0.5031 0.3337 3.0624 0.3265
3(F) −0.0836 −0.1895 −0.067 0.0166 0.1058 0.0612 0.0892 0.37532 −0.03064 0.0789 0.5021 0.2905 6.3679 0.157
4(F) −0.091 −0.1044 −0.0867 0.0042 0.0134 0.0088 0.0092 0.04755 −0.00779 0.02 0.0636 0.0418 3.1751 0.3149
5(F) −0.0973 −0.1082 −0.0927 0.0046 0.0109 0.0077 0.0063 0.03867 −0.00845 0.0218 0.0517 0.0367 2.3785 0.4204
6(F) −0.0913 −0.1123 −0.0786 0.0127 0.021 0.0168 0.0083 0.07443 −0.02338 0.0602 0.0996 0.0799 1.655 0.6042
7(F) −0.0906 −0.1016 −0.0888 0.0019 0.0109 0.0064 0.009 0.03867 −0.00346 0.0089 0.0517 0.0303 5.8174 0.1719
8(F) −0.0913 −0.1061 −0.0861 0.0053 0.0148 0.01 0.0095 0.05239 −0.0097 0.025 0.0701 0.0475 2.8072 0.3562
9(F) −0.0906 −0.0967 −0.088 0.0026 0.0061 0.0043 0.0036 0.02175 −0.00472 0.0121 0.0291 0.0206 2.3963 0.4173
10(F) −0.0913 −0.0978 −0.0886 0.0026 0.0065 0.0046 0.0039 0.0231 −0.00482 0.0124 0.0309 0.0216 2.493 0.4011
11(F) −0.0873 −0.0671 −0.0028 0.0844 −0.0201 0.0321 −0.1046 −0.07145 −0.15561 0.4005 −0.0956 0.1524 −0.2387 −4.1892
12(F) −0.0907 −0.0954 −0.0888 0.002 0.0046 0.0033 0.0027 0.01638 −0.0036 0.0093 0.0219 0.0156 2.3647 0.4229
13(F) −0.0912 −0.0946 −0.0906 0.0007 0.0034 0.002 0.0027 0.01209 −0.00123 0.0032 0.0162 0.0097 5.1031 0.196
14(F) −0.0914 −0.0939 −0.0899 0.0015 0.0024 0.002 0.001 0.00868 −0.00269 0.0069 0.0116 0.0093 1.6761 0.5966
15(F) −0.0899 −0.1063 −0.056 0.0339 0.0164 0.0252 −0.0175 0.05823 −0.06259 0.1611 0.0779 0.1195 0.4837 2.0675
16(F) −0.0881 −0.1081 −0.0604 0.0277 0.02 0.0239 −0.0077 0.07103 −0.05116 0.1317 0.095 0.1133 0.7218 1.3854
17(F) −0.0903 −0.1191 −0.0636 0.0267 0.0288 0.0278 0.0021 0.10217 −0.04929 0.1269 0.1367 0.1318 1.0775 0.9281
18(O) −0.1405 −0.1526 −0.1352 0.0053 0.0121 0.0087 0.0067 0.04286 −0.00984 0.0253 0.0573 0.0413 2.2651 0.4415
19(O) −0.137 −0.4135 −0.0844 0.0526 0.2765 0.1646 0.2239 0.98059 −0.09701 0.2496 1.3118 0.7807 5.2551 0.1903
20(O) −0.1471 −0.1935 −0.0139 0.1332 0.0463 0.0898 −0.0869 0.16434 −0.24555 0.6319 0.2199 0.4259 0.3479 2.8742
21(O) −0.2681 −0.317 −0.0092 0.2589 0.0489 0.1539 −0.21 0.17338 −0.47727 1.2282 0.2319 0.7301 0.1888 5.2952
22(C) 0.1574 0.144 0.1606 0.0032 0.0134 0.0083 0.0103 0.04758 −0.00583 0.015 0.0636 0.0393 4.2432 0.2357
23(C) 0.2541 0.1833 0.27 0.0159 0.0708 0.0433 0.0549 0.25092 −0.02929 0.0754 0.3357 0.2055 4.4537 0.2245
24(C) 0.257 0.2524 0.2584 0.0015 0.0046 0.003 0.0031 0.0163 −0.00268 0.0069 0.0218 0.0144 3.1586 0.3166
25(C) 0.281 0.2751 0.2842 0.0032 0.0059 0.0045 0.0028 0.021 −0.00582 0.015 0.0281 0.0215 1.8755 0.5332
26(C) 0.1759 0.1724 0.1775 0.0016 0.0034 0.0025 0.0018 0.01222 −0.00302 0.0078 0.0163 0.0121 2.101 0.476
27(C) 0.1612 0.1118 0.2238 0.0626 0.0494 0.056 −0.0132 0.17514 −0.11545 0.2971 0.2343 0.2657 0.7886 1.268
28(C) 0.2795 0.2775 0.2801 0.0006 0.002 0.0013 0.0014 0.00725 −0.00117 0.003 0.0097 0.0064 3.2262 0.31
29(C) 0.2842 0.2819 0.3033 0.0191 0.0023 0.0107 −0.0168 0.00804 −0.03523 0.0907 0.0108 0.0507 0.1186 8.4287
30(C) 0.1929 0.1789 0.3019 0.109 0.014 0.0615 −0.0949 0.04977 −0.2009 0.517 0.0666 0.2918 0.1288 7.7651
31(H) 0.2006 0.1315 0.2625 0.0619 0.0691 0.0655 0.0072 0.24509 −0.11407 0.2935 0.3279 0.3107 1.117 0.8952

Note: q(N): Hirshfeld charges in neutral state; q(N+1): Hirshfeld charges in a positive charge state; q(N−1): Hirshfeld charges in a negative charge state; f(r): electrophilic Fukui function; f(r)+: nucleophilic Fukui function; f(r)0: radical Fukui function; Δf: condensed dual descriptors; electrophilicity: reduced local electrophilic index; nucleophilicity: reduced local nucleophilic index; s: reduced local softness; s+: relative electrophilic index; s0: relative nucleophilic index; E(N): −1383.391208 Hartree; E(N+1): −1383.487614 Hartree; E(N−1): −1383.166034 Hartree; E_HOMO(N): −0.40295 Hartree, −10.9648 eV; E_HOMO(N+1):−0.314238 Hartree, −8.5509 eV; E_HOMO(N−1): −0.453262 Hartree,−12.3339 eV; vertical IP: 0.33978 Hartree, 9.2459 eV; vertical EA:0.129003 Hartree, 3.5103 eV; Mulliken electronegativity: 0.234392 Hartree, 6.3781 eV; chemical potential: −0.234392 Hartree, −6.3781 eV; hardness (=fundamental gap): 0.210778 Hartree, 5.7356 eV; softness: 4.744334 Hartree−1, 0.1744 eV−1; electrophilicity index: 0.130325 Hartree, 3.5463 eV; nucleophilicity index: −0.067752 Hartree, −1.8436 eV.

Table A31 shows the detailed CDFT descriptors, indicating the possible reactive sites of the PFOA molecule.

Table A31.

Detailed information of CDFT descriptors of PFOA.

Atom q(N) q(N + 1) q(N − 1) f (r) f (r) + f (r) 0 Δf(r) Electrophilicity Nucleophilicity s s+ s 0 s+/s s/s+
1(F) −0.0909 −0.0969 −0.0836 0.0074 0.0059 0.0066 −0.0015 0.0144 −0.01243 0.0293 0.0235 0.0264 0.8016 1.2476
2(F) −0.0909 −0.0969 −0.0836 0.0074 0.0059 0.0066 −0.0015 0.0144 −0.01243 0.0293 0.0235 0.0264 0.8016 1.2476
3(F) −0.0922 −0.1031 −0.0777 0.0145 0.011 0.0127 −0.0035 0.0267 −0.02439 0.0576 0.0436 0.0506 0.7571 1.3209
4(F) −0.0922 −0.1031 −0.0777 0.0145 0.011 0.0127 −0.0035 0.0267 −0.02439 0.0576 0.0436 0.0506 0.7571 1.3209
5(F) −0.0909 −0.0939 −0.0872 0.0037 0.003 0.0034 −0.0007 0.00733 −0.00624 0.0147 0.012 0.0134 0.8131 1.2298
6(F) −0.0909 −0.0939 −0.0872 0.0037 0.003 0.0034 −0.0007 0.00733 −0.00624 0.0147 0.012 0.0134 0.8131 1.2298
7(F) −0.0924 −0.119 −0.064 0.0284 0.0266 0.0275 −0.0017 0.06497 −0.04787 0.113 0.1061 0.1096 0.9387 1.0653
8(F) −0.0924 −0.119 −0.064 0.0284 0.0266 0.0275 −0.0017 0.06497 −0.04787 0.113 0.1061 0.1096 0.9387 1.0653
9(F) −0.0917 −0.0934 −0.0897 0.002 0.0017 0.0018 −0.0003 0.00407 −0.00339 0.008 0.0066 0.0073 0.8293 1.2058
10(F) −0.0917 −0.0934 −0.0897 0.002 0.0017 0.0018 −0.0003 0.00407 −0.00339 0.008 0.0066 0.0073 0.8293 1.2058
11(F) −0.095 −0.216 −0.0117 0.0834 0.121 0.1022 0.0377 0.29504 −0.14055 0.3319 0.4819 0.4069 1.4519 0.6888
12(F) −0.095 −0.216 −0.0117 0.0834 0.121 0.1022 0.0377 0.29504 −0.14055 0.3319 0.4819 0.4069 1.4519 0.6888
13(F) −0.092 −0.0934 −0.0903 0.0017 0.0014 0.0016 −0.0003 0.00349 −0.00286 0.0068 0.0057 0.0062 0.845 1.1834
14(F) −0.0915 −0.0924 −0.0904 0.0011 0.0009 0.001 −0.0002 0.0022 −0.00183 0.0043 0.0036 0.004 0.8336 1.1996
15(F) −0.0915 −0.0924 −0.0904 0.0011 0.0009 0.001 −0.0002 0.0022 −0.00183 0.0043 0.0036 0.004 0.8336 1.1996
16(O) −0.1485 −0.2674 −0.0093 0.1392 0.1189 0.129 −0.0203 0.28986 −0.2347 0.5542 0.4734 0.5138 0.8542 1.1707
17(O) −0.2623 −0.4741 0.0529 0.3152 0.2118 0.2635 −0.1034 0.51631 −0.53152 1.2551 0.8433 1.0492 0.6719 1.4884
18(C) 0.1818 0.1792 0.1853 0.0035 0.0026 0.003 −0.001 0.00624 −0.00596 0.0141 0.0102 0.0121 0.724 1.3812
19(C) 0.1809 0.1781 0.1876 0.0067 0.0027 0.0047 −0.004 0.0067 −0.01138 0.0269 0.0109 0.0189 0.4074 2.4544
20(C) 0.1813 0.18 0.1829 0.0016 0.0013 0.0015 −0.0003 0.00318 −0.00274 0.0065 0.0052 0.0058 0.8031 1.2452
21(C) 0.1817 0.1778 0.1917 0.01 0.0039 0.0069 −0.0061 0.00946 −0.01685 0.0398 0.0155 0.0276 0.3884 2.5748
22(C) 0.1772 0.1764 0.1781 0.0009 0.0008 0.0009 −0.0002 0.0019 −0.00158 0.0037 0.0031 0.0034 0.8333 1.2001
23(C) 0.191 0.122 0.2517 0.0607 0.069 0.0648 0.0083 0.16819 −0.10236 0.2417 0.2747 0.2582 1.1365 0.8799
24(C) 0.2789 0.2783 0.2798 0.0008 0.0007 0.0007 −0.0001 0.00167 −0.00137 0.0032 0.0027 0.003 0.838 1.1933
25(C) 0.2117 0.0227 0.3243 0.1126 0.189 0.1508 0.0764 0.46068 −0.18988 0.4484 0.7524 0.6004 1.6781 0.5959
26(H) 0.2095 0.1525 0.2753 0.0658 0.0569 0.0614 −0.0089 0.1388 −0.11096 0.262 0.2267 0.2444 0.8652 1.1558

Note: q(N): Hirshfeld charges in neutral state; q(N+1): Hirshfeld charges in a positive charge state; q(N−1): Hirshfeld charges in a negative charge state; f(r): electrophilic Fukui function; f(r)+: nucleophilic Fukui function; f(r)0: radical Fukui function; Δf(r): condensed dual descriptors; electrophilicity: reduced local electrophilic index; nucleophilicity: reduced local nucleophilic index; s: reduced local softness; s+: relative electrophilic index; s0: relative nucleophilic index; E(N): −1952.944666 Hartree; E(N+1): −1953.031224 Hartree; E(N−1): −1952.606956 Hartree; E_HOMO(N): −0.397162 Hartree, −10.8073 eV; E_HOMO(N+1): −0.165717 Hartree, −4.5094 eV; E_HOMO(N−1): −0.437355 Hartree, −11.901 eV; vertical IP: 0.33771 Hartree, 9.1896 eV; vertical EA: 0.086558 Hartree, 2.3554 eV; Mulliken electronegativity: 0.212134 Hartree, 5.7725 eV; chemical potential: −0.212134 Hartree, −5.7725 eV; hardness (=fundamental gap): 0.251152 Hartree, 6.8342 eV; softness: 3.981655 Hartree−1, 0.1463 eV−1; electrophilicity index: 0.089589 Hartree, 2.4378 eV; nucleophilicity index: −0.061964 Hartree, −1.6861 eV.

Table A32 shows the detailed CDFT descriptors, indicating the possible reactive sites of the PFO3DA molecule.

Table A32.

Detailed information of CDFT descriptors of PFO3DA.

Atom q(N) q(N + 1) q(N − 1) f (r) f (r) + f (r) 0 Δf(r) Electrophilicity Nucleophilicity s s+ s 0 s+/s s/s+
1(F) −0.0955 −0.1015 −0.0898 0.0056 0.006 0.0058 0.0004 0.01387 −0.01054 0.0219 0.0233 0.0226 1.0662 0.9379
2(F) −0.0955 −0.1015 −0.0898 0.0056 0.006 0.0058 0.0004 0.01387 −0.01054 0.0219 0.0233 0.0226 1.0662 0.9379
3(F) −0.0952 −0.098 −0.0924 0.0028 0.0028 0.0028 0 0.00656 −0.00529 0.011 0.011 0.011 1.0057 0.9943
4(F) −0.0952 −0.098 −0.0924 0.0028 0.0028 0.0028 0 0.00656 −0.00529 0.011 0.011 0.011 1.0057 0.9943
5(F) −0.0971 −0.1159 −0.079 0.018 0.0188 0.0184 0.0007 0.04334 −0.03376 0.0701 0.0729 0.0715 1.0398 0.9617
6(F) −0.0971 −0.1159 −0.079 0.018 0.0188 0.0184 0.0007 0.04334 −0.03376 0.0701 0.0729 0.0715 1.0398 0.9617
7(F) −0.0965 −0.0973 −0.0957 0.0008 0.0008 0.0008 0 0.00186 −0.00144 0.003 0.0031 0.0031 1.046 0.9561
8(F) −0.0965 −0.0973 −0.0957 0.0008 0.0008 0.0008 0 0.00186 −0.00144 0.003 0.0031 0.0031 1.046 0.9561
9(F) −0.1022 −0.2002 −0.049 0.0532 0.098 0.0756 0.0448 0.22628 −0.09947 0.2066 0.3808 0.2937 1.8431 0.5426
10(F) −0.1022 −0.2002 −0.049 0.0532 0.098 0.0756 0.0448 0.22628 −0.09947 0.2066 0.3808 0.2937 1.8431 0.5426
11(F) −0.0861 −0.0868 −0.0856 0.0006 0.0006 0.0006 0.0001 0.00144 −0.00104 0.0022 0.0024 0.0023 1.1242 0.8895
12(F) −0.0961 −0.0966 −0.0956 0.0005 0.0005 0.0005 0 0.0011 −0.00097 0.002 0.0019 0.0019 0.9244 1.0818
13(F) −0.0961 −0.0966 −0.0956 0.0005 0.0005 0.0005 0 0.0011 −0.00097 0.002 0.0019 0.0019 0.9244 1.0818
14(O) −0.1423 −0.1448 −0.1398 0.0025 0.0025 0.0025 0.0001 0.00585 −0.00462 0.0096 0.0099 0.0097 1.0256 0.975
15(O) −0.1362 −0.1491 −0.1267 0.0095 0.0129 0.0112 0.0034 0.02976 −0.01771 0.0368 0.0501 0.0434 1.3614 0.7345
16(O) −0.1464 −0.1469 −0.146 0.0004 0.0005 0.0004 0.0001 0.0011 −0.00074 0.0015 0.0019 0.0017 1.2134 0.8241
17(O) −0.1496 −0.2779 0 0.1496 0.1283 0.139 −0.0212 0.29633 −0.27981 0.5812 0.4987 0.5399 0.858 1.1655
18(O) −0.265 −0.5089 0.1535 0.4185 0.2438 0.3312 −0.1747 0.56303 −0.78292 1.6262 0.9475 1.2868 0.5826 1.7163
19(C) 0.2595 0.2558 0.263 0.0035 0.0037 0.0036 0.0002 0.00854 −0.00651 0.0135 0.0144 0.0139 1.0628 0.9409
20(C) 0.2598 0.258 0.2617 0.0019 0.0018 0.0018 −0.0001 0.00418 −0.00352 0.0073 0.007 0.0072 0.9608 1.0408
21(C) 0.2585 0.2484 0.2698 0.0113 0.0101 0.0107 −0.0011 0.02338 −0.02105 0.0437 0.0393 0.0415 0.8998 1.1114
22(C) 0.258 0.2575 0.2584 0.0005 0.0005 0.0005 0 0.00116 −0.00088 0.0018 0.002 0.0019 1.0662 0.9379
23(C) 0.2721 0.2138 0.3125 0.0405 0.0582 0.0494 0.0178 0.13448 −0.07572 0.1573 0.2263 0.1918 1.4388 0.695
24(C) 0.3609 0.3605 0.3614 0.0004 0.0004 0.0004 0 0.00094 −0.00079 0.0016 0.0016 0.0016 0.957 1.0449
25(C) 0.2138 −0.0088 0.3366 0.1228 0.2226 0.1727 0.0998 0.514 −0.22967 0.477 0.865 0.671 1.8132 0.5515
26(H) 0.2094 0.15 0.2857 0.0763 0.0594 0.0678 −0.0169 0.13707 −0.14275 0.2965 0.2307 0.2636 0.778 1.2854

Note: q(N): Hirshfeld charges in neutral state; q(N+1): Hirshfeld charges in a positive charge state; q(N−1): Hirshfeld charges in a negative charge state; f(r): electrophilic Fukui function; f(r)+: nucleophilic Fukui function; f(r)0: radical Fukui function; Δf(r): condensed dual descriptors; electrophilicity: reduced local electrophilic index; nucleophilicity: reduced local nucleophilic index; s: reduced local softness; s+: relative electrophilic index; s0: relative nucleophilic index; E(N): −1940.870842 Hartree; E(N+1): −1940.951158 Hartree; E(N−1): −1940.53318 Hartree; E_HOMO(N): −0.403948 Hartree, −10.992 eV; E_HOMO(N+1): −0.157532 Hartree, −4.2867 eV; E_HOMO(N−1): −0.480193 Hartree, −13.0667 eV; vertical IP: 0.337662 Hartree, 9.1883 eV; vertical EA: 0.080315 Hartree, 2.1855 eV; Mulliken electronegativity: 0.208989 Hartree, 5.6869 eV; chemical potential: −0.208989 Hartree, −5.6869 eV; hardness (=fundamental gap): 0.257347 Hartree, 7.0028 eV; softness: 3.885805 Hartree−1, 0.1428 eV−1; electrophilicity index: 0.084859 Hartree, 2.3091 eV; nucleophilicity index: −0.06875 Hartree, −1.8708 eV.

Table A33 shows the detailed CDFT descriptors, indicating the possible reactive sites of the PFHpA molecule.

Table A33.

Detailed information of CDFT descriptors of PFHpA.

Atom q(N) q(N + 1) q(N − 1) f (r) f (r) + f (r) 0 Δf(r) Electrophilicity Nucleophilicity s s+ s 0 s+/s s/s+
1(F) −0.092 −0.1029 −0.0775 0.0144 0.0109 0.0127 −0.0035 0.02664 −0.02451 0.0575 0.0435 0.0505 0.7554 1.3238
2(F) −0.092 −0.1029 −0.0775 0.0144 0.0109 0.0127 −0.0035 0.02664 −0.02451 0.0575 0.0435 0.0505 0.7554 1.3238
3(F) −0.0912 −0.0971 −0.0838 0.0073 0.006 0.0067 −0.0014 0.01455 −0.01245 0.0292 0.0237 0.0265 0.8123 1.231
4(F) −0.0912 −0.0971 −0.0838 0.0073 0.006 0.0067 −0.0014 0.01455 −0.01245 0.0292 0.0237 0.0265 0.8123 1.231
5(F) −0.0923 −0.1189 −0.064 0.0283 0.0267 0.0275 −0.0017 0.06507 −0.04802 0.1127 0.1061 0.1094 0.9416 1.062
6(F) −0.0923 −0.1189 −0.064 0.0283 0.0267 0.0275 −0.0017 0.06507 −0.04802 0.1127 0.1061 0.1094 0.9416 1.062
7(F) −0.0919 −0.0951 −0.0881 0.0039 0.0032 0.0035 −0.0007 0.0078 −0.00656 0.0154 0.0127 0.0141 0.8257 1.2111
8(F) −0.0919 −0.0951 −0.0881 0.0039 0.0032 0.0035 −0.0007 0.0078 −0.00656 0.0154 0.0127 0.0141 0.8257 1.2111
9(F) −0.0949 −0.2159 −0.0116 0.0833 0.121 0.1022 0.0376 0.2953 −0.14136 0.3319 0.4817 0.4068 1.4516 0.6889
10(F) −0.0949 −0.2159 −0.0116 0.0833 0.121 0.1022 0.0376 0.2953 −0.14136 0.3319 0.4817 0.4068 1.4516 0.6889
11(F) −0.0921 −0.0948 −0.0889 0.0032 0.0027 0.0029 −0.0005 0.00657 −0.00543 0.0128 0.0107 0.0117 0.8405 1.1898
12(F) −0.0916 −0.0933 −0.0895 0.0021 0.0018 0.0019 −0.0003 0.0043 −0.00355 0.0083 0.007 0.0077 0.8417 1.188
13(F) −0.0916 −0.0933 −0.0895 0.0021 0.0018 0.0019 −0.0003 0.0043 −0.00355 0.0083 0.007 0.0077 0.8417 1.188
14(O) −0.1486 −0.2675 −0.0093 0.1393 0.119 0.1291 −0.0203 0.2904 −0.2362 0.5545 0.4737 0.5141 0.8543 1.1705
15(O) −0.2623 −0.4743 0.0527 0.3149 0.212 0.2635 −0.1029 0.51754 −0.5342 1.2541 0.8443 1.0492 0.6732 1.4854
16(C) 0.1811 0.1783 0.1879 0.0068 0.0028 0.0048 −0.004 0.00683 −0.01156 0.0271 0.0111 0.0191 0.4107 2.4349
17(C) 0.1812 0.1787 0.1847 0.0035 0.0026 0.003 −0.0009 0.00624 −0.00588 0.0138 0.0102 0.012 0.737 1.3568
18(C) 0.1818 0.1779 0.1917 0.0099 0.0039 0.0069 −0.0061 0.00946 −0.01686 0.0396 0.0154 0.0275 0.3901 2.5633
19(C) 0.1771 0.1756 0.1788 0.0018 0.0014 0.0016 −0.0003 0.00348 −0.00297 0.007 0.0057 0.0063 0.8129 1.2301
20(C) 0.1909 0.1221 0.2518 0.0609 0.0689 0.0649 0.008 0.16812 −0.10327 0.2424 0.2743 0.2583 1.1313 0.884
21(C) 0.2789 0.2776 0.2804 0.0015 0.0013 0.0014 −0.0002 0.00314 −0.00259 0.0061 0.0051 0.0056 0.8442 1.1846
22(C) 0.2117 0.0228 0.3246 0.1129 0.1889 0.1509 0.076 0.46115 −0.19145 0.4495 0.7523 0.6009 1.6738 0.5975
23(H) 0.2095 0.1526 0.2759 0.0664 0.057 0.0617 −0.0094 0.13902 −0.11256 0.2642 0.2268 0.2455 0.8582 1.1652

Note: q(N): Hirshfeld charges in neutral state; q(N+1): Hirshfeld charges in a positive charge state; q(N−1): Hirshfeld charges in a negative charge state; f(r): electrophilic Fukui function; f(r)+: nucleophilic Fukui function; f(r)0: radical Fukui function; Δf(r): condensed dual descriptors; electrophilicity: reduced local electrophilic index; nucleophilicity: reduced local nucleophilic index; s: reduced local softness; s+: relative electrophilic index; s0: relative nucleophilic index; E(N): −1715.227813 Hartree; E(N+1): −1715.314508 Hartree; E(N−1): −1714.889987 Hartree; E_HOMO(N): −0.397531 Hartree, −10.8174 eV; E_HOMO(N+1):−0.165856 Hartree, −4.5132 eV; E_HOMO(N−1): −0.444055 Hartree, −12.0834 eV; vertical IP: 0.337826 Hartree, 9.1927 eV; Vertical EA: 0.086695 Hartree, 2.3591 eV; Mulliken electronegativity: 0.21226 Hartree, 5.7759 eV; chemical potential: −0.21226 Hartree, −5.7759 eV; hardness (=fundamental gap): 0.251131 Hartree, 6.8336 eV; softness: 3.981982 Hartree−1, 0.1463 eV−1; electrophilicity index: 0.089703 Hartree, 2.4409 eV; nucleophilicity index: −0.062333 Hartree, −1.6962 eV.

Table A34 shows detailed CDFT descriptors, indicating the possible reactive sites of the DFSA molecule.

Table A34.

Detailed information of CDFT descriptors of DFSA.

Atom q(N) q(N + 1) q(N − 1) f (r) f (r) + f (r) 0 Δf(r) Electrophilicity Nucleophilicity s s+ s 0 s+/s s/s+
1(F) −0.0929 −0.1018 −0.0715 0.0214 0.0089 0.0152 −0.0125 0.01727 −0.03423 0.0715 0.0298 0.0506 0.4174 2.3959
2(F) −0.0929 −0.1018 −0.0715 0.0214 0.0089 0.0152 −0.0125 0.01727 −0.03423 0.0715 0.0298 0.0506 0.4174 2.3959
3(F) −0.0929 −0.1018 −0.0715 0.0214 0.0089 0.0152 −0.0125 0.01727 −0.03423 0.0715 0.0298 0.0506 0.4174 2.3959
4(F) −0.0929 −0.1018 −0.0715 0.0214 0.0089 0.0152 −0.0125 0.01727 −0.03423 0.0715 0.0298 0.0506 0.4174 2.3959
5(F) −0.0928 −0.1075 −0.0674 0.0254 0.0147 0.0201 −0.0107 0.02848 −0.04068 0.0849 0.0492 0.067 0.5792 1.7265
6(F) −0.0928 −0.1075 −0.0674 0.0254 0.0147 0.0201 −0.0107 0.02848 −0.04068 0.0849 0.0492 0.067 0.5792 1.7265
7(F) −0.0928 −0.1075 −0.0674 0.0254 0.0147 0.0201 −0.0107 0.02848 −0.04068 0.0849 0.0492 0.067 0.5792 1.7265
8(F) −0.0928 −0.1075 −0.0674 0.0254 0.0147 0.0201 −0.0107 0.02848 −0.04068 0.0849 0.0492 0.067 0.5792 1.7265
9(F) −0.0951 −0.1467 −0.055 0.0402 0.0515 0.0459 0.0113 0.09964 −0.06429 0.1342 0.1721 0.1531 1.2824 0.7798
10(F) −0.0951 −0.1467 −0.055 0.0402 0.0515 0.0459 0.0113 0.09964 −0.06429 0.1342 0.1721 0.1531 1.2824 0.7798
11(F) −0.0951 −0.1467 −0.055 0.0402 0.0515 0.0459 0.0113 0.09964 −0.06429 0.1342 0.1721 0.1531 1.2824 0.7798
12(F) −0.0951 −0.1467 −0.055 0.0402 0.0515 0.0459 0.0113 0.09964 −0.06429 0.1342 0.1721 0.1531 1.2824 0.7798
13(O) −0.1488 −0.2127 −0.084 0.0648 0.0639 0.0643 −0.0008 0.12358 −0.10359 0.2162 0.2134 0.2148 0.987 1.0131
14(O) −0.1488 −0.2127 −0.084 0.0648 0.0639 0.0643 −0.0008 0.12358 −0.10359 0.2162 0.2134 0.2148 0.987 1.0131
15(O) −0.2624 −0.3758 −0.1248 0.1376 0.1134 0.1255 −0.0242 0.21928 −0.2201 0.4595 0.3787 0.4191 0.8243 1.2132
16(O) −0.2624 −0.3758 −0.1248 0.1376 0.1134 0.1255 −0.0242 0.21928 −0.2201 0.4595 0.3787 0.4191 0.8243 1.2132
17(C) 0.1805 0.1772 0.1904 0.0099 0.0033 0.0066 −0.0067 0.00633 −0.0159 0.0332 0.0109 0.0221 0.3293 3.0368
18(C) 0.1805 0.1772 0.1904 0.0099 0.0033 0.0066 −0.0067 0.00633 −0.0159 0.0332 0.0109 0.0221 0.3293 3.0368
19(C) 0.1814 0.1778 0.1904 0.009 0.0036 0.0063 −0.0054 0.00695 −0.0144 0.0301 0.012 0.021 0.3991 2.5055
20(C) 0.1814 0.1778 0.1904 0.009 0.0036 0.0063 −0.0054 0.00695 −0.0144 0.0301 0.012 0.021 0.3991 2.5055
21(C) 0.1908 0.1604 0.2148 0.024 0.0304 0.0272 0.0064 0.05874 −0.03836 0.0801 0.1015 0.0908 1.2671 0.7892
22(C) 0.1908 0.1604 0.2148 0.024 0.0304 0.0272 0.0064 0.05874 −0.03836 0.0801 0.1015 0.0908 1.2671 0.7892
23(C) 0.2116 0.1077 0.2627 0.051 0.1039 0.0775 0.0529 0.20088 −0.08163 0.1704 0.3469 0.2587 2.036 0.4912
24(C) 0.2116 0.1077 0.2627 0.051 0.1039 0.0775 0.0529 0.20088 −0.08163 0.1704 0.3469 0.2587 2.036 0.4912
25(H) 0.2093 0.1789 0.2389 0.0297 0.0304 0.03 0.0008 0.05882 −0.04743 0.099 0.1016 0.1003 1.026 0.9747
26(H) 0.2093 0.1789 0.2389 0.0297 0.0304 0.03 0.0008 0.05882 −0.04743 0.099 0.1016 0.1003 1.026 0.9747

Note: q(N): Hirshfeld charges in neutral state; q(N+1): Hirshfeld charges in a positive charge state; q(N−1): Hirshfeld charges in a negative charge state; f(r): electrophilic Fukui function; f(r)+: nucleophilic Fukui function; f(r)0: radical Fukui function; Δf(r): condensed dual descriptors; electrophilicity: reduced local electrophilic index; nucleophilicity: reduced local nucleophilic index; s: reduced local softness; s+: relative electrophilic index; s0: relative nucleophilic index; E(N): −1804.507374 Hartree; E(N+1): −1804.563939 Hartree; E(N−1): −1804.151354 Hartree; E_HOMO(N): −0.393987 Hartree, −10.7209 eV; E_HOMO(N+1): −0.101246 Hartree, −2.755 eV; E_HOMO(N−1): −0.364223 Hartree, −9.911 eV; vertical IP: 0.35602 Hartree, 9.6878 eV; vertical EA: 0.056566 Hartree, 1.5392 eV; Mulliken electronegativity: 0.206293 Hartree, 5.6135 eV; chemical potential: −0.206293 Hartree, −5.6135 eV; hardness (=fundamental gap): 0.299454 Hartree, 8.1486 eV; softness: 3.339412 Hartree−1, 0.1227 eV−1; electrophilicity index: 0.071057 Hartree, 1.9336 eV; nucleophilicity index: −0.058789 Hartree, −1.5997 eV.

Figure A1.

Figure A1

Stern–Volmer plots for quenching of HSA with PFAS at different temperatures. C[HSA] = 1 × 10−6 mol·L−1, C[PFAS] = 0, 3, 6, 9, 12, 15, and 18 × 10−6 mol·L−1, T = 298 K, 304 K, 310 K. (a) HSA–PFNA (b) HSA–HFPO-TA (c) HSA–PFOA (d) HSA–PFO3DA (e) HSA–PFHpA (f) HSA–DFSA.

Figure A2.

Figure A2

Double-logarithm plots of HSA–PFAS system at different temperatures. C[HSA] = 1 × 10−6 mol·L−1, C[PFAS] = 0, 3, 6, 9, 12, 15, and 18 × 10−6 mol·L−1, T = 298 K, 304 K, 310 K. (a) HSA–PFNA (b) HSA–HFPO-TA (c) HSA–PFOA (d) HSA–PFO3DA (e) HSA–PFHpA (f) HSA–DFSA.

Author Contributions

M.P.: writing—original draft, methodology. Y.X.: data curation, writing—review and editing. Y.W.: software, visualization. X.C.: data curation, visualization. W.Z.: software, visualization. E.D.: visualization, writing—review and editing. L.Z.: conceptualization, visualization. J.F.: methodology, visualization. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

Thanks for the support from the Science and technology project of China Petroleum and Changzhou University Innovation Consortium (research on key supporting technologies for multi-element thermal fluid heavy oil production), the Science and Technology Program of Changzhou City (CE20225069) and carbon peak and carbon neutral technology innovation special project of Jiangsu province (BE2022426). This work was also funded by the Research and Practice Innovation Program for Graduate Students in Jiangsu Province (SJCX22_1369, KYCX22_3083, SJCX22_1373, SJCX23_1544, SJCX23_1547). We thank the High-Performance Computing Cluster System of Changzhou University (HPCCS-CCZU) for providing chemical calculation and software service.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Gao K., Zhuang T., Liu X., Fu J., Zhang J., Fu J., Wang L., Zhang A., Liang Y., Song M., et al. Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFASs) and Association between the Placental Transfer Efficiencies and Dissociation Constant of Serum Proteins–PFAS Complexes. Environ. Sci. Technol. 2019;53:6529–6538. doi: 10.1021/acs.est.9b00715. [DOI] [PubMed] [Google Scholar]
  • 2.Lu Y., Meng L., Ma D., Cao H., Liang Y., Liu H., Wang Y., Jiang G. The occurrence of PFAS in human placenta and their binding abilities to human serum albumin and organic anion transporter 4. Environ. Pollut. 2021;273:116460. doi: 10.1016/j.envpol.2021.116460. [DOI] [PubMed] [Google Scholar]
  • 3.Zhao L., Teng M., Zhao X., Li Y., Sun J., Zhao W., Ruan Y., Leung K.M.Y., Wu F. Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes. Environ. Int. 2023;175:107951. doi: 10.1016/j.envint.2023.107951. [DOI] [PubMed] [Google Scholar]
  • 4.Liu X., Fang M., Xu F., Chen D. Characterization of the binding of per- and poly-fluorinated substances to proteins: A methodological review. TrAC Trends Anal. Chem. 2019;116:177–185. doi: 10.1016/j.trac.2019.05.017. [DOI] [Google Scholar]
  • 5.Fedorenko M., Alesio J., Fedorenko A., Slitt A., Bothun G.D. Dominant entropic binding of perfluoroalkyl substances (PFASs) to albumin protein revealed by 19F NMR. Chemosphere. 2021;263:128083. doi: 10.1016/j.chemosphere.2020.128083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tian Y., Zhou Q., Zhang L., Li W., Yin S., Li F., Xu C. In utero exposure to per-/polyfluoroalkyl substances (PFASs): Preeclampsia in pregnancy and low birth weight for neonates. Chemosphere. 2023;313:137490. doi: 10.1016/j.chemosphere.2022.137490. [DOI] [PubMed] [Google Scholar]
  • 7.Chi Q., Li Z., Huang J., Ma J., Wang X. Interactions of perfluorooctanoic acid and perfluorooctanesulfonic acid with serum albumins by native mass spectrometry, fluorescence and molecular docking. Chemosphere. 2018;198:442–449. doi: 10.1016/j.chemosphere.2018.01.152. [DOI] [PubMed] [Google Scholar]
  • 8.Calore F., Guolo P.P., Wu J., Xu Q., Lu J., Marcomini A. Legacy and novel PFASs in wastewater, natural water, and drinking water: Occurrence in Western Countries vs China. Emerg. Contam. 2023;9:100228. doi: 10.1016/j.emcon.2023.100228. [DOI] [Google Scholar]
  • 9.An X., Lei H., Lu Y., Xie X., Wang P., Liao J., Liang Z., Sun B., Wu Z. Per- and polyfluoroalkyl substances (PFASs) in water and sediment from a temperate watershed in China: Occurrence, sources, and ecological risks. Sci. Total Environ. 2023;890:164207. doi: 10.1016/j.scitotenv.2023.164207. [DOI] [PubMed] [Google Scholar]
  • 10.Xu L., Chen H., Han X., Yu K., Wang Y., Du B., Zeng L. First report on per- and polyfluoroalkyl substances (PFASs) in coral communities from the Northern South China sea: Occurrence, seasonal variation, and interspecies differences. Environ. Pollut. 2022;314:120214. doi: 10.1016/j.envpol.2022.120214. [DOI] [PubMed] [Google Scholar]
  • 11.Jian J.-M., Chen D., Han F.-J., Guo Y., Zeng L., Lu X., Wang F. A short review on human exposure to and tissue distribution of per- and polyfluoroalkyl substances (PFASs) Sci. Total Environ. 2018;636:1058–1069. doi: 10.1016/j.scitotenv.2018.04.380. [DOI] [PubMed] [Google Scholar]
  • 12.Li X.-Y., Huang Z.-Y., Niu Y., Wang Z.-H., Hu L.-Y., Bai A.-M., Hu Y.-J. Synthesis of a IAP antagonist analogue and its binding investigation with BSA/HSA. J. Mol. Struct. 2022;1251:131989. doi: 10.1016/j.molstruc.2021.131989. [DOI] [Google Scholar]
  • 13.Chen H., He P., Rao H., Wang F., Liu H., Yao J. Systematic investigation of the toxic mechanism of PFOA and PFOS on bovine serum albumin by spectroscopic and molecular modeling. Chemosphere. 2015;129:217–224. doi: 10.1016/j.chemosphere.2014.11.040. [DOI] [PubMed] [Google Scholar]
  • 14.Sen P., Karn R., Kanake D.W., Emerson I.A., Khan J.M., Ahmad A. Picloram binds to the h1 and h4 helices of HSA domain IIIA at drug binding site 2. Int. J. Biol. Macromol. 2023;242:124836. doi: 10.1016/j.ijbiomac.2023.124836. [DOI] [PubMed] [Google Scholar]
  • 15.Chugh H., Kumar P., Tomar V., Kaur N., Sood D., Chandra R. Interaction of noscapine with human serum albumin (HSA): A spectroscopic and molecular modelling approach. J. Photochem. Photobiol. A Chem. 2019;372:168–176. doi: 10.1016/j.jphotochem.2018.12.001. [DOI] [Google Scholar]
  • 16.Meng X., Yu G., Luo T., Zhang R., Zhang J., Liu Y. Transcriptomics integrated with metabolomics reveals perfluorobutane sulfonate (PFBS) exposure effect during pregnancy and lactation on lipid metabolism in rat offspring. Chemosphere. 2023;341:140120. doi: 10.1016/j.chemosphere.2023.140120. [DOI] [PubMed] [Google Scholar]
  • 17.Iwata H., Kobayashi S., Itoh M., Itoh S., Mesfin Ketema R., Tamura N., Miyashita C., Yamaguchi T., Yamazaki K., Masuda H., et al. The association between prenatal per-and polyfluoroalkyl substance levels and Kawasaki disease among children of up to 4 years of age: A prospective birth cohort of the Japan Environment and Children’s Study. Environ. Int. 2023;183:108321. doi: 10.1016/j.envint.2023.108321. [DOI] [PubMed] [Google Scholar]
  • 18.Peng M., Wang Y., Wu C., Cai X., Wu Y., Du E., Zheng L., Fu J. Investigating sulfonamides—Human serum albumin interactions: A comprehensive approach using multi-spectroscopy, DFT calculations, and molecular docking. Biochem. Biophys. Res. Commun. 2023;683:149108. doi: 10.1016/j.bbrc.2023.10.040. [DOI] [PubMed] [Google Scholar]
  • 19.Negrea E., Oancea P., Leonties A., Ana Maria U., Avram S., Raducan A. Spectroscopic studies on binding of ibuprofen and drotaverine with bovine serum albumin. J. Photochem. Photobiol. A Chem. 2023;438:114512. doi: 10.1016/j.jphotochem.2022.114512. [DOI] [Google Scholar]
  • 20.Neamtu S., Mic M., Bogdan M., Turcu I. The artifactual nature of stavudine binding to human serum albumin. A fluorescence quenching and isothermal titration calorimetry study. J. Pharm. Biomed. Anal. 2013;72:134–138. doi: 10.1016/j.jpba.2012.09.023. [DOI] [PubMed] [Google Scholar]
  • 21.Miles A.J., Ramalli S.G., Wallace B.A. DichroWeb, a website for calculating protein secondary structure from circular dichroism spectroscopic data. Protein Sci. 2022;31:37–46. doi: 10.1002/pro.4153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gan N., Sun Q., Tang P., Wu D., Xie T., Zhang Y., Li H. Determination of interactions between human serum albumin and niraparib through multi-spectroscopic and computational methods. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2019;206:126–134. doi: 10.1016/j.saa.2018.07.100. [DOI] [PubMed] [Google Scholar]
  • 23.Ali M.S., Muthukumaran J., Jain M., Santos-Silva T., Al-Lohedan H.A., Al-Shuail N.S. Molecular interactions of cefoperazone with bovine serum albumin: Extensive experimental and computational investigations. J. Mol. Liq. 2021;337:116354. doi: 10.1016/j.molliq.2021.116354. [DOI] [Google Scholar]
  • 24.Frisch M., Trucks G., Schlegel H., Scuseria G., Robb M., Cheeseman J., Scalmani G., Barone V., Petersson G., Nakatsuji H. Gaussian 16 Rev. C. 01. Gaussian, Inc.; Wallingford, CT, USA: 2016. [Google Scholar]
  • 25.Fu W., Xia G.-J., Zhang Y., Hu J., Wang Y.-G., Li J., Li X., Li B. Using general computational chemistry strategy to unravel the reactivity of emerging pollutants: An example of sulfonamide chlorination. Water Res. 2021;202:117391. doi: 10.1016/j.watres.2021.117391. [DOI] [PubMed] [Google Scholar]
  • 26.Wen J., Li L., Yuan L., Li J., Ning P. Insight into the weak interaction between organic primary amine and propionic acid or phenol solvents in solvent extraction. J. Mol. Liq. 2022;367:120524. doi: 10.1016/j.molliq.2022.120524. [DOI] [Google Scholar]
  • 27.Sahoo D.K., Dasgupta S., Kistwal T., Datta A. Fluorescence monitoring of binding of a Zn (II) complex of a Schiff base with human serum albumin. Int. J. Biol. Macromol. 2023;226:1515–1522. doi: 10.1016/j.ijbiomac.2022.11.263. [DOI] [PubMed] [Google Scholar]
  • 28.Lu T., Chen F. Multiwfn: A multifunctional wavefunction analyzer. J. Comput. Chem. 2012;33:580–592. doi: 10.1002/jcc.22885. [DOI] [PubMed] [Google Scholar]
  • 29.Humphrey W., Dalke A., Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]
  • 30.Radha A., Singh A., Sharma L., Thakur K.K. Molecular interactions of acebutolol hydrochloride to human serum albumin: A combined calorimetric, spectroscopic and molecular modelling approach. Mater. Today Proc. 2021;44:1700–1706. doi: 10.1016/j.matpr.2020.11.872. [DOI] [Google Scholar]
  • 31.Eberhardt J., Santos-Martins D., Tillack A.F., Forli S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J. Chem. Inf. Model. 2021;61:3891–3898. doi: 10.1021/acs.jcim.1c00203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455–461. doi: 10.1002/jcc.21334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Schrödinger, Inc. The AxPyMOL Molecular Graphics Plugin for Microsoft PowerPoint, Version 1.8. Schrödinger, Inc.; New York, NY, USA: 2015. [Google Scholar]
  • 34.Salomon-Ferrer R., Case D.A., Walker R.C. An overview of the Amber biomolecular simulation package. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2013;3:198–210. doi: 10.1002/wcms.1121. [DOI] [Google Scholar]
  • 35.Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157–1174. doi: 10.1002/jcc.20035. [DOI] [PubMed] [Google Scholar]
  • 36.Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696–3713. doi: 10.1021/acs.jctc.5b00255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mark P., Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J. Phys. Chem. A. 2001;105:9954–9960. doi: 10.1021/jp003020w. [DOI] [Google Scholar]
  • 38.Sagui C., Darden T.A. Molecular dynamics simulations of biomolecules: Long-range electrostatic effects. Annu. Rev. Biophys. Biomol. Struct. 1999;28:155–179. doi: 10.1146/annurev.biophys.28.1.155. [DOI] [PubMed] [Google Scholar]
  • 39.Kräutler V., Van Gunsteren W.F., Hünenberger P.H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 2001;22:501–508. doi: 10.1002/1096-987X(20010415)22:5&#x0003c;501::AID-JCC1021&#x0003e;3.0.CO;2-V. [DOI] [Google Scholar]
  • 40.Larini L., Mannella R., Leporini D. Langevin stabilization of molecular-dynamics simulations of polymers by means of quasisymplectic algorithms. J. Chem. Phys. 2007;126:104101. doi: 10.1063/1.2464095. [DOI] [PubMed] [Google Scholar]
  • 41.Hou T., Wang J., Li Y., Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J. Chem. Inf. Model. 2011;51:69–82. doi: 10.1021/ci100275a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Genheden S., Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 2015;10:449–461. doi: 10.1517/17460441.2015.1032936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rastelli G., Rio A.D., Degliesposti G., Sgobba M. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J. Comput. Chem. 2010;31:797–810. doi: 10.1002/jcc.21372. [DOI] [PubMed] [Google Scholar]
  • 44.Chen Y., Zheng Y., Fong P., Mao S., Wang Q. The application of the MM/GBSA method in the binding pose prediction of FGFR inhibitors. Phys. Chem. Chem. Phys. 2020;22:9656–9663. doi: 10.1039/D0CP00831A. [DOI] [PubMed] [Google Scholar]
  • 45.Nguyen H., Roe D.R., Simmerling C. Improved Generalized Born Solvent Model Parameters for Protein Simulations. J. Chem. Theory Comput. 2013;9:2020–2034. doi: 10.1021/ct3010485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Weiser J., Shenkin P.S., Still W.C. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) J. Comput. Chem. 1999;20:217–230. doi: 10.1002/(SICI)1096-987X(19990130)20:2&#x0003c;217::AID-JCC4&#x0003e;3.0.CO;2-A. [DOI] [Google Scholar]
  • 47.Bagheri M., Fatemi M.H. Fluorescence spectroscopy, molecular docking and molecular dynamic simulation studies of HSA-Aflatoxin B1 and G1 interactions. J. Lumin. 2018;202:345–353. doi: 10.1016/j.jlumin.2018.05.066. [DOI] [Google Scholar]
  • 48.Rostamnezhad F., Hossein Fatemi M. Comprehensive investigation of binding of some polycyclic aromatic hydrocarbons with bovine serum albumin: Spectroscopic and molecular docking studies. Bioorg. Chem. 2022;120:105656. doi: 10.1016/j.bioorg.2022.105656. [DOI] [PubMed] [Google Scholar]
  • 49.Li W., Chen S., Hong X., Fang M., Zong W., Li X., Wang J. The molecular interaction of three haloacetic acids with bovine serum albumin and the underlying mechanisms. J. Mol. Liq. 2023;370:120976. doi: 10.1016/j.molliq.2022.120976. [DOI] [Google Scholar]
  • 50.Gu J., Huang X., Liu H., Dong D., Sun X. A mutispectroscopic study on the structure–affinity relationship of the interactions of bisphenol analogues with bovine serum albumin. Chemosphere. 2022;291:132769. doi: 10.1016/j.chemosphere.2021.132769. [DOI] [PubMed] [Google Scholar]
  • 51.Chang S., Qin D., Wang L., Zhang M., Yan R., Zhao C. Preparation of novel cinnamaldehyde derivative–BSA nanoparticles with high stability, good cell penetrating ability, and promising anticancer activity. Colloids Surf. A Physicochem. Eng. Asp. 2021;624:126765. doi: 10.1016/j.colsurfa.2021.126765. [DOI] [Google Scholar]
  • 52.Ovung A., Bhattacharyya J. Binding effects of antibiotic drug sulfamethazine on the serum albumins: Multi-spectroscopic and computation approach. Chem. Phys. Impact. 2022;5:100087. doi: 10.1016/j.chphi.2022.100087. [DOI] [Google Scholar]
  • 53.Zhu M., Pang X., Wan J., Xu X., Wei X., Hua R., Zhang X., Wang Y., Yang X. Potential toxic effects of sulfonamides antibiotics: Molecular modeling, multiple-spectroscopy techniques and density functional theory calculations. Ecotoxicol. Environ. Saf. 2022;243:113979. doi: 10.1016/j.ecoenv.2022.113979. [DOI] [PubMed] [Google Scholar]
  • 54.Farajzadeh-Dehkordi N., Farhadian S., Zahraei Z., Gholamian-Dehkordi N., Shareghi B. Interaction of reactive Red195 with human serum albumin: Determination of the binding mechanism and binding site by spectroscopic and molecular modeling methods. J. Mol. Liq. 2021;327:114835. doi: 10.1016/j.molliq.2020.114835. [DOI] [Google Scholar]
  • 55.Ansari A. Decoding the binding interaction of steroidal pyridines with bovine serum albumin using spectroscopic and molecular docking techniques. Steroids. 2023;192:109156. doi: 10.1016/j.steroids.2022.109156. [DOI] [PubMed] [Google Scholar]
  • 56.Liu T., Liu M., Guo Q., Liu Y., Zhao Y., Wu Y., Sun B., Wang Q., Liu J., Han J. Investigation of binary and ternary systems of human serum albumin with oxyresveratrol/piceatannol and/or mitoxantrone by multipectroscopy, molecular docking and cytotoxicity evaluation. J. Mol. Liq. 2020;311:113364. doi: 10.1016/j.molliq.2020.113364. [DOI] [Google Scholar]
  • 57.Ouaket A., Chraka A., Raissouni I., Amrani M.A.E., Berrada M., Knouzi N. Synthesis, spectroscopic (13C/1H-NMR, FT-IR) investigations, quantum chemical modelling (FMO, MEP, NBO analysis), and antioxidant activity of the bis-benzimidazole molecule. J. Mol. Struct. 2022;1259:132729. doi: 10.1016/j.molstruc.2022.132729. [DOI] [Google Scholar]
  • 58.Zhang C., Liu Y., Song F., Wang J. Inter-/intra-molecular interactions, preferential solvation, and dissolution and transfer property for tirofiban in aqueous co-solvent mixtures. J. Mol. Liq. 2022;361:119665. doi: 10.1016/j.molliq.2022.119665. [DOI] [Google Scholar]
  • 59.Mishma J.N.C., Jothy V.B., Irfan A., Narayana B., Muthu S. Role of solvents in molecular level interaction, reactivity and spectral characterisation of 2-Amino-3-(((E)-4-(dimethylamino)benzylidene)amino) maleonitrile: Anti depressant agent. J. Mol. Liq. 2023;389:122937. doi: 10.1016/j.molliq.2023.122937. [DOI] [Google Scholar]
  • 60.Jeba Reeda V.S., Bena Jothy V. Vibrational spectroscopic, quantum computational (DFT), reactivity (ELF, LOL and Fukui), molecular docking studies and molecular dynamic simulation on (6-methoxy-2-oxo-2H-chromen-4-yl) methyl morpholine-4-carbodithioate. J. Mol. Liq. 2023;371:121147. doi: 10.1016/j.molliq.2022.121147. [DOI] [Google Scholar]
  • 61.Radder S.B., Melavanki R., Radder U., Hiremath S.M., Kusanur R., Khemalapure S.S. Synthesis, spectroscopic (FT-IR, FT-Raman, NMR), reactivity (ELF, LOL and Fukui) and docking studies on 3-(2-hydroxy-3-methoxy-phenyl)-1-(3-nitro-phenyl)-propenone by experimental and DFT methods. J. Mol. Struct. 2022;1255:132443. doi: 10.1016/j.molstruc.2022.132443. [DOI] [Google Scholar]
  • 62.Bharathy G., Christian Prasana J., Muthu S., Irfan A., Basha Asif F., Saral A., Aayisha S., Niranjana Devi R. Evaluation of electronic and biological interactions between N-[4-(Ethylsulfamoyl)phenyl]acetamide and some polar liquids (IEFPCM solvation model) with Fukui function and molecular docking analysis. J. Mol. Liq. 2021;340:117271. doi: 10.1016/j.molliq.2021.117271. [DOI] [Google Scholar]
  • 63.Arulaabaranam K., Muthu S., Mani G., Ben Geoffrey A.S. Speculative assessment, molecular composition, PDOS, topology exploration (ELF, LOL, RDG), ligand-protein interactions, on 5-bromo-3-nitropyridine-2-carbonitrile. Heliyon. 2021;7:e07061. doi: 10.1016/j.heliyon.2021.e07061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Steffy A.D., Dhas D.A., Joe I.H., Balachandran S. Theoretical investigations on structural, spectral, NBO, NLO and topology exploration (AIM, ELF, LOL, RDG) of piperazine-2,5-dione oxalic acid monohydrate. J. Mol. Struct. 2024;1295:136653. doi: 10.1016/j.molstruc.2023.136653. [DOI] [Google Scholar]
  • 65.Sagaama A., Issaoui N., Al-Dossary O., Kazachenko A.S., Wojcik M.J. Non covalent interactions and molecular docking studies on morphine compound. J. King Saud Univ. -Sci. 2021;33:101606. doi: 10.1016/j.jksus.2021.101606. [DOI] [Google Scholar]
  • 66.Lu T., Chen Q. Interaction region indicator: A simple real space function clearly revealing both chemical bonds and weak interactions. Chemistry-Methods. 2021;1:231–239. doi: 10.1002/cmtd.202100007. [DOI] [Google Scholar]
  • 67.Islam M.M., Sonu V.K., Gashnga P.M., Moyon N.S., Mitra S. Caffeine and sulfadiazine interact differently with human serum albumin: A combined fluorescence and molecular docking study. Spectrochim. Acta Part A. 2016;152:23–33. doi: 10.1016/j.saa.2015.07.051. [DOI] [PubMed] [Google Scholar]
  • 68.Zhang S., Gan R., Zhao L., Sun Q., Xiang H., Xiang X., Zhao G., Li H. Unveiling the interaction mechanism of alogliptin benzoate with human serum albumin: Insights from spectroscopy, microcalorimetry, and molecular docking and molecular dynamics analyses. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2021;246:119040. doi: 10.1016/j.saa.2020.119040. [DOI] [PubMed] [Google Scholar]
  • 69.Zhan F., Ding S., Xie W., Zhu X., Hu J., Gao J., Li B., Chen Y. Towards understanding the interaction of β-lactoglobulin with capsaicin: Multi-spectroscopic, thermodynamic, molecular docking and molecular dynamics simulation approaches. Food Hydrocoll. 2020;105:105767. doi: 10.1016/j.foodhyd.2020.105767. [DOI] [Google Scholar]
  • 70.Kharazian B., Ahmad A.A., Mabudi A. A molecular dynamics study on the binding of gemcitabine to human serum albumin. J. Mol. Liq. 2021;337:116496. doi: 10.1016/j.molliq.2021.116496. [DOI] [Google Scholar]
  • 71.Cao J., Li L., Xiong L., Wang C., Chen Y., Zhang X. Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking. Phytomed. Plus. 2022;2:100252. doi: 10.1016/j.phyplu.2022.100252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Weatherly L.M., Shane H.L., Lukomska E., Baur R., Anderson S.E. Systemic toxicity induced by topical application of perfluoroheptanoic acid (PFHpA), perfluorohexanoic acid (PFHxA), and perfluoropentanoic acid (PFPeA) in a murine model. Food Chem. Toxicol. 2023;171:113515. doi: 10.1016/j.fct.2022.113515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Smeltz M., Wambaugh J.F., Wetmore B.A. Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment. Chem. Res. Toxicol. 2023;36:870–881. doi: 10.1021/acs.chemrestox.3c00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Starnes H.M., Jackson T.W., Rock K.D., Belcher S.M. Quantitative Cross-Species Comparison of Serum Albumin Binding of Per- and Polyfluoroalkyl Substances from Five Structural Classes. bioRxiv. 2023;14 doi: 10.1101/2023.11.10.566613. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data is contained within the article.


Articles from Toxics are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES